hospital,time,event,cases.case_id,cases.days_to_consent,demographic.age_at_index,demographic.days_to_birth,diagnoses.age_at_diagnosis,diagnoses.days_to_diagnosis,demographic.days_to_death,diagnoses.days_to_last_follow_up,project.project_id,cases.consent_type,cases.disease_type,cases.index_date,cases.primary_site,cases.submitter_id,demographic.age_is_obfuscated,demographic.country_of_residence_at_enrollment,demographic.demographic_id,demographic.ethnicity,demographic.gender,demographic.race,demographic.submitter_id,demographic.vital_status,diagnoses.classification_of_tumor,diagnoses.diagnosis_id,diagnoses.diagnosis_is_primary_disease,diagnoses.morphology,diagnoses.primary_diagnosis,diagnoses.prior_treatment,diagnoses.site_of_resection_or_biopsy,diagnoses.submitter_id,diagnoses.tissue_or_organ_of_origin,treatments.submitter_id,treatments.treatment_id,treatments.treatment_or_therapy,treatments.treatment_type,had_pharmaceutical,had_radiation,had_chemotherapy,had_immunotherapy,had_surgery,had_targeted_therapy,had_hormone_therapy,tumor_origin,MAPK_Score,CellCycle_Score,TumorSuppressor_Score,Differentiation_Score,AntigenPresentation_Score,ImmuneCheckpoint_Score,RTK_PI3K_Score,Metabolic_Score,WNT_Score,Migration_Score
D3,422.0,1.0,0153f141-625e-4623-9f8a-296678002c63,187.0,70.0,-25643.0,26029.0,386.0,422.0,422.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A3ML,False,United States,ca027566-a9f1-5603-8d9d-40f3694cddb8,not hispanic or latino,male,white,TCGA-D3-A3ML_demographic,Dead,metastasis,0a102aff-0832-4b0b-a7a7-6a61a4b835a2,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A3ML_diagnosis7,Not Reported,TCGA-D3-A3ML_treatment23,719116f5-9715-466f-9cc6-9db30f6ab0bb,yes,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,-0.3915542516223481,0.1502626891485785,0.0558744319041314,-0.0236468275349771,-0.888762807750183,-1.76470113140073,0.3041187805115711,-0.5557731753255913,0.8250165377504061,0.4235665752351842
EE,420.0,1.0,015ba831-106b-4b84-9e8c-243a9eeeebf6,89.0,48.0,-17731.0,18064.0,333.0,420.0,420.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A3AF,False,Australia,2af67b87-b7a2-5c98-a746-20e5cecd182a,not hispanic or latino,female,white,TCGA-EE-A3AF_demographic,Dead,Progression,09325ad6-b363-5771-b86e-d5961b852dd5,True,8720/3,"Malignant melanoma, NOS",No,"Lymph nodes of head, face and neck",TCGA-EE-A3AF_diagnosis,"Skin, NOS",TCGA-EE-A3AF_treatment5,0fc05773-9c0a-41f7-92fd-2cfe4f068515,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.4800888900373558,-0.0195833030485085,-0.1565343874992288,0.4633856974086859,0.3627455380384128,-0.1729493076115633,-0.4400543282686002,0.2587143984267407,1.6322748706353658,-0.1796757653331394
DA,5370.0,1.0,01ad975d-c2ed-4e4d-bd3b-c9512fc9073c,,45.0,-16701.0,22006.0,5305.0,5370.0,5370.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-DA-A1I2,False,United States,1b1e6105-998a-54eb-be77-8e642db5678c,not hispanic or latino,male,white,TCGA-DA-A1I2_demographic,Dead,Progression,110ca7cf-dd11-4973-a960-bce441312fe2,True,8720/3,"Malignant melanoma, NOS",No,"Lymph node, NOS",TCGA-DA-A1I2_diagnosis2,"Skin, NOS",TCGA-DA-A1I2_treatment4,5f92b2fc-6074-49fa-b4c5-73dbb8f9bc3b,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.6462592472684442,-0.3260875639037169,1.1001074501288302,0.0826841880503981,1.1661170927921232,-0.1088994849949964,0.1810017426200915,-1.0311544683716456,-0.0528128496250727,-0.1677469320034165
EE,787.0,1.0,01cb0004-fc1e-4da5-9d27-f458f8d711ee,15.0,85.0,-31092.0,31805.0,713.0,787.0,787.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EE-A29V,False,Australia,c1181625-8f34-5a23-80c1-dee517604a3e,not hispanic or latino,male,white,TCGA-EE-A29V_demographic,Dead,metastasis,22f55c18-68a4-4369-8feb-4874584a34b0,True,8720/3,"Malignant melanoma, NOS",No,Skin of trunk,TCGA-EE-A29V_diagnosis2,"Skin, NOS",TCGA-EE-A29V_treatment5,122ba013-d85a-471c-b226-707b34eb6040,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.526063744563572,0.0468802459872281,-1.3614202627724874,0.4753453114783406,-0.8384151677402886,-0.8372380032727875,-0.4179335760822925,1.2464207378641314,0.6934236473637932,0.7045895221392973
EE,6590.0,1.0,01cfbfae-f344-439d-aeab-a9e15d636325,4622.0,35.0,-13140.0,19665.0,6525.0,6590.0,6590.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2ML,False,Australia,ad888cc2-74d3-514b-b2a4-3f460cd66126,not hispanic or latino,male,white,TCGA-EE-A2ML_demographic,Dead,metastasis,13eea9d4-10b7-444a-88be-c64bcdc8665c,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A2ML_diagnosis12,"Peritoneum, NOS",TCGA-EE-A2ML_treatment32,1cc283e7-697c-4282-8a88-576dd05168ae,yes,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2305139354484549,-0.3148003880455162,0.6534459311243465,0.163475928487875,0.7410582479084926,0.5691431380222582,0.0796528569840192,0.7267644408089478,0.987353253855662,-1.597483957527448
ER,4533.0,0.0,021a9431-7fdc-42b8-9ff0-e17ded79ff1d,3828.0,49.0,-17984.0,21796.0,3812.0,,4533.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Adrenal gland,TCGA-ER-A42L,False,United States,2c41ba35-d58c-5dbe-abc2-cafde484483c,not hispanic or latino,male,white,TCGA-ER-A42L_demographic,Alive,primary,5a0dd004-1e07-459e-b551-0ed8883ad7a5,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-ER-A42L_diagnosis3,"Skin, NOS",TCGA-ER-A42L_treatment3,cac95095-4eb2-4f72-b166-a73bfb1a9ace,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2374183311425251,-0.4088778365157815,-0.2748173765228483,-0.255937433535244,-0.1072210525711941,0.781531103387572,0.7614782826758372,3.349914678336749,-0.2449617603665867,0.1135683196216173
HR,7.0,0.0,021d32b0-a94a-4dad-95f4-8eb0abd894bf,7.0,59.0,-21767.0,21767.0,0.0,,7.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-HR-A2OG,False,Canada,322cc4eb-62ca-5f56-a46e-087f083d5a6b,not reported,female,not reported,TCGA-HR-A2OG_demographic,Alive,metastasis,20f1d89c-b104-58d1-88bc-45f53fd9f269,True,8720/3,"Malignant melanoma, NOS",No,Skin of upper limb and shoulder,TCGA-HR-A2OG_diagnosis,"Skin, NOS",TCGA-HR-A2OG_treatment2,0480426e-c57f-4bdb-9aa5-dfc93982e862,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.3748453654549002,-0.4158457058180902,0.3102411683120196,-0.3366698678632228,0.4652999500685728,0.4922547986831169,-0.0916455440117187,-0.0059293755369103,0.4204557402255431,-1.7078154471925422
XV,403.0,0.0,04add7f0-d212-486e-ae70-d41d8112f523,3.0,54.0,-20058.0,20058.0,0.0,,403.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-XV-AB01,False,Russia,c0413f73-76fa-5ab9-9f8e-5b2fb5d250ec,not hispanic or latino,female,white,TCGA-XV-AB01_demographic,Alive,primary,27047958-28f0-4c1e-933d-054b1017b4f9,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-XV-AB01_diagnosis2,"Skin, NOS",TCGA-XV-AB01_treatment3,d24a66fd-9be6-45b3-a446-831a3ef60669,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.2313442507004526,-0.0938268479024314,-0.0620236292252343,0.3773949183668698,0.3177575397878017,-0.6126734077325781,-1.3931795486121203,-4.455998528493296,-0.7722649529954229,-0.1517325552242533
FW,411.0,0.0,04c3d01d-a949-4dc7-9829-a8c99180dba0,5.0,57.0,-20972.0,21111.0,139.0,,411.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FW-A3TV,False,United States,2b04520b-58ed-54c4-b498-623e6c4f16fd,not hispanic or latino,female,white,TCGA-FW-A3TV_demographic,Alive,Progression,aef03f51-e38a-5fbd-90ce-741b2dd3b05c,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-FW-A3TV_diagnosis,"Skin, NOS",TCGA-FW-A3TV_treatment3,02d22d29-611f-4f85-9950-a9be05c5a788,unknown,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0778563104658782,0.0563524186595296,0.2326541326671002,0.6025985082476594,0.0546884626956272,-0.1110986825144254,0.3939610321212396,0.5385956737701543,0.2097906617216647,-0.9899719347521868
D3,2010.0,0.0,04f7ecc8-4f6b-41ac-a984-9ea604698a21,94.0,50.0,-18577.0,20587.0,2010.0,,2010.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-D3-A2JO,False,United States,6ca2c91a-9fd5-5bf8-8c48-d01e1f3d1d37,not hispanic or latino,female,white,TCGA-D3-A2JO_demographic,Alive,not reported,238c8ae2-613c-521b-af6b-1466fd7c9b50,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-D3-A2JO_diagnosis,"Skin, NOS",TCGA-D3-A2JO_treatment2,3ae52cec-116b-4fc8-8824-c34bfedc7ce0,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.1192866867002216,0.2595569374776319,-0.5361419994658544,0.1823496281600207,-0.138694937270003,0.9700234748109068,-0.0370314053400684,1.7383332824071027,0.5032544526723429,0.0392909390303327
EB,472.0,1.0,05f4058d-3066-4d16-8320-cf92f122945f,2.0,56.0,-20698.0,20698.0,0.0,472.0,472.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A57M,False,Vietnam,c29f66f3-b3c6-590f-85ae-c7432d56a60a,not hispanic or latino,male,asian,TCGA-EB-A57M_demographic,Dead,primary,2f511d1d-043d-4ae1-91af-7fcafd18d48f,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A57M_diagnosis2,"Skin, NOS",TCGA-EB-A57M_treatment10,609ab6fc-cc44-4c6a-bd06-2d9ab4c4928c,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.4394912114750262,-0.4706096202057672,0.3975557823148925,0.2077590581973563,-0.2891005997984374,-0.6135636151880296,-0.0644765040301661,-0.3217481541344865,-0.6300747590467022,0.5262479902649192
EE,423.0,1.0,06f09d1c-ba44-4cf9-a518-762d241a30db,10.0,80.0,-29501.0,29759.0,258.0,423.0,423.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2GP,False,Australia,7fe9ad14-80fe-511a-a9b6-d20db8dea588,not hispanic or latino,male,white,TCGA-EE-A2GP_demographic,Dead,Progression,0c48b97f-dfe4-4e59-93b9-9b66a1d4b96d,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-EE-A2GP_diagnosis2,"Skin, NOS",TCGA-EE-A2GP_treatment4,7d1b6a51-8b97-4ba8-8f98-7cea0276bab1,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.7039161022810572,-0.1762215733904338,0.2812449004381551,0.2489820175905693,-0.7945104805611488,-0.1847774464945087,0.6882427069689928,-0.0937606334900821,0.7858880322903159,-0.1536682930704557
EE,1446.0,1.0,0797caaf-18ad-41c6-820a-e96554d14b31,,58.0,-21202.0,22561.0,1359.0,1446.0,1446.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2MN,False,Australia,dab8d630-1e5f-502c-b545-fe1cb6eb6656,not hispanic or latino,male,white,TCGA-EE-A2MN_demographic,Dead,metastasis,09ed6bf9-ad17-40cb-a5e2-99d1bbb11feb,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A2MN_diagnosis12,"Thorax, NOS",TCGA-EE-A2MN_treatment35,5b70201f-6439-4cc7-ad80-bf5108552b91,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.1387122917659409,-0.3456543744576227,0.3968722539221778,0.4979660595516303,1.2069801573314864,0.4695928113323088,0.248953160785518,-0.371773158664281,0.0437274212868767,0.9662166220651048
EB,214.0,0.0,080bb1f8-f20c-4daa-9de3-b5782b69583c,192.0,74.0,-27364.0,27562.0,198.0,,214.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EB-A5VV,False,Ukraine,615369e3-6e6e-5dc3-8b81-289296f04ef6,not hispanic or latino,female,white,TCGA-EB-A5VV_demographic,Alive,primary,23786bd0-0fd8-565b-9f61-85aa17b311ba,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-EB-A5VV_diagnosis,"Skin, NOS",TCGA-EB-A5VV_treatment2,8fe79152-a1ae-4feb-b74d-cc9d7a5dc445,unknown,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0819540329670165,-1.357118183785962,0.8449558028761656,-3.134291309685841,0.77216188488211,1.1885070358012004,-0.0580161976365684,-1.4141045030479986,-2.020883511159377,-0.2134366152366864
GN,317.0,1.0,088c296e-8e13-4dc8-8a99-b27f4b27f95e,20.0,56.0,-20458.0,20641.0,183.0,317.0,317.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-GN-A4U7,False,United States,b1c47164-8622-5a7b-a0b5-ced019a69be3,not hispanic or latino,female,white,TCGA-GN-A4U7_demographic,Dead,Progression,31deaa5f-77db-4e7a-ac85-1b11c004c335,True,8720/3,"Malignant melanoma, NOS",No,Pelvic lymph nodes,TCGA-GN-A4U7_diagnosis2,"Skin, NOS",TCGA-GN-A4U7_treatment5,5848504d-bb16-4026-9cb3-f9dd9f48102f,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.1818865430098369,0.7467531057695376,-0.8847949343263773,0.6660245365847121,-1.2907945325996044,-0.3898695191168868,-0.923071963189171,2.1089208159640247,0.2988778839745482,0.9380876625071416
GN,467.0,1.0,08d2b181-2b6e-4754-bfa9-5a94a1f18526,8.0,24.0,-8952.0,8991.0,39.0,467.0,467.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-GN-A263,False,United States,857367b8-5c03-5e5f-b6b6-ebb9dd4b5bc0,not hispanic or latino,male,white,TCGA-GN-A263_demographic,Dead,primary,7095cf11-59af-4a40-8273-38727867ca89,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-GN-A263_diagnosis2,"Skin, NOS",TCGA-GN-A263_treatment3,37e89af9-6fb7-4f2d-89e5-a0346b75103f,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.0783287693451269,0.4753473058069958,0.0948238875827931,0.456654963852802,0.0215423271708935,-0.3402676873764178,-0.0445868323081351,2.7358146227296283,0.7198586793264142,1.4752175188064425
EE,2051.0,0.0,0a4b780e-8143-4118-ad98-fd2a2a6678c3,20.0,82.0,-30084.0,31092.0,1008.0,,2051.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2GC,False,Australia,160231e4-6aa2-56df-b8a4-1ce98992f01f,not hispanic or latino,male,white,TCGA-EE-A2GC_demographic,Alive,not reported,48e51b56-443a-54a8-be6d-c8004e28f948,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-EE-A2GC_diagnosis,"Skin, NOS",TCGA-EE-A2GC_treatment2,77cbb46d-754d-4425-a822-5ba963b2dcdc,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.1610269449587701,-0.2128228762730625,0.1787504268294086,0.6048047832998735,0.8474214628422024,1.1879212000013644,0.6302364546430904,-0.6459044334870293,1.317849380331067,0.2988587539166378
D9,1663.0,0.0,0b1f4f52-12ec-44ab-8283-a502bdf48c3a,1074.0,65.0,-23779.0,25069.0,1290.0,,1663.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-D9-A149,False,Poland,ab887da3-24ef-5d75-86aa-b251b0e25691,not hispanic or latino,female,white,TCGA-D9-A149_demographic,Alive,Subsequent Primary,0d055943-e88e-43db-a16a-b475f9eede2a,False,8720/3,"Melanoma, NOS",Yes,Not Reported,TCGA-D9-A149_diagnosis4,Not Reported,TCGA-D9-A149_treatment5,94f39b59-103b-48d5-b40d-ecaaff2db666,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,1.177944140696014,0.3355708247492757,0.6135267319087064,0.4404283500670511,0.8385856230135613,0.3521360495918813,-0.3473779007168049,0.2030831433892971,0.0603803268844752,-0.4765219658384907
ER,802.0,1.0,0bb8c284-412b-4bbc-a508-d0a21db376cd,552.0,82.0,-30176.0,30640.0,464.0,802.0,802.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-ER-A19F,False,United States,d8ece416-5a4e-50ca-acfb-1170699e7f78,not hispanic or latino,male,white,TCGA-ER-A19F_demographic,Dead,primary,6105966d-e52e-4499-afb9-c38f8647ccc1,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-ER-A19F_diagnosis3,"Skin, NOS",TCGA-ER-A19F_treatment3,432a37e8-7a44-4c83-b267-8fa9fbd93f5c,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.0982995177410692,-0.1533131271752494,0.6446511217739077,0.6711062661111699,-1.1898252870760473,-0.6971913319556396,-0.1149005693719618,0.5444894243038384,1.07131650515544,-1.2990956490011547
FS,1035.0,0.0,0caa706a-251f-43a0-897a-111aec0acc82,8.0,80.0,-29324.0,30020.0,696.0,,1035.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A4F9,False,Germany,f633a12b-ef0a-53d2-a8fa-5c9b3cfecfa3,not hispanic or latino,male,white,TCGA-FS-A4F9_demographic,Alive,metastasis,7085a4bb-adb4-4e3d-999b-fef511772aac,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-FS-A4F9_diagnosis4,"Skin, NOS",TCGA-FS-A4F9_treatment7,42ebd50e-3947-4d48-a490-d3e5cf5aa4d1,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.13224124855662,0.4017955650008823,-1.5555082116763312,0.2143341955330212,-0.1593877380296236,-0.3795959034713458,0.1155402329040508,-0.0328106279710222,-0.2177115512068824,-0.746261971171849
EE,1044.0,1.0,0d68acef-b6a0-4a8b-9088-15b9103e6aaf,543.0,59.0,-21688.0,22723.0,1035.0,1044.0,1044.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A3J8,False,Australia,4263a665-fc6a-5df9-9009-745375d459c0,not hispanic or latino,male,white,TCGA-EE-A3J8_demographic,Dead,Progression,00fb2595-a8b2-40f9-bb96-beea203d434b,True,8720/3,"Malignant melanoma, NOS",No,"Connective, subcutaneous and other soft tissues of thorax",TCGA-EE-A3J8_diagnosis2,"Skin, NOS",TCGA-EE-A3J8_treatment4,28183901-9f1d-4730-a552-44d5795ce036,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,1.2018434770994122,0.128784509013256,0.9759943077020627,-0.2124967035781827,-2.587362583495994,-1.4207084909263454,0.5201990247290673,-0.8642607032593176,0.4492198498941226,1.9831954417843012
EE,1620.0,0.0,0dcd7af7-ea83-4131-821d-a17943919c1a,1467.0,71.0,-26237.0,27688.0,1451.0,,1620.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A2MU,False,Australia,55c43e0c-12e0-5d4b-83e2-e2e510c07199,not hispanic or latino,male,white,TCGA-EE-A2MU_demographic,Alive,not reported,40992a30-a507-557c-a9ae-26c6bb79786f,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-EE-A2MU_diagnosis,"Skin, NOS",TCGA-EE-A2MU_treatment,3aedc7a7-99ae-5573-b9e7-ec2010c9aaee,yes,"Radiation, External Beam",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0943105585995005,-0.5116188336761462,-0.248647154204586,0.407945915686705,1.216971666689226,1.2476699280257442,-0.326561965636286,1.0644332213850547,0.7690022189221222,-0.0479441005626413
EE,8174.0,1.0,0e2af161-5a1e-47e1-a7ef-010e47b8cb40,,39.0,-14312.0,22438.0,8126.0,8174.0,8174.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2MF,False,Australia,a1413795-b38f-5a13-b374-803bfd4f51ef,not hispanic or latino,female,white,TCGA-EE-A2MF_demographic,Dead,primary,143129dc-10db-4fe9-8f11-7c00f630636b,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A2MF_diagnosis3,"Skin, NOS",TCGA-EE-A2MF_treatment3,8d37ff76-83c0-410e-9386-f55030ee6d4b,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0266359537469151,-0.4478737571154176,-0.4384473046375285,0.6851387105772002,0.5609992304610766,-0.1466798981161934,0.4863053861977434,0.6382144327906919,-0.4337335084344636,-0.4480363326874204
D3,3151.0,0.0,0e597498-44ad-40ae-bb83-f1b27388ec0a,2724.0,42.0,-15695.0,18803.0,3108.0,,3151.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-D3-A3MR,False,United States,0122c1aa-b9b0-5d51-aaf8-9ec58c8a5c63,not hispanic or latino,male,white,TCGA-D3-A3MR_demographic,Alive,Progression,a27dfca7-7257-52b8-a1f0-84bf214e6280,True,8720/3,"Malignant melanoma, NOS",No,"Connective, subcutaneous and other soft tissues, NOS",TCGA-D3-A3MR_diagnosis,"Skin, NOS",TCGA-D3-A3MR_treatment,145135b3-c87c-52fa-9116-93d531f876cf,yes,"Radiation, External Beam",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.2483951225709351,-0.2876566618818945,0.0777892488051007,0.002652149577167,0.7982280295046555,0.9253679057370124,0.0402493716874871,-1.1237294767543686,-1.0384785347863947,0.0872773582024931
EB,619.0,1.0,0eb0b477-1c7a-4416-895a-ea6463dbe847,536.0,55.0,-20424.0,20963.0,539.0,619.0,619.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EB-A5KH,False,Vietnam,aebde2be-038f-5fc1-ab82-d8d7c234ab10,not hispanic or latino,male,asian,TCGA-EB-A5KH_demographic,Dead,primary,560be382-16ba-576f-8fb8-9f2d1a2175af,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-EB-A5KH_diagnosis,"Skin, NOS",TCGA-EB-A5KH_treatment5,1f90b882-b6bd-4fbc-b27c-ae1d02d70b64,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.6328295534755078,-0.7698228753122127,-0.3315275462354116,0.5877926535748577,-2.068726561091952,-1.5585899594596746,-0.8869219010643234,-1.189423232702977,0.1583180444199982,0.3244815182051768
EE,875.0,1.0,0f1fb775-c4a2-4a1e-8b09-f935233cdaee,15.0,50.0,-18491.0,19139.0,648.0,875.0,875.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A3AD,False,Australia,ebef1eea-82ab-5ccb-9aea-f65a6f4496cb,not hispanic or latino,male,white,TCGA-EE-A3AD_demographic,Dead,Progression,5049fe04-3f58-50cc-8acc-64e87e213b9a,True,8720/3,"Malignant melanoma, NOS",No,"Lymph nodes of head, face and neck",TCGA-EE-A3AD_diagnosis,"Skin, NOS",TCGA-EE-A3AD_treatment3,0b07fbe5-e79b-4436-a0da-ac1bb44a8f58,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2336563243305784,0.2486016426662641,0.5658075650543747,0.3711395344028744,0.3917317553901343,-1.5057843747330064,0.0410873029731862,0.3719894086838587,1.7771435039459378,0.1036979259421611
WE,1860.0,1.0,0f579238-5a11-4adc-9c80-572cbb2ce58f,1457.0,65.0,-23837.0,25335.0,1498.0,1860.0,1860.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-WE-A8K5,False,United Kingdom,cc96277b-9064-5952-8778-550efbc688f7,not hispanic or latino,male,white,TCGA-WE-A8K5_demographic,Dead,Progression,18fc59fd-f2fd-40d0-b6e0-72e7dee175d7,True,8742/3,Lentigo maligna melanoma,No,"Connective, subcutaneous and other soft tissues of lower limb and hip",TCGA-WE-A8K5_diagnosis2,"Skin, NOS",TCGA-WE-A8K5_treatment8,8b3447a0-f392-432d-93be-4d3eb298b6be,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.5293042672472066,-0.0206505397309718,-0.2341982778912769,0.5296865380152759,0.9394314440942414,-0.0128517871281476,-0.2480704664473015,-0.5830856777987522,0.7786678914018471,0.5896978854236474
EE,3733.0,0.0,0f7ff1fc-95ec-4eb5-a308-6b8f24eec29a,3682.0,30.0,-11054.0,11054.0,0.0,,3733.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A3AB,False,Australia,d328a33f-ab51-54ff-9c4c-3f9d7a3f699d,not hispanic or latino,male,white,TCGA-EE-A3AB_demographic,Alive,Progression,0bf4ebfe-8648-54df-b9ec-abad6a23cdc2,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-EE-A3AB_diagnosis,"Skin, NOS",TCGA-EE-A3AB_treatment2,0972aff9-7a19-474d-a012-1cf59ba45846,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.8921714910343106,-0.0635188313236274,0.7316627849884555,-1.89344742924693,0.0455166652420932,0.1959998767983738,0.3252322362783552,0.2487956475285921,-0.3385906841460896,-0.5351340886277351
ER,613.0,1.0,1068ad76-612e-40ee-b2fa-916da14b7916,195.0,39.0,-14259.0,14826.0,567.0,613.0,613.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-ER-A2NE,False,United States,bb982e6d-f7b8-5fa7-a87d-ff1917d48e53,not hispanic or latino,male,white,TCGA-ER-A2NE_demographic,Dead,not reported,08712f8a-2383-568c-a737-f1f2086d3755,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-ER-A2NE_diagnosis,"Skin, NOS",TCGA-ER-A2NE_treatment,f4e51751-bf7b-59d2-a6d7-8d7e18db3387,yes,"Radiation, External Beam",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3765327091267189,1.1701079145077666,-0.2704879032539185,0.5825773837702032,-0.9502264175867272,-0.6034594820742735,-0.0036611989052007,0.2483643974895406,1.341140157390646,0.0857840482545588
GF,62.0,0.0,11463605-7086-48f4-b9bd-027715071880,36.0,62.0,-22731.0,22767.0,36.0,,62.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-GF-A6C8,False,United States,b3af4cbe-c92e-5061-87f0-94debff509ee,not hispanic or latino,female,white,TCGA-GF-A6C8_demographic,Alive,primary,9e80a18e-f1c7-53c1-a218-354917388a6e,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-GF-A6C8_diagnosis,"Skin, NOS",TCGA-GF-A6C8_treatment2,3ec142dc-b1a6-4b9b-a086-cb33f5885ac5,unknown,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2152027218349557,0.1031377627583633,-1.0640248856500538,-0.0116416540944153,-0.4692245011031945,0.202870099038045,-0.2035906276348419,0.9165144579909232,-1.4738996119151984,0.0385509675103982
WE,370.0,0.0,122f855b-f3b8-440b-bf9b-e24e1d3db867,34.0,37.0,-13850.0,13884.0,34.0,,370.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-WE-AA9Y,False,United Kingdom,2ae19bab-9f42-5f66-b783-deed4c34c029,not hispanic or latino,male,white,TCGA-WE-AA9Y_demographic,Alive,Progression,5986b4f5-0138-4021-87ef-b5df22bff1cb,True,8743/3,Superficial spreading melanoma,No,Lymph nodes of inguinal region or leg,TCGA-WE-AA9Y_diagnosis2,"Skin, NOS",TCGA-WE-AA9Y_treatment4,0b1fcab9-8e45-4988-a821-38e101ec2376,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0331656986849514,-1.178865002798182,0.0997385018234677,0.2056801746134008,-0.5224099576839074,-0.0159522517915221,0.634153878683803,-1.0547294705063772,0.6515002486565541,0.7993028557594017
ER,3196.0,0.0,1251acee-ceb4-4530-ba5b-4d163fcab8d2,81.0,58.0,-21209.0,23180.0,1971.0,,3196.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-ER-A1A1,False,United States,ae44b82f-ed8b-55da-9058-d73da27e7bef,not hispanic or latino,male,white,TCGA-ER-A1A1_demographic,Alive,not reported,242f648c-312f-4349-9131-6409165945ec,False,Not Reported,Not Reported,Yes,Not Reported,TCGA-ER-A1A1_diagnosis3,Not Reported,TCGA-ER-A1A1_treatment4,6e3ba123-773e-4505-a915-03aa7b00f8a4,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.1593513557721877,-0.5681939506990439,0.9189822979597104,-0.8452058451934104,0.4019018186211371,1.2653531903297313,0.8514571167373362,-1.0440919695431443,-1.4888057092333284,-0.2509487117218338
D3,746.0,1.0,132cdde9-70d8-4753-8e99-fc4ce3d371a4,29.0,61.0,-22409.0,23064.0,655.0,746.0,746.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A3CF,False,United States,c8b707bd-9286-5d21-a10b-eda1e0a470be,not hispanic or latino,female,white,TCGA-D3-A3CF_demographic,Dead,metastasis,1ff6e554-d903-4835-a93c-5a9f84d9d2b4,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A3CF_diagnosis4,"Bone, NOS",TCGA-D3-A3CF_treatment7,4ff4c9d9-e44e-4713-a00b-333834d5a102,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1578896691428146,0.6369096359859331,0.3301445221621736,0.3837340818915763,0.0739147011915791,0.4130199528674538,0.1504918202773369,-0.0188668767084066,0.7447798107801621,0.2431337427922442
FS,728.0,1.0,1404791b-86bf-4dfd-85b4-c8ff356f109c,,68.0,-24839.0,25206.0,367.0,728.0,728.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-FS-A1ZK,False,Germany,9257a2ee-b967-50a8-8d8c-b82acfc0858b,not hispanic or latino,male,white,TCGA-FS-A1ZK_demographic,Dead,primary,6d58ff29-059d-5243-8917-e722870292cb,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-FS-A1ZK_diagnosis,"Skin, NOS",TCGA-FS-A1ZK_treatment2,66053c21-f2e0-4cd8-af22-324b1c261510,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.38320618507722,0.7621869861652993,-0.2153822479070347,0.4149558281065866,-0.3682200502775274,-1.3195411244570028,0.5564697557663086,1.838239541453673,1.1315231638544485,0.464435056923693
BF,440.0,0.0,1412ed30-82b3-4a89-9d19-f04196dc3a9c,0.0,77.0,-28312.0,28312.0,0.0,,440.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-BF-A9VF,False,Russia,24840f28-996b-5abc-8584-4e0954f38b1d,not hispanic or latino,male,white,TCGA-BF-A9VF_demographic,Alive,primary,48f6ee85-17a4-4608-a6b5-31542f3b551c,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-BF-A9VF_diagnosis2,"Skin, NOS",TCGA-BF-A9VF_treatment3,a2622fa1-475d-448c-9334-349bf9bf6d21,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.3929796914284698,0.8495678186526144,-0.4640654410368447,0.2958585935553056,-1.8873271494524388,-0.0531237863165879,-0.9963899382664624,0.7648581942583602,0.2223676813338362,-0.2045939091797947
D3,2711.0,1.0,14407399-b1f0-46bf-9179-8bf11c39d919,1683.0,43.0,-15947.0,18523.0,2576.0,2711.0,2711.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-D3-A8GL,False,United States,c63fffa0-27ca-536f-b89e-ca88de346751,not hispanic or latino,male,white,TCGA-D3-A8GL_demographic,Dead,Progression,0c026977-94a4-4e65-b6f1-c1cba1052172,True,8720/3,"Malignant melanoma, NOS",Yes,"Connective, subcutaneous and other soft tissues of lower limb and hip",TCGA-D3-A8GL_diagnosis2,"Skin, NOS",TCGA-D3-A8GL_treatment4,6c523b17-799d-4ce5-990f-92ee3ec7e955,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2385540706737299,-0.5244431916552617,0.1459870773172147,0.5943505957596115,-0.4699508491942479,-1.1411936070956623,-0.0670906777640588,1.433008254759743,1.4616699286739605,-1.8158069169401587
D3,1409.0,0.0,16182443-12a1-4b0f-a6ab-33c2942e2991,590.0,58.0,-21281.0,21457.0,176.0,,1409.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-D3-A3C8,False,United States,b2975124-a260-55c8-9fdf-765ea8b755f2,not hispanic or latino,female,white,TCGA-D3-A3C8_demographic,Alive,primary,216dc42d-db24-4611-bd5a-437299977026,False,Not Reported,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A3C8_diagnosis2,"Skin, NOS",TCGA-D3-A3C8_treatment7,4861fdb3-de24-4bb0-9c83-d479cf85d793,yes,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.3495407562048428,0.1096046719564693,0.1162726209126117,-1.2952226242111924,1.5035229788364246,1.7871534154426505,-0.0695782256420614,0.1661393900440178,-1.0423215130012262,1.2416708841007238
FS,843.0,1.0,177b515e-bcb9-4a08-9b38-3ccdec0e293f,,45.0,-16705.0,17368.0,663.0,843.0,843.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A1ZA,False,Germany,3b7dad8e-006e-5dc0-8c04-a1c0b7e22b94,not hispanic or latino,female,white,TCGA-FS-A1ZA_demographic,Dead,primary,2dab88af-f659-484a-8213-13c88b2363c2,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-FS-A1ZA_diagnosis3,"Skin, NOS",TCGA-FS-A1ZA_treatment3,dd371c88-9169-4369-a784-9d51ea09c1f0,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.5341285620190732,-1.422851548734945,0.661691998123208,-1.9833035272739128,0.048084343570278,0.1050613151492542,0.3881164310356896,0.1802268913196497,-0.8408562914358803,-0.209117005640576
EB,774.0,0.0,187376e0-b4f3-44ed-ab43-88b6eff3e552,-1.0,77.0,-28315.0,28315.0,0.0,,774.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A4IS,False,Ukraine,af0d2991-3057-56c5-83ce-7e331a9dfbbc,not hispanic or latino,male,white,TCGA-EB-A4IS_demographic,Alive,primary,1be31309-516d-4b88-b717-e498df0a5e23,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A4IS_diagnosis2,"Skin, NOS",TCGA-EB-A4IS_treatment4,5c2e3994-335f-4573-8a9f-481bbf6040c9,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.3359724366241201,-0.1503131250106043,0.4592142842105822,0.4747697082847072,1.4670094658252737,0.8122223723752956,-0.0721368364780515,-0.5208419221625454,-0.8124415434231956,-0.7717067238050621
FR,5299.0,0.0,18e7b73c-4520-42cd-ac9b-23bac1c8ecc6,2691.0,29.0,-10707.0,13398.0,2691.0,,5299.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FR-A44A,False,United States,e1ab177e-453d-5468-88f1-5de1e1972774,not hispanic or latino,female,white,TCGA-FR-A44A_demographic,Alive,Progression,a1caf6ea-ade2-4ef0-ac0e-b70fc23ce1f7,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-FR-A44A_diagnosis2,"Skin, NOS",TCGA-FR-A44A_treatment4,78682002-f52c-4a73-9e51-96a0a26ae4fc,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3813073750856056,-0.7193706542112083,-0.7339357784564239,0.0114559659100604,1.0703022798201964,1.2642234998077104,-0.2628457588356833,0.178358141150435,-1.1754283038967122,0.1400262042285388
D3,3136.0,1.0,19322032-c144-4962-b886-37606dad33b7,114.0,67.0,-24692.0,26854.0,2162.0,3136.0,3136.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A2J7,False,United States,fc90b157-2800-529b-9cf4-5dc7a8d0249d,not hispanic or latino,male,white,TCGA-D3-A2J7_demographic,Dead,primary,001f1808-6728-4a16-88a7-4c1140f09d45,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-D3-A2J7_diagnosis3,"Skin, NOS",TCGA-D3-A2J7_treatment3,923050e3-39ed-4030-916d-18a265f18d1f,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.1191156179594415,0.4575896838896377,0.6310797125403553,0.182715364662575,0.3973107330519166,0.3885011102286944,-0.0662412563114626,0.3945581607274736,-1.561007118118018,-1.1259370677958362
BF,282.0,1.0,197ac33e-d5df-40de-92f2-6ef7fe2ad6dd,0.0,56.0,-20626.0,20626.0,0.0,282.0,282.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-A1PX,False,Russia,3446d611-8204-5912-abe7-139ae67a790c,not hispanic or latino,male,white,TCGA-BF-A1PX_demographic,Dead,primary,a7e51543-3a54-5602-881f-33e928b7eb13,True,8720/3,"Malignant melanoma, NOS",No,"Skin, NOS",TCGA-BF-A1PX_diagnosis,"Skin, NOS",TCGA-BF-A1PX_treatment4,21a78ee9-d483-427d-83d4-34f5afad4945,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.0088899675277888,0.0336943473925261,0.2330082243856669,0.1718414394371354,0.9945630574239726,0.7858210693303773,0.2312061767454495,0.4369644145673856,-0.7614347416627196,-0.0720921662495383
YG,1154.0,1.0,19e9ba4b-8f8e-4899-b667-b49fdd7ef6f4,900.0,62.0,-22999.0,23998.0,999.0,1154.0,1154.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-YG-AA3O,False,Puerto Rico,23a83892-7ce0-5a2e-8590-b46cd75d4d3a,hispanic or latino,male,Unknown,TCGA-YG-AA3O_demographic,Dead,Progression,15191c7d-a54d-4a88-8ad3-ea4eb8905871,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-YG-AA3O_diagnosis2,"Skin, NOS",TCGA-YG-AA3O_treatment6,38dc4edd-0ca2-4bfd-80ca-2053691bdbe4,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3898020169887395,0.737410261827622,-0.1885527760226438,0.3401341290820646,-0.8979118174088025,0.5229749778457199,-0.0845843026703752,0.8084144482024054,1.0624660098728005,0.6191166767981195
EE,1729.0,0.0,1af5d168-a3ff-4648-b195-ede2e7a5ca26,540.0,33.0,-12350.0,12874.0,524.0,,1729.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A29M,False,Australia,24fd41ba-6779-5185-a012-1abcf47aa416,not hispanic or latino,female,white,TCGA-EE-A29M_demographic,Alive,Progression,709333a8-893c-4dc8-b1be-e7eeefa44443,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-EE-A29M_diagnosis2,"Skin, NOS",TCGA-EE-A29M_treatment5,73585e89-1922-4b1b-a649-e59b7d12dbb2,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.5803745653771033,0.4925464200113139,-0.0203088022058332,0.4468063444747676,0.195207687450935,0.703609171278503,-0.1419137561555514,2.3773020902661046,2.262872659523428,0.2346149128846158
ER,710.0,1.0,1b3f92b7-658a-4bbd-b086-20c1cd976d54,401.0,57.0,-20867.0,21520.0,653.0,710.0,710.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-ER-A2ND,False,United States,cacd15d5-a8c6-58b4-a961-d40e415e7cbb,not hispanic or latino,female,white,TCGA-ER-A2ND_demographic,Dead,metastasis,3f432a70-1278-4f40-92d6-1a3f201018f4,True,8720/3,"Malignant melanoma, NOS",No,Skin of trunk,TCGA-ER-A2ND_diagnosis2,"Skin, NOS",TCGA-ER-A2ND_treatment4,3b54a13b-e150-4591-9983-2c85937db623,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.738813054349238,-0.1492808740773266,0.5508118999523753,0.403780466501024,-0.101340567243561,-0.167459288848751,-0.3186980874299993,-0.6069481799595163,-2.1205680369743685,1.02933474864451
YG,306.0,0.0,1c052cde-7a70-410b-a273-dbe39dd968f4,-10.0,67.0,-24525.0,24525.0,0.0,,306.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-YG-AA3N,False,Puerto Rico,8ed37f77-77b2-5280-9e85-ac82ca838855,hispanic or latino,male,Unknown,TCGA-YG-AA3N_demographic,Alive,primary,7007c254-496a-5b14-890b-7fa117249001,True,8721/3,Nodular melanoma,No,Skin of trunk,TCGA-YG-AA3N_diagnosis,"Skin, NOS",TCGA-YG-AA3N_treatment5,433f0326-ee82-4ef0-8cef-d1893621aa38,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.334047289929385,0.0776897107593375,-0.1641697674037031,0.6427793305280387,0.4570780803125389,0.8008612062363172,-0.2464792998450251,-0.4364606645217728,0.3681679457267933,-0.8754255421522774
BF,601.0,0.0,1ca2eb9f-9496-450f-83fe-c7a6cb1a075b,-9.0,63.0,-23076.0,23076.0,0.0,,601.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-A3DM,False,Russia,aadf8bf6-928e-5734-942f-4e40aa66b4eb,not hispanic or latino,male,white,TCGA-BF-A3DM_demographic,Alive,primary,3ec8f727-1e6a-45dd-9f8b-aed93824ac01,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-BF-A3DM_diagnosis2,"Skin, NOS",TCGA-BF-A3DM_treatment3,e52a1cd2-ba79-4ecf-9d09-c573088be846,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.6957754309852164,-0.2371505845861738,-0.2690330857161971,0.1937363439009597,0.1317674530018997,-1.157487541233171,0.6823518824759998,0.6031394296146296,-0.3404539463108556,-0.9032302877469016
D9,505.0,0.0,1cad4b22-ec8b-4e34-bfef-5464d185923a,8.0,73.0,-26812.0,26912.0,100.0,,505.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-D9-A4Z3,False,Poland,31964ffd-1ef3-5787-8b70-7d153d8d7b1c,not hispanic or latino,female,white,TCGA-D9-A4Z3_demographic,Alive,recurrence,294ad4a4-2d5a-4bd9-8547-8a1b969553ac,False,8721/3,Nodular melanoma,Yes,Not Reported,TCGA-D9-A4Z3_diagnosis3,Not Reported,TCGA-D9-A4Z3_treatment7,72a65117-aa91-4b93-bd74-655ef0b7bbb2,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.6426865240413335,-0.3698460994064843,-0.0610544844129568,-0.69697602613307,-2.202281341686904,-0.7573530277177595,-0.2970724735310984,-0.5458544244274401,0.0462894067634305,-1.3797133057588815
D3,2184.0,1.0,1e05da2e-7dd7-4c98-9e77-59514e5f2582,48.0,55.0,-20230.0,20280.0,50.0,2184.0,2184.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A1Q6,False,United States,587657f4-9ae8-58bd-82db-c6cd66179a8a,not hispanic or latino,male,white,TCGA-D3-A1Q6_demographic,Dead,not reported,1e20ee1c-3bce-55f9-89f1-930d34bf36ed,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-D3-A1Q6_diagnosis,"Skin, NOS",TCGA-D3-A1Q6_treatment,8660c81f-2907-5051-b520-d50fb49d78ec,yes,Immunotherapy (Including Vaccines),0.0,0.0,0.0,1.0,0.0,0.0,0.0,Metastatic,0.5052562438612223,-0.3021083811499049,0.1433232664070399,-1.8859598618618596,-1.0276777890211155,-0.1510069661506616,0.2855952630999595,-0.4821731686610652,-1.4694743642738786,1.373332623092419
D3,2421.0,1.0,1e3bc429-50eb-4087-b39a-6d92f03412f7,1781.0,48.0,-17668.0,19956.0,2288.0,2421.0,2421.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A8GC,False,United States,86ca6fd7-46f8-5e87-bca9-05feb4e1ff3b,not hispanic or latino,male,white,TCGA-D3-A8GC_demographic,Dead,not reported,02da401f-8c55-5f1f-9d3c-2cddc738d6ec,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A8GC_diagnosis,"Skin, NOS",TCGA-D3-A8GC_treatment,2557f7b5-aeab-580e-a4c0-226e9c7b3f1e,yes,"Radiation, External Beam",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1216329869835697,-0.5581300997191094,-0.4033523492130489,0.0707409039822185,-1.005180190464361,0.1597850530458212,-0.1103391331461982,1.9285145496281295,0.917364468791631,0.6612754597495383
D3,1941.0,0.0,1f66a0e1-640a-4caa-85f1-61c6de475cf1,18.0,60.0,-22040.0,23702.0,1662.0,,1941.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-D3-A51R,False,United States,9403150f-ca82-598a-a20b-dcc72a3e2f40,not hispanic or latino,male,white,TCGA-D3-A51R_demographic,Alive,metastasis,4af56d27-c8ee-435a-a9f2-81843b24b13d,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A51R_diagnosis6,Intra-abdominal lymph nodes,TCGA-D3-A51R_treatment12,2400443c-b9e6-43f9-af5d-bf9c7f2f13cc,yes,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,1.1322189011698949,-0.7349369661210978,0.7570681243254601,-2.7222170101585528,-2.391314184710384,-1.8783551886336705,-0.0570344551107691,-0.2904106512968561,-0.8706684860721383,1.39220589078186
FR,571.0,0.0,1fb5b4fd-8891-4a21-96b6-45d4b848cc66,30.0,63.0,-23245.0,23476.0,231.0,,571.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FR-A7U9,False,United States,15ff7687-9cc3-51a3-8f75-306f513b1927,not hispanic or latino,female,white,TCGA-FR-A7U9_demographic,Alive,recurrence,7f472959-c450-4a15-b5d7-2300ac53d901,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-FR-A7U9_diagnosis4,Not Reported,TCGA-FR-A7U9_treatment9,08537579-8823-4a6b-b853-76cfabd33c52,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,-0.5219843552531656,-0.1729380600496277,-0.4912658289052807,-3.079528474943617,0.3104086501348488,0.756160037471502,-0.0007541704522678,-0.384566909822761,-1.68165334328663,0.2290274993082293
D3,2022.0,1.0,20ae4c90-ea2e-42e8-bc0e-f0e6be0dadeb,31.0,46.0,-17128.0,17128.0,0.0,2022.0,2022.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A2JN,False,United States,52b42f1d-6cce-5f09-a839-62db3e8beba1,not hispanic or latino,female,white,TCGA-D3-A2JN_demographic,Dead,Progression,35a6f5c7-7c37-59d4-9cdc-c3c651a3f3fd,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-D3-A2JN_diagnosis,"Skin, NOS",TCGA-D3-A2JN_treatment,762c379d-4f2a-53db-ac2e-2dd5c9ec5408,yes,"Radiation, External Beam",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.3579438321365069,-0.6168123175589145,0.1024344851273182,-2.2044866370274216,-0.3919434965147396,-0.1134447016354539,-0.6218851751658759,0.6416644331030911,-2.46899806178565,0.7867080950063801
DA,2329.0,0.0,210726bd-db19-48ae-9a3d-e6ac44480e85,,75.0,-27553.0,28419.0,866.0,,2329.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-DA-A1HV,False,United States,7626b938-f114-5a79-91d5-635116093f11,not hispanic or latino,female,white,TCGA-DA-A1HV_demographic,Alive,metastasis,29732d64-1398-4e54-a4c1-d2ded5bf088b,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-DA-A1HV_diagnosis3,"Mediastinum, NOS",TCGA-DA-A1HV_treatment7,241132c1-8eda-4526-a70c-1706cf990b36,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,-0.3376225229563758,0.0558297646174801,0.264886691708223,0.3180884771595436,2.0735516516141783,0.8076246369960353,0.4788142249014325,0.2174581446909617,-0.9456647882039791,0.1154869965344238
D3,1695.0,0.0,2316bc62-974a-4dfd-8ee2-9e4a08660a45,756.0,51.0,-18776.0,18806.0,30.0,,1695.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A51F,False,United States,03853c66-7000-5933-bcd5-83521b81ea0e,not hispanic or latino,male,white,TCGA-D3-A51F_demographic,Alive,primary,014aaddb-e8a3-4cdf-aa0a-62e425f4ea15,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-D3-A51F_diagnosis3,"Skin, NOS",TCGA-D3-A51F_treatment3,abe302da-6f16-4f94-b940-2acd83ab0191,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.3692155120823694,-0.3072609667033482,-0.1002218783165575,-0.3433845090029193,1.3331575696250404,1.5917028548348195,-0.1155685555859122,0.6146394306559628,-0.8890681999492052,-0.1324473532941616
EB,620.0,0.0,236ef9ca-9362-44f3-a36b-2a19509bab9d,-3.0,41.0,-15337.0,15337.0,0.0,,620.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A4OZ,False,Ukraine,8a1189a2-043e-57cd-958e-f3a1f1b555d6,not hispanic or latino,female,white,TCGA-EB-A4OZ_demographic,Alive,primary,2527df1c-ad2a-5709-9f29-7352c9a6149c,True,8720/3,"Malignant melanoma, NOS",No,Skin of trunk,TCGA-EB-A4OZ_diagnosis,"Skin, NOS",TCGA-EB-A4OZ_treatment2,1f563b7b-c8e5-4d5f-a986-04f7d18ae992,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-1.6470933082255628,-0.0961282820393444,-0.1915989032993451,-0.2203673915439178,1.454924539380885,0.4201101611781273,-0.941328397374214,-1.9734358036957769,-3.422522474604756,0.6368417612937666
FR,847.0,0.0,23809ce7-77b4-432f-bda2-678f822b604a,352.0,50.0,-18346.0,18913.0,567.0,,847.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Small intestine,TCGA-FR-A7U8,False,United States,307b5375-158f-53e2-a8d3-f6c85f39abbb,not hispanic or latino,male,white,TCGA-FR-A7U8_demographic,Alive,metastasis,54f05227-4ae7-4ad8-8ae5-53b96f3bacd4,True,8720/3,"Malignant melanoma, NOS",Yes,"Small intestine, NOS",TCGA-FR-A7U8_diagnosis2,"Skin, NOS",TCGA-FR-A7U8_treatment3,d90d46ed-c1af-4737-9825-45fefedba776,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.2731991715795213,-0.1780625868782351,0.0965985634070409,0.3896656478236832,-1.0432263626887452,-1.1725948737152316,-0.4604074706758962,-0.2331981461162305,0.3212370299517443,0.9378380858399762
D3,3424.0,1.0,238111f9-a08b-49b4-9035-cc43026330e7,2483.0,60.0,-22200.0,24652.0,2452.0,3424.0,3424.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A1Q5,False,United States,796ccdee-7ee3-5bcc-846e-7f1c16685617,not hispanic or latino,male,white,TCGA-D3-A1Q5_demographic,Dead,Progression,54930071-0ba3-4885-91c6-9fc08c4aa55e,True,8720/3,"Malignant melanoma, NOS",No,"Lymph node, NOS",TCGA-D3-A1Q5_diagnosis2,"Skin, NOS",TCGA-D3-A1Q5_treatment4,8222a425-874d-4801-b3ce-b6b0c0c4fa4b,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3962137090641289,-1.0861024206216818,0.5699207449761402,-1.8065084369308555,-1.364958573893548,-0.2195538128751893,1.813850318197972,-0.9489294609261228,-0.8420208302888585,-1.2911616894583116
EE,2884.0,0.0,24faa36a-268d-4a13-b3ae-eacd431a2bcc,1786.0,65.0,-23784.0,25563.0,1779.0,,2884.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2GU,False,Australia,28f9ba0f-e6b3-5621-bf0c-595fdd7d5dd2,not hispanic or latino,female,white,TCGA-EE-A2GU_demographic,Alive,primary,a5a5a1a1-f5d3-4288-9eaa-d1d531942e45,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A2GU_diagnosis3,"Skin, NOS",TCGA-EE-A2GU_treatment3,7ec0762e-45af-4c0b-988d-8ac06890c695,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.9476753300295736,-0.6547215705149456,-1.2572343148415888,-0.0188207723395844,1.1780135856671097,0.8376568092061687,0.2964463083281571,1.577908267880524,0.6792162733574509,-0.2058159390217261
D9,301.0,0.0,259b4d49-7cfc-420f-ba5e-65febc328ce4,-25.0,75.0,-27537.0,27537.0,0.0,,301.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D9-A6E9,False,Poland,26546976-899a-566b-be60-117ca3730685,not hispanic or latino,female,white,TCGA-D9-A6E9_demographic,Alive,primary,4d74fafa-9f6d-4c62-a375-e4a5f604944f,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-D9-A6E9_diagnosis2,"Skin, NOS",TCGA-D9-A6E9_treatment3,567f6955-ffd0-49ad-a01b-cf0586287bd0,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.4696161536280551,1.1330932778032856,-0.6473414437256371,0.5009612134947783,1.6836856086558405,1.7074106043046229,-0.8040096310298468,0.7841206960025896,-1.1747295805849245,-0.5655024369475279
EE,545.0,1.0,26293554-04d3-4fc9-b12e-6a199278ed11,11.0,58.0,-21363.0,21868.0,505.0,545.0,545.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A29X,False,Australia,be341072-d433-584e-a260-e726be68a737,not hispanic or latino,female,white,TCGA-EE-A29X_demographic,Dead,primary,0b3adff7-0854-4e3a-a161-29989779780f,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A29X_diagnosis3,"Skin, NOS",TCGA-EE-A29X_treatment3,24f8b141-57a7-4631-a6ac-fda748f154ef,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4304239372645827,0.1846918264619482,-0.093884630329302,0.2760562650058739,0.7616327593227495,0.7244405264631331,-0.5851823831271502,-0.134729387199826,0.875091708428499,-0.418248839505451
EE,5118.0,1.0,267b98e7-708f-458a-82d1-5faa415b9ee7,4913.0,56.0,-20476.0,25466.0,4990.0,5118.0,5118.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EE-A20H,False,Australia,ff300754-81f6-538c-bc59-6b463b939a6e,not hispanic or latino,male,white,TCGA-EE-A20H_demographic,Dead,metastasis,034835ac-815d-4807-be6a-55123c42f865,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A20H_diagnosis5,"Thorax, NOS",TCGA-EE-A20H_treatment12,5e03d0e1-271b-4b6e-ad70-5179941fb2d2,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.4368757052375429,-0.7848181960959074,0.930472078321998,-1.622980911849379,-0.3935281601032501,-0.2778617520415169,0.3208924640388431,0.6464081835326422,-0.7602702028097414,-0.4130917050555741
EB,1039.0,0.0,27c9e7aa-1760-4cfc-95b0-a091d35d317b,-1.0,48.0,-17569.0,17569.0,0.0,,1039.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A1NK,False,Russia,9ceb0001-9ceb-5e0a-a20c-d58c15c14997,not hispanic or latino,male,white,TCGA-EB-A1NK_demographic,Alive,primary,3b29ecbf-c8ed-5447-8831-bc182cc2bc0a,True,8720/3,"Malignant melanoma, NOS",No,"Skin, NOS",TCGA-EB-A1NK_diagnosis,"Skin, NOS",TCGA-EB-A1NK_treatment2,6f70f1a4-df9e-4c7d-815c-dca74b767a04,unknown,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.1568484041566995,0.0539453574166753,-0.4505304912830725,0.2410467660297258,-0.2716954335344768,-0.6476217861902589,-0.1495909557935272,-0.9286607090907768,0.6922591085108151,0.4491035106691498
GF,21.0,0.0,285d8e2c-f183-49d5-bc1c-fd47c6670acc,1.0,48.0,-17545.0,17545.0,0.0,,21.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-GF-A2C7,False,United States,5be468e8-1732-5efd-8e07-93f204bd5ee8,not hispanic or latino,male,white,TCGA-GF-A2C7_demographic,Alive,not reported,9e935c14-9ea9-5aa4-bd72-daa2d33c08a9,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-GF-A2C7_diagnosis,"Skin, NOS",TCGA-GF-A2C7_treatment,07ee2b80-0d60-50c5-b53f-6a4cb1494803,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.4020342866349438,0.6130611779031201,-0.1425899765822712,0.6618975805717866,-1.4641887497959845,-1.303538290895898,0.7787256063610601,-0.0257668773332075,0.790196826046338,0.788869438715341
FR,1103.0,1.0,2897a728-ec7b-4321-b0fe-3575b7c6ee39,747.0,56.0,-20782.0,21535.0,753.0,1103.0,1103.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Bronchus and lung,TCGA-FR-A8YD,False,United States,ef502619-4d20-5b82-b284-0758f1335798,not hispanic or latino,female,white,TCGA-FR-A8YD_demographic,Dead,not reported,42292381-47eb-5bf2-a8c1-51819df1dff3,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-FR-A8YD_diagnosis,"Skin, NOS",TCGA-FR-A8YD_treatment2,46580898-e362-4e27-9e70-ef38b10d6108,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.2102315326682378,0.0692422448694626,-0.2051489422114459,0.4516290934085335,-0.6391303731433735,-0.7266900137509374,-0.007524190110753,-0.0108168759794752,0.0317326711011933,1.0767502630969652
D3,5219.0,0.0,28cf244b-77dc-4b31-a65a-9746f15bb07e,3017.0,43.0,-15710.0,18705.0,2995.0,,5219.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A2JL,False,United States,187902a2-8c69-51e3-ac9e-bd4050b5c4ea,not hispanic or latino,female,white,TCGA-D3-A2JL_demographic,Alive,metastasis,0600fb47-e7f4-4ea3-97a1-38e649166b86,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A2JL_diagnosis4,"Lung, NOS",TCGA-D3-A2JL_treatment9,8d9e9ecb-7bdf-429e-bd78-285ce0146360,yes,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,-0.5665283176087232,-0.2591576872132334,-0.2361184057617079,0.578586027713489,0.5752971406378435,0.6624989249018448,-0.6225037135960103,0.6847894370080873,-0.1183763870477838,-0.1189450641633936
D3,507.0,1.0,29476d6a-0d06-4a18-8910-c0502f6539ff,248.0,64.0,-23604.0,23852.0,248.0,507.0,507.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A1Q3,False,United States,366a5563-716e-5d97-b122-eab88b353920,not hispanic or latino,male,white,TCGA-D3-A1Q3_demographic,Dead,primary,4fa020f2-c988-4769-849b-577c02eb015b,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-D3-A1Q3_diagnosis3,"Skin, NOS",TCGA-D3-A1Q3_treatment3,a1818c32-c58a-4655-bc9e-02c658e85222,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.9402921926289146,-0.0557854304879658,0.7565943009981951,0.5468507455370366,0.7208488588921087,0.4365080520428724,0.5602952845195481,0.0468268792401992,0.0875140821588819,0.7009165838752242
EE,4648.0,1.0,296f44f9-3ecb-4b40-ae51-c3a06e3fbe00,3502.0,48.0,-17835.0,22282.0,4447.0,4648.0,4648.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A3JI,False,Australia,2bc6b2a9-7787-56e5-893d-0bea35658f77,not hispanic or latino,male,white,TCGA-EE-A3JI_demographic,Dead,Subsequent Primary,14f9bb64-5cbb-4da8-9d4f-a14b29532c18,False,8720/3,"Melanoma, NOS",Yes,Not Reported,TCGA-EE-A3JI_diagnosis7,"Skin, NOS",TCGA-EE-A3JI_treatment16,0c412d35-af6e-41e3-a4f4-9b6d7c145ed5,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0134889491888617,1.2194334259520372,0.0910034327792415,0.2704228104889146,-0.6935674564470427,-0.4573871197055109,-0.8336866321689478,0.4126706623675699,1.5502913353856511,-1.8610764403720728
FS,636.0,1.0,29bcb876-5a91-4d56-af47-7b4c856c151f,,72.0,-26435.0,26711.0,276.0,636.0,636.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-FS-A1Z3,False,Germany,f425d2a6-d688-5b36-b3cf-9b486d5c116d,not hispanic or latino,female,white,TCGA-FS-A1Z3_demographic,Dead,not reported,1143eb50-0546-5287-a5da-5e9d729f0c6e,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-FS-A1Z3_diagnosis,"Skin, NOS",TCGA-FS-A1Z3_treatment,51ca20d6-d630-5626-bd9d-585c65df0b2d,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.6036865796246549,-0.908729806169844,0.8487769194848678,0.5033041366860606,-0.421408724922435,-0.6304360093221127,0.5042211643198193,-0.9211857084139106,0.9383261681452516,-0.3729737647044054
ER,1354.0,1.0,2bbf00f4-7798-4dad-9894-96202c9132be,0.0,77.0,-28175.0,28253.0,78.0,1354.0,1354.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-ER-A194,False,United States,763938b0-7d9f-5f85-8317-ee9a4d11e215,not hispanic or latino,male,white,TCGA-ER-A194_demographic,Dead,primary,4fb60388-42ca-4a73-9443-58221609f21c,True,8720/3,"Malignant melanoma, NOS",No,"Connective, subcutaneous and other soft tissues of upper limb and shoulder",TCGA-ER-A194_diagnosis2,"Skin, NOS",TCGA-ER-A194_treatment5,1bad9475-d514-492e-be69-0e35c6d1c369,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-2.570932887558832,-0.1762438211915072,-0.6090978951636672,0.5959380631161734,1.0439263582819784,0.0242304247977339,-1.371143069899124,-1.7087920297321282,-1.6240086700641756,-0.6129519384386708
QB,549.0,1.0,2bdb65a5-4b72-4379-822d-69cc41fd663f,360.0,73.0,-27009.0,27009.0,0.0,549.0,549.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-QB-AA9O,False,United States,14b26885-384d-5710-9a7b-c9d6791b34f1,not hispanic or latino,male,white,TCGA-QB-AA9O_demographic,Dead,Progression,6f0dc1be-df92-5156-8366-05f2f5798795,True,8720/3,"Malignant melanoma, NOS",No,"Connective, subcutaneous and other soft tissues of upper limb and shoulder",TCGA-QB-AA9O_diagnosis,"Skin, NOS",TCGA-QB-AA9O_treatment9,23c5b141-569b-418e-9e01-cb8aa888c670,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.6600925607022998,-0.2996068836628471,-0.4682018261516575,0.1544305892428336,-0.222211497156608,0.7305055837457531,-0.980928391027214,-0.2442668971185122,-0.8509877794567956,-0.2500724851162385
FS,1413.0,1.0,2c79add1-8093-4e81-8f80-069af7b7c2fa,527.0,40.0,-14618.0,15714.0,1096.0,1413.0,1413.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-FS-A1ZE,False,Germany,3d36f927-1723-5842-9f31-b0c43f03db68,not hispanic or latino,male,white,TCGA-FS-A1ZE_demographic,Dead,primary,a85ac904-a2bd-4e19-9c92-85f53acad371,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-FS-A1ZE_diagnosis3,"Skin, NOS",TCGA-FS-A1ZE_treatment7,32d114c5-5c98-4d12-bb20-16d5f205970e,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.3327042912538997,0.4616927974909337,0.5858387482619813,0.5876133427181933,-1.3312969199610196,-1.345444167552207,0.4502695454878233,-1.0847732232268557,0.7133372617497312,1.604559540005428
HR,0.0,0.0,2c8d436c-4edb-4083-b23f-9a33307d5bb2,0.0,89.0,-32872.0,32872.0,0.0,,0.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-HR-A5NC,True,Canada,2bf37b46-b292-5211-8308-8e7478e13fac,not reported,female,not reported,TCGA-HR-A5NC_demographic,Alive,primary,0a71cde5-a658-58fa-8f7d-5b461ed5ba0d,True,8720/3,"Malignant melanoma, NOS",No,Skin of trunk,TCGA-HR-A5NC_diagnosis,"Skin, NOS",TCGA-HR-A5NC_treatment,5bec652c-8fcf-5693-ba5f-a4c685cfbafd,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.1023250867305086,-0.2282704215938653,-0.4727355812818651,0.8016243305358002,-0.3462814061324258,-1.1773396357352353,0.7110611546021074,0.098720633939211,-0.4147515251309087,-0.8630149058860219
D3,2644.0,0.0,2d36cea4-73e9-493b-8433-0c2b911c0521,2111.0,69.0,-25396.0,27957.0,2561.0,,2644.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-D3-A3CC,False,United States,9a5028b9-9134-5bd0-a00d-b2e27e6a6240,not hispanic or latino,female,white,TCGA-D3-A3CC_demographic,Alive,Progression,2910d7e4-1f35-4f88-914d-b21d95cbefd6,True,8720/3,"Malignant melanoma, NOS",Yes,"Connective, subcutaneous and other soft tissues, NOS",TCGA-D3-A3CC_diagnosis2,"Skin, NOS",TCGA-D3-A3CC_treatment4,1611ce4c-4e6f-40f3-9807-5b12c0972bcf,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4619377738136845,1.8928942105255573,-0.768023837676353,0.646502758076507,-0.5676145196927412,-1.3261811085193884,0.5101343461399656,0.7247519406267143,1.2429695320845258,-0.0169737551285067
D3,4414.0,0.0,2d8868ab-a7db-4cbd-a9af-cc485b29c177,3417.0,19.0,-7194.0,9956.0,2762.0,,4414.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-D3-A51J,False,United States,753f1e5e-5815-544d-a84f-f2029852f59e,not hispanic or latino,male,white,TCGA-D3-A51J_demographic,Alive,Progression,42ab6972-4381-4ba3-a7fd-6dd95900dc10,True,8720/3,"Malignant melanoma, NOS",Yes,"Connective, subcutaneous and other soft tissues of pelvis",TCGA-D3-A51J_diagnosis2,"Skin, NOS",TCGA-D3-A51J_treatment3,082b405a-b50d-4ca3-a49d-743701bdfc7a,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.4121708562484371,0.0036911492013036,-0.0497110537821252,-0.1661072979800732,0.6378255325622914,1.0421479249083945,-0.4187021283700519,-0.3546669071152989,-1.094609307499976,-0.2012423965216489
BF,444.0,0.0,2e0f7da5-9078-4c7f-b074-565246529a83,-14.0,83.0,-30318.0,30318.0,0.0,,444.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-AAOX,False,Russia,db40a8df-ebac-5cb3-93e3-00d5ea596f14,not hispanic or latino,male,white,TCGA-BF-AAOX_demographic,Alive,primary,bd218de5-ae0b-4352-81b0-c90ce598f876,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-BF-AAOX_diagnosis2,"Skin, NOS",TCGA-BF-AAOX_treatment3,b3c4a237-22fd-4186-aa01-05ebd8bc6cb1,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.706794023876162,0.4857361070581846,0.1126890744512125,0.5439653658805907,0.4729353016407489,-0.8418793732305222,-0.9288244381223538,0.4596769166240143,0.5939720293193971,-0.2927785089138597
EB,454.0,1.0,2e6f9985-6d13-4b08-8a40-5ea44e9553f0,6.0,65.0,-23833.0,23857.0,24.0,454.0,454.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A5FP,False,Ukraine,b066b383-e8e2-5dab-8a0c-47b2e9edd057,not hispanic or latino,female,white,TCGA-EB-A5FP_demographic,Dead,primary,1570d560-fef2-5dab-b8f7-2f1f6e131852,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-EB-A5FP_diagnosis,"Skin, NOS",TCGA-EB-A5FP_treatment3,0a2b39c2-f2ab-4e09-b7bf-770de0acf6be,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.9299661228439272,0.1487024421151945,-1.3003423830925072,0.4829294163136957,-0.973267242858571,-0.26336740361002,-0.0393511942459556,1.0516394702265746,1.3059710840306833,1.2604195783715728
EE,4086.0,0.0,2e7cfa51-8965-4c11-8fef-077fd258fbe4,2639.0,54.0,-19852.0,23161.0,3309.0,,4086.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A3JH,False,Australia,3867c02a-0a6c-5a2e-9c85-2e5532d94ee2,not hispanic or latino,male,white,TCGA-EE-A3JH_demographic,Alive,metastasis,233fdfb0-f186-443b-8c26-eb20f46575b0,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A3JH_diagnosis5,"Small intestine, NOS",TCGA-EE-A3JH_treatment11,8470cdb5-2ef4-436a-9b04-4d79959b2a4e,yes,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,0.3609092365635488,-0.1849222315520281,0.0891265406927131,0.1074805437341088,0.6480862482967832,1.364646762700162,0.281214088509583,0.8938019559342948,0.3879651062274337,-0.4748700898957995
DA,2005.0,1.0,2ea7ad21-3324-4eda-8c82-fc2ceea2fc73,,32.0,-11744.0,13599.0,1855.0,2005.0,2005.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,Brain,TCGA-DA-A1IA,False,United States,c9572aed-8619-5ebb-9eca-faf3ca4d92aa,not hispanic or latino,female,white,TCGA-DA-A1IA_demographic,Dead,metastasis,18067eba-95b0-4842-b136-39ea421febe4,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-DA-A1IA_diagnosis4,"Brain, NOS",TCGA-DA-A1IA_treatment6,9c426cb5-2a05-4464-9128-a12e6cad48fd,yes,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.9210903706636036,0.2864742362614622,-0.8362131328665909,0.4646985801548191,-0.3162214792886899,-0.2716475738361183,-0.6143064920333334,-0.6719231858430432,0.3270597242166375,-1.2069293702854689
D3,841.0,1.0,2ec330f8-96e4-4270-aadc-563bb72f4b2c,140.0,75.0,-27604.0,28384.0,780.0,841.0,841.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A2JE,False,United States,8b095967-4538-5dce-ba3a-ea4302ffa263,not hispanic or latino,female,white,TCGA-D3-A2JE_demographic,Dead,metastasis,31ba3ede-35f8-4343-9e88-e9785761f238,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A2JE_diagnosis13,"Connective, subcutaneous and other soft tissues, NOS",TCGA-D3-A2JE_treatment37,34e59fb2-c4ac-4505-a0c4-76c10fe8db9d,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,-0.3418068371039181,0.2620770908298395,0.319044806591682,-0.0190747824969597,-2.935591492524971,-1.6148501464253755,-0.2179117144006049,-1.3430919966177737,-0.8876707533256296,-0.4276870396316805
FS,1441.0,1.0,2f0661e5-5006-481e-9b40-7b1ec96eaa3c,,75.0,-27476.0,28701.0,1225.0,1441.0,1441.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A1ZJ,False,Germany,adb3dd31-4965-56a8-978d-bb1cba533c34,not hispanic or latino,female,white,TCGA-FS-A1ZJ_demographic,Dead,Progression,256b01b6-7cd8-4723-b7de-94ce0c1248cb,True,8720/3,"Malignant melanoma, NOS",No,"Lymph node, NOS",TCGA-FS-A1ZJ_diagnosis2,"Skin, NOS",TCGA-FS-A1ZJ_treatment4,2b16fea1-328d-45a5-accb-9e241c4ea148,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4582970801858295,-0.265304109957657,0.3703551531904444,0.379102423866074,-1.472509091952394,-0.5491323220743114,0.2199060323960763,-0.437035664573838,0.1480701025137852,0.1356965783981432
EB,632.0,0.0,2f1bbe96-49d9-417b-bc9c-a09992489340,-1.0,56.0,-20539.0,21004.0,465.0,,632.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A24C,False,Ukraine,cd00596c-aef7-54eb-9542-e36564eb2803,not hispanic or latino,male,white,TCGA-EB-A24C_demographic,Alive,primary,41d0d80c-98cc-40fa-a8d7-8f2b55e07f61,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A24C_diagnosis2,"Skin, NOS",TCGA-EB-A24C_treatment9,247e9226-1366-4aae-b852-695b74feb8da,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.3832449738521268,0.0693437244614105,1.1078193418896884,0.7773424301894527,-0.369537787708645,-1.3254169740276212,0.5050528618086949,-1.673717026556066,-0.3488386260523026,0.3799422129817332
FS,5318.0,1.0,2f5813a8-97a6-4a96-886d-38f29272b16c,,52.0,-19137.0,24023.0,4886.0,5318.0,5318.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A4F8,False,Germany,605796c8-ba67-5343-9e8c-14a985d57623,not hispanic or latino,male,white,TCGA-FS-A4F8_demographic,Dead,primary,2f280786-a6f6-4430-b043-5ed76ba9544a,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-FS-A4F8_diagnosis3,"Skin, NOS",TCGA-FS-A4F8_treatment3,b95e7698-cef5-46c0-907b-7d1ef8815dea,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0709300611240642,-0.233156256812374,0.4625089589230224,-0.1028557120141989,0.2617464185647122,0.618085001275528,0.7649989056039018,-1.2497982381699693,-0.3687522404382426,0.732003621372854
W3,1917.0,1.0,2f5d8110-35c7-419f-8b35-bc3040f940f3,1491.0,60.0,-22097.0,23741.0,1644.0,1917.0,1917.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Bronchus and lung,TCGA-W3-A825,False,United States,5f8f9c16-0cf3-5f9a-ae0e-335303d04479,not hispanic or latino,female,white,TCGA-W3-A825_demographic,Dead,metastasis,117fcf26-98c0-4f49-bd67-cc3329bbd50f,True,8720/3,"Malignant melanoma, NOS",No,"Lower lobe, lung",TCGA-W3-A825_diagnosis2,"Skin, NOS",TCGA-W3-A825_treatment10,62ca421e-8716-4e28-a8f9-7155f9532301,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4922469497751624,0.499268937070887,0.4715072544010154,-2.3488378351159778,-0.0471732174601127,0.4058136790853406,0.2228243249544786,-0.8126544485863411,-0.1174447559654008,-0.8563933214502796
FS,4526.0,0.0,31e94518-f6dd-4458-94d8-dda3cc7a0831,2896.0,54.0,-19813.0,23862.0,4049.0,,4526.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A1ZS,False,Germany,a5716491-b5bd-525d-8414-9eeca41de834,not hispanic or latino,male,white,TCGA-FS-A1ZS_demographic,Alive,metastasis,01814d63-dd3d-4e45-8c35-ff05b6c8be11,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-FS-A1ZS_diagnosis9,Liver,TCGA-FS-A1ZS_treatment21,1927b898-35ef-4403-a6ad-6913bb7b1f6b,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.8087607456727888,-0.4282983508727075,0.8116410697442719,-3.396767661479809,-0.8725683867221038,-0.7493003685519578,1.5741113716838966,0.531120673093288,-0.9854920169758572,-0.9870158973340856
D3,884.0,1.0,320a2dca-ee07-4d14-a7b8-178636636880,49.0,66.0,-24348.0,25140.0,792.0,884.0,884.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Small intestine,TCGA-D3-A8GQ,False,United States,f53a5da9-d352-5e96-bfff-65ccbdea4fff,not hispanic or latino,male,white,TCGA-D3-A8GQ_demographic,Dead,metastasis,0d93d7e9-6aff-42c4-bcbb-f480b27c2f04,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A8GQ_diagnosis5,Intra-abdominal lymph nodes,TCGA-D3-A8GQ_treatment11,0f715400-70b6-4442-a730-04cae429b735,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,0.5670674791905441,0.462691309783202,-0.794419689121563,-1.831884593029386,-1.5588735672701446,-0.4872276347623754,-0.781236053124079,-0.5314794231257756,0.0652713900669854,0.1971068831718658
EB,369.0,1.0,32e40e0b-e74b-428c-acd3-84ec6a80c024,-1.0,78.0,-28772.0,28772.0,0.0,369.0,369.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A5SF,False,Russia,4c7c97e7-54cb-5889-b29f-930e35180cd9,not hispanic or latino,female,white,TCGA-EB-A5SF_demographic,Dead,primary,20af2c82-936a-5ef9-98f0-270fb9e8e542,True,8721/3,Nodular melanoma,No,"Skin, NOS",TCGA-EB-A5SF_diagnosis,"Skin, NOS",TCGA-EB-A5SF_treatment2,118be81d-f46d-4225-86a1-6b5486eaa36f,unknown,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-1.7843413582835783,-0.6994947972135857,-1.261729605656276,-0.1691784062756262,0.2251702303943803,-1.2212587365845835,-1.1244010774427058,0.1031768843427269,-1.692832916275226,-0.2425072131101674
D3,3514.0,0.0,33d7cccb-6349-4337-8c5b-6e3e8b3c7af1,21.0,68.0,-25085.0,25907.0,822.0,,3514.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-D3-A2JA,False,United States,2057c229-02df-5510-8cf9-715851a2f61d,not hispanic or latino,male,white,TCGA-D3-A2JA_demographic,Alive,metastasis,2081abf2-847b-4ff1-bca6-cbd1012abf4d,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A2JA_diagnosis4,Not Reported,TCGA-D3-A2JA_treatment8,29a171f4-bc1a-44a3-be81-b07ce481e901,yes,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,-0.1161083077329077,0.4624832329860247,0.1312436137274817,-1.9729009877612955,0.4228282254490075,0.411242707288127,0.1946413843218353,1.832202040906975,-0.8264160096589407,0.4427918192710909
ER,383.0,1.0,3409f118-1798-48d6-9556-12a5c77ebefb,252.0,46.0,-16968.0,17325.0,357.0,383.0,383.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-ER-A19D,False,United States,fafdb341-2596-5a5e-9df3-4fe471764c37,not hispanic or latino,female,white,TCGA-ER-A19D_demographic,Dead,not reported,295f6798-f039-5980-bced-871fe30bc336,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-ER-A19D_diagnosis,"Skin, NOS",TCGA-ER-A19D_treatment2,45597ea1-5600-4a85-9721-21a8faa0864e,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.6390520398993851,0.0473447733025629,1.2526464030140996,-1.5090346516579896,-0.4654599031022471,-0.0261077831163077,1.4435091264594946,0.085064382702628,0.5683521745538616,0.1356962516590327
GN,308.0,1.0,3429967f-4f77-4894-bf27-c4a22698ca92,49.0,45.0,-16456.0,16565.0,109.0,308.0,308.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-GN-A266,False,United States,53ae805a-d6da-535b-b21c-727498d0f296,not hispanic or latino,male,white,TCGA-GN-A266_demographic,Dead,Progression,41346f90-4559-5208-8620-f6e0d92c9af6,True,8720/3,"Malignant melanoma, NOS",No,Skin of scalp and neck,TCGA-GN-A266_diagnosis,"Skin, NOS",TCGA-GN-A266_treatment2,18022f1f-273b-4dc5-9912-af0d75582b76,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.1824548219828564,-0.1738487611821334,0.3611166842367783,-0.7706555561289687,0.906434023847221,0.770219119791283,0.1538345070398881,0.3346144052995304,0.5603168564683073,0.725923852509029
DA,319.0,1.0,3582fb74-f43d-4fcd-8f22-bb1506fcff1c,,52.0,-19330.0,19436.0,106.0,319.0,319.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-DA-A3F3,False,United States,15287e9f-c350-59e8-aa0e-d22b20275a73,not hispanic or latino,male,white,TCGA-DA-A3F3_demographic,Dead,not reported,0aa22346-2562-5feb-aba9-81f90cb035a5,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-DA-A3F3_diagnosis,"Skin, NOS",TCGA-DA-A3F3_treatment2,78861657-e1bb-463c-a388-9916036a7ee0,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1178766901300567,-0.5321116513473155,0.4203720039313315,0.4408810342784301,0.1353555776878727,-0.1094639340750924,0.7118186147708748,-0.3099606530671207,0.7219548492617754,-0.7438945956972536
W3,6666.0,0.0,36f4be75-cbcf-431b-9199-dba295a905a1,1034.0,64.0,-23711.0,24745.0,1034.0,,6666.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-W3-AA1W,False,United States,683bd516-1bdc-5093-831e-92129ecbfbfc,not hispanic or latino,male,white,TCGA-W3-AA1W_demographic,Alive,not reported,163e7321-d78b-53f3-bb1c-80110eec1841,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-W3-AA1W_diagnosis,"Skin, NOS",TCGA-W3-AA1W_treatment2,9de64568-7e66-453a-ada0-3b19b83faae7,yes,Immunotherapy (Including Vaccines),0.0,0.0,0.0,1.0,0.0,0.0,0.0,Metastatic,-0.3211556537860222,-0.159537297896031,0.4731130939334001,0.2964648803640124,1.249441613243879,1.672101165767886,-0.0246119831574306,-0.1670731401285731,1.6674439439953266,-0.3234340348779443
EE,1871.0,1.0,3791bd88-c61e-46c3-aaa4-942c2169887c,,73.0,-26872.0,27956.0,1084.0,1871.0,1871.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2MC,False,Australia,3831904e-97ee-5e5d-91c1-668ad267a298,not hispanic or latino,male,white,TCGA-EE-A2MC_demographic,Dead,Progression,1c8506ae-862f-4b74-8555-9c56f79bb114,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-EE-A2MC_diagnosis2,"Skin, NOS",TCGA-EE-A2MC_treatment5,5137384d-0c46-4529-9b0a-750002e9de4b,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.7922916045316619,-0.3441656508760075,0.043047607150152,-2.066905643662247,0.2042926918268742,1.0767609728411514,0.6890493711975618,0.3198081539588169,-0.8575091970334766,0.5932490846344942
ER,1548.0,1.0,391eab51-b140-4bc2-bc8c-99400fba9066,1227.0,37.0,-13648.0,15127.0,1479.0,1548.0,1548.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-ER-A19Q,False,United States,9b8eb14a-9668-55fd-b015-bae4e163d1ed,not hispanic or latino,female,white,TCGA-ER-A19Q_demographic,Dead,metastasis,12b01de8-e360-461f-bba8-92096fa917d6,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-ER-A19Q_diagnosis7,Spleen,TCGA-ER-A19Q_treatment19,38c0bd48-d118-4595-b66d-accd7e82c68e,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Primary,0.9211265004655697,0.031594172721491,0.4294685251310235,0.434647423310611,0.2033347446411975,0.3163553023409431,0.1029518642763647,0.6896769374506521,1.2900169017448726,-1.3446675996749125
D3,1280.0,0.0,3a27966b-2c4c-402f-b71b-df7925c36a7c,19.0,68.0,-24882.0,25451.0,569.0,,1280.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-D3-A2JH,False,United States,cd772663-08bf-518f-aa9b-f5c219c32772,not hispanic or latino,male,white,TCGA-D3-A2JH_demographic,Alive,Progression,53744179-0aac-4c01-8f2f-48dcb555104f,True,8720/3,"Malignant melanoma, NOS",No,"Connective, subcutaneous and other soft tissues of trunk, NOS",TCGA-D3-A2JH_diagnosis2,"Skin, NOS",TCGA-D3-A2JH_treatment4,864bf762-1ebe-4566-afd3-0fe78b577947,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4392695144645451,0.3317037438119989,-0.0001444073315726,0.306495593793066,0.9435390883997388,1.380327559634274,-0.1783950026216769,1.1555707296376094,0.1747380422470014,0.0014340425301598
D3,5101.0,1.0,3a71189d-aabd-475a-997c-b66cbc978e06,4502.0,25.0,-9344.0,14182.0,4838.0,5101.0,5101.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-D3-A8GV,False,United States,f54c070f-9614-58d2-b964-272c4805d285,not hispanic or latino,male,white,TCGA-D3-A8GV_demographic,Dead,not reported,0259b7b2-a0f6-5f49-9291-218d08d928d0,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A8GV_diagnosis,"Skin, NOS",TCGA-D3-A8GV_treatment,6e44d087-ed6f-5fca-9cda-b96ba449e530,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3476585820109369,0.0406575562301459,-1.3217260226255052,-0.1145428047471453,-0.8527084282080684,0.1863033332961666,-0.6659839799544878,1.2692769899337788,-0.0927565322822482,0.701087106730731
EE,2073.0,1.0,3a8cfea5-1dcd-4dbb-bbd9-5bb602c54922,,72.0,-26447.0,28364.0,1917.0,2073.0,2073.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-EE-A184,False,Australia,9dc99812-6098-5aa1-91bd-51a851798adf,not hispanic or latino,male,white,TCGA-EE-A184_demographic,Dead,primary,2b051805-4ddb-4289-85ae-d2859264fa7e,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A184_diagnosis3,"Skin, NOS",TCGA-EE-A184_treatment5,58f9e0c6-bc63-4c3b-bd85-db9f2154c0fe,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.0749599995402978,0.6701117124157835,-0.580466422604531,0.6716439337545546,-0.3459997964002348,0.3787969495522965,-0.2072961694575661,0.3827706596601078,1.527466373867267,-0.5446665406177368
RP,10.0,0.0,3b618072-3bf5-4609-865d-ce3611c729cf,0.0,77.0,-28394.0,28394.0,0.0,,10.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Brain,TCGA-RP-A693,False,United States,045c71c0-088d-5ed5-af84-c3d2209be380,not hispanic or latino,male,white,TCGA-RP-A693_demographic,Alive,metastasis,191d0ecb-2850-5c97-9a8d-141ceaf93fcb,True,8720/3,"Malignant melanoma, NOS",No,"Brain, NOS",TCGA-RP-A693_diagnosis,"Skin, NOS",TCGA-RP-A693_treatment,1609b913-807d-56e4-a992-bd41968e68bf,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.2214843309022384,-0.1470452595476791,-0.4924308543578153,0.1872589075039688,0.2597473690474072,0.292552462826997,-1.0093758472412937,0.7957644470569392,-0.2835079964001888,-1.736518168839551
D3,1429.0,0.0,3b62e38c-d473-4329-86ab-5d4977f92b09,588.0,57.0,-20979.0,20979.0,0.0,,1429.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A3C7,False,United States,9ff3866b-aa8f-5e46-8a83-e720a932f0ec,not hispanic or latino,female,white,TCGA-D3-A3C7_demographic,Alive,Progression,da4bfd1d-1fb4-5f3e-af0b-be11115a1156,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of inguinal region or leg,TCGA-D3-A3C7_diagnosis,"Skin, NOS",TCGA-D3-A3C7_treatment2,37111209-2c6a-40b6-bd59-4e4514ab4caf,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1616735369234705,-0.5917254569674544,-0.1818387617306371,-1.5015101422276644,-0.5468861378077295,0.6417247969286276,-0.4717511163358957,-0.53521692346421,-0.4627305258736384,0.4330001383934534
EE,2296.0,0.0,3d0cbbc9-f2ef-4d3e-ad55-b5cae6787c28,1206.0,70.0,-25711.0,27426.0,1715.0,,2296.0,TCGA-SKCM,,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A2GM,False,Australia,24687840-2230-5540-aca8-1e23f0b4073f,not hispanic or latino,female,white,TCGA-EE-A2GM_demographic,Alive,primary,164c4736-5362-497f-8742-cdef7aee5e6f,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A2GM_diagnosis3,"Skin, NOS",TCGA-EE-A2GM_treatment3,1b830848-b4a4-4f37-b71c-fc61534a48dc,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.174468912355163,0.7727743059009122,0.4870651672822137,0.589713633600641,-0.7444226990139509,-0.0945772290762768,0.1955663977900108,0.0784518821038622,0.9001292937675445,-0.9498684501547672
BF,484.0,0.0,3dd5a206-d7f3-42f1-b9cc-4b31c76d495d,-1.0,46.0,-17025.0,17509.0,484.0,,484.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-A1PU,False,Russia,ed65859a-5a1f-53ee-afbe-2760014049df,Unknown,female,white,TCGA-BF-A1PU_demographic,Alive,metastasis,2857d20f-a1b3-49f4-8f89-70db1a623514,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-BF-A1PU_diagnosis3,"Lung, NOS",TCGA-BF-A1PU_treatment7,7807c7f9-2111-4724-82f3-f4e3bcd04280,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.6469750177011138,0.4859323150884166,-1.5664065765324535,0.7048999763943502,-0.3490474011348996,-1.6344027225364357,-0.1765642985618572,0.2863144009259367,0.6115565659993786,0.7703177139934296
EE,1949.0,0.0,3df3f0a9-ba52-4c50-910f-828439b0ee14,1292.0,43.0,-15896.0,17188.0,1292.0,,1949.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A3J7,False,Australia,983efdf5-f346-589b-a749-d04e31a3afd9,not hispanic or latino,male,white,TCGA-EE-A3J7_demographic,Alive,Progression,18ac68f1-ac7d-4a99-8bcc-3a908d2a3b32,True,8720/3,"Malignant melanoma, NOS",No,"Connective, subcutaneous and other soft tissues of upper limb and shoulder",TCGA-EE-A3J7_diagnosis2,"Skin, NOS",TCGA-EE-A3J7_treatment5,31da41fe-998e-4109-aa4d-b4d4383c4ed6,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.143240859106997,-0.2334549646556486,0.2919418489664058,0.2801729467936281,-0.009513939165246,-0.2407379512154742,0.2384581595937411,-0.5195481720453935,-0.1179105715065913,0.5900976510843289
BF,318.0,0.0,3e39c93e-ccae-48d5-9b27-62dae0e75c07,0.0,76.0,-28073.0,28073.0,0.0,,318.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-AAP7,False,Russia,1b68ed29-fcf2-5699-8aa1-56212b02632a,not hispanic or latino,female,white,TCGA-BF-AAP7_demographic,Alive,primary,7c9e703e-e1ab-5110-a8db-815c0beb3e94,True,8771/3,Epithelioid cell melanoma,No,Skin of lower limb and hip,TCGA-BF-AAP7_diagnosis,"Skin, NOS",TCGA-BF-AAP7_treatment5,5a30e8d4-2633-45bb-8eaa-827ecac86aa3,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.4059911868610671,0.5171085021119199,0.0406164252821817,0.5065342150310137,1.5481442990336554,0.6080973710465507,-0.8601185793623465,-0.1795793912610205,-1.166461354728773,-0.3521348333649903
ER,424.0,1.0,3ebb2374-4518-4e19-9b65-9c3e66252c4c,56.0,83.0,-30454.0,30564.0,110.0,424.0,424.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Vulva,TCGA-ER-A197,False,United States,43b03a14-5d6e-5417-bc9b-641e95235627,not hispanic or latino,female,white,TCGA-ER-A197_demographic,Dead,not reported,03aac1e2-dc97-4e1b-b42e-3b4269f86e82,True,8720/3,"Malignant melanoma, NOS",No,"Vulva, NOS",TCGA-ER-A197_diagnosis2,"Skin, NOS",TCGA-ER-A197_treatment4,0c9a0434-edc9-4f45-986e-89a54b95b6f3,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.1181999381355943,0.6460099881407467,-0.4649551699650564,0.2287211857040368,1.5940885312282236,0.622092979764544,0.2156135182930597,1.3604144981863335,-0.1151156782594423,-0.8873555793475735
ER,396.0,1.0,3fea3f02-2db3-44e0-984e-c61130d92c9b,55.0,36.0,-13297.0,13361.0,64.0,396.0,396.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-ER-A19E,False,United States,0e2c539a-7479-5a61-9fc3-b3daea44ef9f,not hispanic or latino,female,white,TCGA-ER-A19E_demographic,Dead,metastasis,0024d776-86b6-4d54-a033-d175a14a10dd,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-ER-A19E_diagnosis4,"Lymph nodes of head, face and neck",TCGA-ER-A19E_treatment9,1180d08a-c4af-4098-8319-3034a94fcb1a,yes,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.5340927755989755,0.2019730400588103,-0.0712240653103228,-0.8297032799605123,-1.7878662152307128,-0.8981099266415656,0.610628262727231,0.8713769539036962,0.8385251884449606,1.5167633454666067
EE,3869.0,1.0,40005536-5325-4063-929d-0917726607cb,,72.0,-26540.0,30216.0,3676.0,3869.0,3869.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A3J4,False,Australia,2ab27a35-8634-55fe-b20e-e8f1fd5658f4,not hispanic or latino,male,white,TCGA-EE-A3J4_demographic,Dead,recurrence,05e3efab-0912-4ea1-87e1-c6b7d1f23c17,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A3J4_diagnosis10,Not Reported,TCGA-EE-A3J4_treatment26,0e01d974-a5df-439d-b505-4348a03db2b6,yes,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,-0.2743266780342795,-0.0711030236055784,0.5817561584993841,0.6171401849969955,-1.1388281431473892,-0.1755869865596055,0.0306127526857127,-0.4018169113847595,1.3374136330611142,0.473908020465917
DA,430.0,1.0,40a4b549-09a4-4621-9715-e44d4b9d1198,,68.0,-25083.0,25421.0,338.0,430.0,430.0,TCGA-SKCM,Consent Waiver,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-DA-A95Y,False,United States,1072fc9d-f2ab-598e-b98a-939a5ce83102,not hispanic or latino,male,white,TCGA-DA-A95Y_demographic,Dead,Progression,0a128f7d-a75e-4c01-b938-0f62dd84a993,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-DA-A95Y_diagnosis2,"Skin, NOS",TCGA-DA-A95Y_treatment5,613f8e01-48fa-4b27-8ac2-a659fcfef3e0,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0323097148612554,1.3829758792580853,-0.6649454451468485,0.5791540929356074,0.747388662745185,-0.5256214345466513,-0.9954851945583468,1.090595723754085,-0.2125875802537748,-0.1175390105838496
DA,4407.0,0.0,40e17bf8-6c19-4e5e-b60d-ad54f504a970,,42.0,-15357.0,17367.0,2010.0,,4407.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-DA-A1HY,False,United States,387f4fd9-da8b-5502-a421-4f9187ca531f,not hispanic or latino,male,white,TCGA-DA-A1HY_demographic,Alive,primary,177f450a-5590-4f0f-ab7c-bb21932b7f66,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-DA-A1HY_diagnosis3,"Skin, NOS",TCGA-DA-A1HY_treatment3,46a254c5-cf10-41a1-b78d-d001aa16b1d9,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0808047034169708,0.6063182121566155,0.2598003729972391,-1.830344912813283,0.3015382380904591,0.2149524618541738,0.2708288965625146,-0.9397294600930584,-0.5698681003476938,0.7936489582398512
EE,1618.0,1.0,41c4f51a-e908-42f9-9805-5cff5b12708c,922.0,44.0,-16430.0,17787.0,1357.0,1618.0,1618.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A3JA,False,Australia,9d9b1080-db0a-5b44-b364-63ec57790364,not hispanic or latino,male,white,TCGA-EE-A3JA_demographic,Dead,primary,1b9b1021-84a5-4810-ac71-2b2a1c6ad604,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A3JA_diagnosis3,"Skin, NOS",TCGA-EE-A3JA_treatment3,f2e20621-15ad-4522-870e-637427621339,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3785290396186035,-0.5202671640016623,0.4784044191937251,0.7658507140938343,0.2850623516810487,-0.0617175980245581,0.4127433002397251,-0.8383857009163199,0.8978002160615859,0.489009251682038
ER,2365.0,0.0,41fcb9d3-9fb0-4625-98f4-1f564095ebc2,13.0,79.0,-29167.0,30784.0,1617.0,,2365.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-ER-A19A,False,United States,e8d74c55-7f7f-5ed7-8fb4-1e5f0e92fbb1,not hispanic or latino,male,white,TCGA-ER-A19A_demographic,Alive,Subsequent Primary,11c8751d-9887-494e-be38-f25475737c18,False,8130/3,Papillary urothelial carcinoma,Yes,Not Reported,TCGA-ER-A19A_diagnosis3,"Bladder, NOS",TCGA-ER-A19A_treatment6,58bc828b-cee4-4ccd-a3c7-3e0ef16b56b9,yes,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,0.4027724801880098,-0.4345329820436492,0.2988716622517183,-1.0556764235861924,0.8438788727482583,1.386325685475306,0.9174739676134456,0.6765956862661369,-0.2320353790985223,0.2448893253706841
D3,938.0,1.0,4274d9ab-679f-453c-b086-7535cf798f0a,32.0,48.0,-17871.0,18332.0,461.0,938.0,938.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A8GB,False,United States,5a5a7c91-f537-526e-8237-22d55af4056c,not hispanic or latino,male,white,TCGA-D3-A8GB_demographic,Dead,primary,62ac1cbc-257d-4cda-9bf2-f145653bb7f7,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-D3-A8GB_diagnosis3,"Skin, NOS",TCGA-D3-A8GB_treatment3,f93f4a48-0a72-425a-a21f-b1a570f67a84,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.6078309114446009,0.4241156553823524,-0.3803587781679319,0.1145262140844841,0.7784806742698839,0.8594958801665623,0.1075365592258011,-0.0043481253937258,-1.7996211290933908,-0.8769504718782234
D3,7342.0,0.0,42fb358c-cc9b-4963-9d16-4a7aa915002a,2650.0,18.0,-6684.0,9316.0,2632.0,,7342.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Small intestine,TCGA-D3-A8GJ,False,United States,b3db56c6-141b-59b1-b1a5-b63027d28033,not hispanic or latino,male,white,TCGA-D3-A8GJ_demographic,Alive,primary,168218e4-e680-4981-aae1-f698ae09c1c8,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-D3-A8GJ_diagnosis3,"Skin, NOS",TCGA-D3-A8GJ_treatment3,5c463297-0f55-4329-874f-14b2c066d414,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.7633235738184775,-0.3586394243250438,0.0073082065848888,0.4715337437844374,1.511931334901586,1.3913154588328105,-0.5088809097411675,0.1774956410723346,-0.8004467932375122,-0.684314118242867
FW,531.0,0.0,436a0116-eada-4b8f-aafe-29eb7f3241c4,6.0,59.0,-21731.0,21731.0,0.0,,531.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Vagina,TCGA-FW-A3I3,False,United States,cb1b7942-35a1-5b98-b61e-8cbaef5319ea,not hispanic or latino,female,white,TCGA-FW-A3I3_demographic,Alive,metastasis,80224f3a-b0cd-569a-ac85-c9a0625cd385,True,8720/3,"Malignant melanoma, NOS",No,"Vagina, NOS",TCGA-FW-A3I3_diagnosis,"Skin, NOS",TCGA-FW-A3I3_treatment3,66e7e2e1-af63-465f-8318-4924370b3d00,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.3337236485918217,-0.5766904489286633,0.0589657997581778,0.4656781822114816,-1.1211074670729502,-0.5053471611001125,0.5629165081781013,0.2430456470079268,-0.2587033188317386,0.4371215515710739
EE,4088.0,0.0,449c9d70-d8aa-41d4-beeb-0bbfc73a23d8,2252.0,61.0,-22535.0,26308.0,3773.0,,4088.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2MR,False,Australia,0d52d3de-6685-598a-9ec3-543954363458,not hispanic or latino,male,white,TCGA-EE-A2MR_demographic,Alive,Synchronous primary,392d696c-abc6-4271-bbca-7b5ccc282390,False,8090/3,"Basal cell carcinoma, NOS",Yes,Not Reported,TCGA-EE-A2MR_diagnosis7,"Thorax, NOS",TCGA-EE-A2MR_treatment3,1c0ca512-6bea-4757-9cc8-9e27a7e46e23,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3716644254077536,-0.4214192617783976,0.6494170174807978,-2.0453117721017184,0.0822262108818199,1.355150017806407,0.5661305664287697,-0.0131168761877413,-0.9812996771051326,0.032469172395739
D3,3259.0,1.0,44b5453a-3009-43b9-bc34-71a11a6d5e63,608.0,73.0,-26782.0,27378.0,596.0,3259.0,3259.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A8GM,False,United States,6cae7cbe-2742-5c81-9ac1-34be5e975b81,not hispanic or latino,male,white,TCGA-D3-A8GM_demographic,Dead,Progression,43572e02-dc43-4054-bfd2-e0516713dc60,True,8720/3,"Malignant melanoma, NOS",No,"Lymph nodes of head, face and neck",TCGA-D3-A8GM_diagnosis2,"Skin, NOS",TCGA-D3-A8GM_treatment5,018f5d14-d1db-4997-9097-7a9f8440d90e,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,1.0494381026193935,0.5099961819344225,-0.0361713206888348,0.6700347634688878,0.3755891883497724,0.9537355721785584,-0.0726014678600452,-1.1866919824556594,1.1778718102030072,-0.3896041359802195
EB,2076.0,0.0,44eb0daa-a3ed-4ab5-a3e8-91911bab0dea,1371.0,57.0,-20978.0,22350.0,1372.0,,2076.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EB-A5SG,False,Russia,e91157f8-cd0b-59a7-beec-0055836456bd,not hispanic or latino,female,white,TCGA-EB-A5SG_demographic,Alive,Progression,3d89a2b6-a88c-4b75-b791-43036be480e2,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-EB-A5SG_diagnosis2,"Skin, NOS",TCGA-EB-A5SG_treatment4,36a6a88e-95a8-4de7-a1a2-8957a889e564,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.2106708709062944,-0.5117240891820113,-0.1090021697517524,0.1085698023103557,1.048287641641979,1.5403161246808077,-0.3480093296245686,0.7177081899888996,0.3289229863814035,-0.6710843590916291
FS,1478.0,1.0,4537c0e1-b2bd-425f-a6f4-27f4733dc25a,,39.0,-14387.0,15760.0,1373.0,1478.0,1478.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-FS-A1YX,False,Germany,81201012-af16-5d62-bd44-4f3ca9b31253,not hispanic or latino,female,white,TCGA-FS-A1YX_demographic,Dead,primary,1e79699b-e278-5680-80b3-48f5381d0708,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-FS-A1YX_diagnosis,"Skin, NOS",TCGA-FS-A1YX_treatment2,00fb13fa-57ff-413d-aac8-b2e846b34222,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3657202473728714,-0.6912055752309932,-0.2781399662104509,0.3552928426797878,0.5339811868400628,-1.0013752914083842,0.5045943975276524,0.4241706634089031,-1.1226746938567678,-0.4856628602620264
BF,853.0,0.0,455f982c-a067-46ac-bf89-3e535d0ffca0,0.0,71.0,-26240.0,26240.0,0.0,,853.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-A1PZ,False,Russia,a951cc17-255b-52c1-8b16-06a110a1f256,not hispanic or latino,female,white,TCGA-BF-A1PZ_demographic,Alive,primary,18597159-b888-4ca1-a563-41becd85422d,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-BF-A1PZ_diagnosis2,"Skin, NOS",TCGA-BF-A1PZ_treatment3,2953fe9c-c7d3-41e5-a646-462368c259fa,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.0556468648390481,-0.5311954552496057,-0.1718277213761931,0.6184997497212752,0.4903491252924419,-0.2822303502651914,-0.7435929750307257,0.7661519443755096,-0.6070168897577203,-0.0699387927158156
GF,480.0,0.0,46801be1-f035-421f-aae4-81baf3bb8d40,4.0,78.0,-28774.0,28778.0,4.0,,480.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Parotid gland,TCGA-GF-A6C9,False,United States,d97a93cc-1c18-5d5b-bfb2-b26d4f28ea96,not hispanic or latino,male,white,TCGA-GF-A6C9_demographic,Alive,not reported,00737eab-036f-562d-85a0-25862d55673e,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-GF-A6C9_diagnosis,"Skin, NOS",TCGA-GF-A6C9_treatment,8ae9dfd5-3326-5df8-a066-ea2623a21d6c,yes,"Radiation, External Beam",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1403744983875689,-0.628986470329321,-0.0157947271816893,-2.4777389243169514,2.0644056544000366,0.4795911734125758,-0.2269582605184422,0.2637456488823219,-1.581852363586339,0.7457225231616211
D3,3453.0,1.0,47a16bf2-229b-4e9a-8b5e-3dcc61fa9106,3245.0,30.0,-11105.0,14384.0,3279.0,3453.0,3453.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A2JG,False,United States,2569089b-aaec-5cd4-878d-f5b8441b3dff,not hispanic or latino,female,white,TCGA-D3-A2JG_demographic,Dead,metastasis,1afc121e-6f70-4740-ac9a-0b31d9507841,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A2JG_diagnosis4,"Pelvis, NOS",TCGA-D3-A2JG_treatment7,0d31a599-4c4c-4b69-9390-d265bba3572c,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1402213785489545,-0.4122356248030558,-1.3629298506277412,0.4820664420156642,-0.2926778768211365,-0.5205068259659575,-0.262152066568382,-0.362573157831214,0.7084461985672209,0.470780843988792
EE,5487.0,0.0,47ffe5ef-7d1f-44eb-9307-104771b39381,2881.0,18.0,-6831.0,7834.0,1003.0,,5487.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2MK,False,Australia,2ef54124-b020-58b1-819a-ed8a137a892f,not hispanic or latino,female,white,TCGA-EE-A2MK_demographic,Alive,primary,27b8afad-e3d0-4701-96a7-cef9bf235492,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A2MK_diagnosis3,"Skin, NOS",TCGA-EE-A2MK_treatment3,51022c14-96e9-44d8-bc04-014479187738,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.1811503307842485,-0.6886796185747475,-0.4178765355552903,0.0333209419662205,1.1563126549751417,0.4549811636269947,-0.2224106109582904,-0.3628606578572466,1.2973534965186388,0.809794912666238
EE,5286.0,0.0,4801c721-166f-4939-8ab7-aa024bec7089,3064.0,44.0,-16353.0,21629.0,5276.0,,5286.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2GE,False,Australia,444e8d8a-c60d-5d0c-b82e-72d47e9ebd83,not hispanic or latino,male,white,TCGA-EE-A2GE_demographic,Alive,Subsequent Primary,41ace8f0-2983-4a7f-a20c-76f3a67fa0a8,False,8090/3,"Basal cell carcinoma, NOS",Yes,Not Reported,TCGA-EE-A2GE_diagnosis5,Not Reported,TCGA-EE-A2GE_treatment10,6b7786eb-016d-4af8-a46a-5d55b05c85cc,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0112363836172962,-0.5548423691559308,0.2936942467554265,-0.4242118529071972,0.6732803780762829,1.0341639243404253,0.3969583281006743,1.0155582169593955,-0.7476931831975699,0.1615196969883377
EE,1927.0,1.0,4811d530-ae99-4670-9f99-86996d667676,1845.0,68.0,-25095.0,26890.0,1795.0,1927.0,1927.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A29A,False,Australia,f0d4845a-a2d7-5f95-8ca9-a17965e3ae48,Unknown,male,white,TCGA-EE-A29A_demographic,Dead,metastasis,055ce728-aa8f-4788-9bdf-a35048c5567f,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A29A_diagnosis12,Liver,TCGA-EE-A29A_treatment31,91f2e499-2329-4bb0-b445-f43986cd7342,unknown,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.3485084987172345,-0.4071979462940613,0.7457177000065784,-1.2532415942400663,-0.2092912560339957,-0.3900406017455167,0.0267206192631927,-1.5945107693838934,0.0653878439522831,1.6511322645036275
FS,1505.0,0.0,49a6f6a6-bf6f-45cf-93dc-b006b4a0637d,25.0,65.0,-24087.0,24759.0,672.0,,1505.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A1ZW,False,Germany,805a8625-83f6-5c2c-b7e5-476945d97d66,not hispanic or latino,male,white,TCGA-FS-A1ZW_demographic,Alive,primary,84f01f71-b547-5ed8-8e25-f25850f09708,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-FS-A1ZW_diagnosis,"Skin, NOS",TCGA-FS-A1ZW_treatment,aec8b1e7-83dc-527d-8afa-129628f62092,yes,Immunotherapy (Including Vaccines),0.0,0.0,0.0,1.0,0.0,0.0,0.0,Metastatic,0.7747038234357444,-0.0876450599843832,0.7304977408194316,0.2608668826761055,0.0833884982807325,0.4957613003115556,-0.0353518248774508,0.2677706492467889,0.493588780192618,0.5207678195175353
FR,0.0,1.0,49f961af-1126-431d-93cd-18941c1738f3,0.0,89.0,-32872.0,32872.0,0.0,0.0,0.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-FR-A726,True,United States,e7abae5b-14a2-5e7e-b041-e66b5a5d7a54,not hispanic or latino,male,white,TCGA-FR-A726_demographic,Dead,primary,2a05b9a0-f56d-4aba-bbbf-d0d8694bf414,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-FR-A726_diagnosis2,"Skin, NOS",TCGA-FR-A726_treatment3,934321ed-d589-48b9-9067-9dc52d67e880,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.2554274395160829,-0.5328408217619554,0.552235732229772,-0.0387740599210836,-1.023712625478381,-1.0016600444305268,0.2186692401532131,-0.0054981254978588,0.2874654032153569,-0.2399109961189202
XV,0.0,0.0,4a2135bd-31ff-4564-9e87-1164b3422f61,0.0,89.0,-32872.0,32872.0,0.0,,0.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-XV-A9VZ,True,Russia,0e5c9fc1-ef15-597a-939a-cb57e5db6f42,not hispanic or latino,female,white,TCGA-XV-A9VZ_demographic,Alive,primary,ca7eaaa9-91dd-4daf-8dc9-25049519dd3d,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-XV-A9VZ_diagnosis2,"Skin, NOS",TCGA-XV-A9VZ_treatment3,200fc6ff-6659-44c8-a3b2-74323c67f6e1,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.3139033271890795,-0.4149330945528206,1.1920847091328524,-1.0485347225346529,-0.8193890682852024,-1.2098535984347258,0.9443806989160402,-1.726760781359208,-0.720908789579054,0.0830206844272769
EE,4942.0,0.0,4a4f5ee9-b588-4357-b058-effbfb53e2c3,3355.0,72.0,-26466.0,30988.0,4522.0,,4942.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2MS,False,Australia,8316154f-24ac-51ac-93f8-2423f8dcbe60,not hispanic or latino,male,white,TCGA-EE-A2MS_demographic,Alive,Progression,23492c2c-8d48-499f-9ea9-cc0e51f86332,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-EE-A2MS_diagnosis2,"Skin, NOS",TCGA-EE-A2MS_treatment4,574a2d2d-456f-4386-8877-fab9224807b2,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2088080843801438,1.5236183874927267,0.6559096105880994,0.2596959311782584,-0.5344990258214376,-0.1292118184175297,0.6936060588879542,-0.9610044620195212,1.0865719641294629,0.4651136343023802
W3,3195.0,1.0,4a9e5dc0-6fc3-47e0-8470-dac16ce16da3,1035.0,26.0,-9527.0,12479.0,2952.0,3195.0,3195.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-W3-AA21,False,United States,fea9688a-0146-527a-b367-a071bd74f9b7,not hispanic or latino,male,white,TCGA-W3-AA21_demographic,Dead,metastasis,41242bbb-988d-43df-a333-2b58732629c9,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-W3-AA21_diagnosis4,"Thorax, NOS",TCGA-W3-AA21_treatment8,13e733ab-c22f-44ac-95d3-214ec8c53aae,yes,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.144662553091366,-0.1408695463687144,0.1170481158797888,0.3641870380381605,0.6319345834823654,-0.7658787195413622,-0.2874807761665475,-1.1010169746977374,-2.51802514749606,1.1516046096939572
ER,2829.0,1.0,4afa82f8-b317-4763-808c-c944ca6661d3,119.0,64.0,-23650.0,26085.0,2435.0,2829.0,2829.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-ER-A3ET,False,United States,278a0733-a2b3-5bbf-9d03-89cd1fcc503d,not hispanic or latino,female,white,TCGA-ER-A3ET_demographic,Dead,primary,0ff83e78-1677-4a67-b9b5-b80ffb0cce02,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-ER-A3ET_diagnosis3,"Skin, NOS",TCGA-ER-A3ET_treatment3,f21a1c88-30cc-412c-aab4-26962474f3f5,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.5029537434643113,-0.1616960186363,0.850778647605679,0.113290470587311,0.1082091540059993,0.0389360923503669,0.6724142420833396,1.3290769953487058,0.5012747366222772,0.6584094955986936
FS,2273.0,1.0,4cdb18f5-47bf-475f-b34c-fa4912515268,,52.0,-19175.0,19864.0,689.0,2273.0,2273.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A1ZP,False,Germany,ca188a4c-2acd-5dd1-ad5c-e169a6777508,not hispanic or latino,male,white,TCGA-FS-A1ZP_demographic,Dead,Progression,030183ef-2859-4dfc-915f-f06a0096d4c4,True,8720/3,"Malignant melanoma, NOS",No,"Lymph node, NOS",TCGA-FS-A1ZP_diagnosis2,"Skin, NOS",TCGA-FS-A1ZP_treatment4,7d04a3eb-4dcb-4d98-bb0a-e782799a3aa3,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2757399399649638,0.1777439251765271,1.155698754439712,0.7708193712937363,-0.998731476615482,-0.2476860919037743,1.102947604358502,0.3075894028523996,1.266260309144103,0.5102580569323298
FS,1525.0,1.0,4d22dce6-0f25-44ee-89e7-5b5ee2ee9799,,46.0,-16944.0,18371.0,1427.0,1525.0,1525.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-FS-A4F2,False,Germany,195387fd-06f2-5dea-9738-c1df012f1f69,not hispanic or latino,female,white,TCGA-FS-A4F2_demographic,Dead,primary,4a677b95-542f-5e7d-b767-37da8f7ff836,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-FS-A4F2_diagnosis,"Skin, NOS",TCGA-FS-A4F2_treatment,6d35ef61-4854-5088-aada-4cd73d9ada91,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2568076201772475,-0.4822070084171793,-0.8963697647125103,0.0846041346959324,-0.8925684714438537,-1.2936585078072798,-0.2438618545945162,0.8493832019121492,-0.4831099558007688,-0.1440215392816094
EB,636.0,1.0,4e9d1a69-1f10-4500-9dda-f8eb1ccc6576,-5.0,42.0,-15516.0,15853.0,337.0,636.0,636.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A4IQ,False,Vietnam,36acdedd-5656-51cf-a9a6-6ecfc9cdeddb,not hispanic or latino,female,asian,TCGA-EB-A4IQ_demographic,Dead,primary,16801dfa-4728-43a0-baba-5bb5246681c5,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A4IQ_diagnosis2,"Skin, NOS",TCGA-EB-A4IQ_treatment3,726f36d7-5107-4275-a02f-fe7e4cc756b6,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.2176542982287017,1.9352695022662023,-0.2600761056510653,0.3166274222415564,-0.8623644666117946,-0.9216592555034332,-0.287679306677623,-1.278835740799331,-0.8837113212255024,0.3444228232352969
FS,2367.0,0.0,4eb16fb1-0fcf-4c47-80fa-b7acc3a59a12,52.0,67.0,-24717.0,26545.0,1828.0,,2367.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-FS-A4F0,False,Germany,069530c6-86da-5efc-b93d-4506f375be41,not hispanic or latino,female,white,TCGA-FS-A4F0_demographic,Alive,Progression,28117cf5-b5c1-42a9-9a4c-5ce7a9fccd2f,True,8720/3,"Malignant melanoma, NOS",Yes,"Connective, subcutaneous and other soft tissues, NOS",TCGA-FS-A4F0_diagnosis2,"Skin, NOS",TCGA-FS-A4F0_treatment7,248412b7-684d-45c3-83e1-52807d2d565f,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3326873613198141,0.0552048214332165,0.7991370629825062,0.193446745932779,0.2253957728247264,-1.1470420702876127,-0.6656214230585829,-0.1683668902457225,-0.3293908272075552,-1.8217951136692665
D9,468.0,1.0,4f7e7a0e-4aa2-4b6a-936f-6429c7d6a2a7,223.0,66.0,-24192.0,24527.0,335.0,468.0,468.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D9-A3Z1,False,Poland,c4b1bb27-f62e-56a8-9651-f7851028f910,not hispanic or latino,male,white,TCGA-D9-A3Z1_demographic,Dead,primary,397ef965-71ee-41ec-a014-aed0639df676,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-D9-A3Z1_diagnosis3,"Skin, NOS",TCGA-D9-A3Z1_treatment3,3c657458-49c5-4d17-8f27-54a860566a18,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4108720438158696,-0.02845936957571,-0.5933595654536075,0.3621163461121668,0.2509551585058014,0.6181731461444483,0.1781849451554155,2.291627082508183,1.1715833003969214,0.0271641186596324
EB,362.0,0.0,50dc9c63-c491-4afc-ab12-74b40eba58b6,-5.0,66.0,-24408.0,24408.0,0.0,,362.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A85I,False,Ukraine,656f0205-d7d0-5a8b-b21a-7698ae270fbe,not hispanic or latino,male,white,TCGA-EB-A85I_demographic,Alive,primary,01782933-3e23-534a-977e-dae2251593d5,True,8720/3,"Malignant melanoma, NOS",No,Skin of lower limb and hip,TCGA-EB-A85I_diagnosis,"Skin, NOS",TCGA-EB-A85I_treatment5,2e642eb1-00f0-4e5c-be67-499278a94a09,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.2632271504971332,0.6076535404627375,-0.2353138769059071,0.1168092180478721,1.594059021803382,0.6592270571443474,-0.7671619109501546,-0.5431231741801251,-1.0719007998668892,0.5649424861682713
D3,1714.0,0.0,50e4cdbc-b10b-4c6c-9981-68defa1a8fe0,850.0,60.0,-22119.0,22957.0,838.0,,1714.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A51H,False,United States,8ca4d08b-c0f5-540f-b4ca-6a1ecd33e593,not hispanic or latino,male,white,TCGA-D3-A51H_demographic,Alive,metastasis,3b5547fa-5d21-4a2b-83b0-0367e0163b0d,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A51H_diagnosis4,Not Reported,TCGA-D3-A51H_treatment10,2f1b4be0-7cb0-4e8b-a393-69f9a494c286,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,-0.2173031336559519,-0.0870671055311764,0.2290200976341439,-0.2844523561853793,0.6577746890048447,1.1017263148884266,-0.0894404457765121,-0.470241917580683,-2.294433687724115,-0.271522447245236
FW,1691.0,1.0,511aa521-f38d-4ab7-9611-d8c1fec4c22b,1445.0,72.0,-26589.0,28031.0,1442.0,1691.0,1691.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Bronchus and lung,TCGA-FW-A3TU,False,United States,13d88110-6e26-5823-8d33-8fe2f63d4638,not hispanic or latino,female,white,TCGA-FW-A3TU_demographic,Dead,primary,47636276-8fb6-40c3-931f-532254a63603,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-FW-A3TU_diagnosis3,"Skin, NOS",TCGA-FW-A3TU_treatment3,3d90a042-f1ba-4557-8337-a7e41679020d,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.5227501154323726,-0.1924283105984963,-1.102411435975417,0.4527058492357179,0.9663211681965396,0.1371626772267642,-0.5333122251156872,-0.2370793964676812,-0.7652777198775493,-0.7689041197676133
ER,1078.0,1.0,51b4e55c-5307-4a13-9b2a-fbd58575335e,412.0,46.0,-16948.0,17460.0,512.0,1078.0,1078.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-ER-A195,False,United States,b8fad3f7-de8b-5799-b38e-308ec3a6c8a3,not hispanic or latino,male,white,TCGA-ER-A195_demographic,Dead,primary,11762761-561b-54f9-882e-fa4aaf12d60b,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-ER-A195_diagnosis,"Skin, NOS",TCGA-ER-A195_treatment2,8a20ea9d-4ff6-470a-a073-c3a3667d4729,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.5325713865043862,-0.0057652444631985,0.5559573591758555,-1.7040665584035832,-0.1012808393741472,1.3632527197273097,0.366445639351385,0.2598643985308738,-0.0582861822340731,-0.650197933439884
EB,414.0,0.0,51f3321b-ed78-4bdd-aa75-7d632ef53df1,11.0,66.0,-24228.0,24228.0,0.0,,414.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A97M,False,Ukraine,4e9607cb-eca7-5916-ad72-9cb369da6ade,not hispanic or latino,male,white,TCGA-EB-A97M_demographic,Alive,primary,2d8495bf-9527-50da-a991-403f1981b8cb,True,8720/3,"Malignant melanoma, NOS",No,Skin of trunk,TCGA-EB-A97M_diagnosis,"Skin, NOS",TCGA-EB-A97M_treatment,0470bdd9-ac9c-5172-a5d0-d38a0346338d,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.0004742182362438,0.1793442625114846,-1.2376145591091772,0.5755334988305624,1.1815959510743144,0.3228349405130932,-1.276486780109374,-0.3627169078442303,-0.3483728105111122,0.4155374010777286
EB,650.0,0.0,5226b25f-e326-4884-af79-916e4bbb701f,-1.0,74.0,-27124.0,27496.0,372.0,,650.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A3XC,False,Russia,ac108ca1-88cf-5f1d-9af7-0da822fa677a,not hispanic or latino,male,white,TCGA-EB-A3XC_demographic,Alive,primary,26100fb6-5222-4de2-a9d6-1b7b198c198f,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A3XC_diagnosis2,"Skin, NOS",TCGA-EB-A3XC_treatment10,87199dd7-05b2-4beb-ae46-bdf9c2d107c3,yes,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Primary,0.1664136023056574,-0.3569193445648455,-0.3782054790761114,0.2944892758751469,0.4797563482306065,-0.4535461138324714,-0.1624167994856868,0.5393144238352383,-0.8872049377844392,0.7066817569172389
EB,17.0,0.0,536e1779-550b-47f1-a204-50a16870a8e1,10.0,70.0,-25850.0,25863.0,13.0,,17.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A82C,False,Vietnam,2ec81e3f-9dd3-5bb2-a353-d82dc2f5b6c1,not hispanic or latino,female,asian,TCGA-EB-A82C_demographic,Alive,not reported,3ad673c2-23ae-53b9-8f94-64a36ea39cf6,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-EB-A82C_diagnosis,"Skin, NOS",TCGA-EB-A82C_treatment2,1010fade-c5d0-4c66-8b6c-e0999da2e7ee,unknown,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.5155660352697545,-0.4666738389740564,0.4891217713900884,0.5736796183486317,0.0962642897383564,-1.469920334685981,0.0024703293976116,0.0718393815050965,0.3398696515994063,-0.3174492284390338
DA,1136.0,0.0,53848dbb-87a1-40fa-a5af-c711ea7c8778,,52.0,-19105.0,19105.0,0.0,,1136.0,TCGA-SKCM,Consent Waiver,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-DA-A95W,False,United States,4c8b8ac8-f053-5149-b1bc-5aa701f65a2e,Unknown,male,white,TCGA-DA-A95W_demographic,Alive,Progression,351a4508-6f3b-5ca0-a148-0b2bc8afb77a,True,8720/3,"Malignant melanoma, NOS",No,"Lymph nodes of head, face and neck",TCGA-DA-A95W_diagnosis,"Skin, NOS",TCGA-DA-A95W_treatment,3afeebec-2335-505d-accb-c176c005c996,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.728902215463656,0.455653162207789,-1.0123002894108053,0.5647052645524628,0.4917819709784209,0.0288138522282449,0.0617862234499776,-0.2573481483030274,0.0056470007944672,-0.1263184421517207
BF,323.0,0.0,53de8f81-a226-4ab9-bddc-856ffd111817,-2.0,63.0,-23353.0,23353.0,0.0,,323.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-A5EQ,False,Russia,eb9d1149-a609-5ea3-a874-1181587653ec,not hispanic or latino,male,white,TCGA-BF-A5EQ_demographic,Alive,primary,428e3bb5-1a96-5a9f-8c3c-2ac1414f7e2e,True,8720/3,"Malignant melanoma, NOS",No,Skin of trunk,TCGA-BF-A5EQ_diagnosis,"Skin, NOS",TCGA-BF-A5EQ_treatment2,2eb80196-13e5-46be-8047-77c0df997964,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.3116745329795615,0.2113122969439839,0.3697953008683736,0.4489306013195829,0.724767192315866,0.2666207593026831,-0.2719020744524178,-0.7238169405420525,0.1831227219884484,-0.4021887369376125
W3,3379.0,1.0,53fbe99c-180c-45e6-8585-796028b3d118,761.0,71.0,-26145.0,29281.0,3136.0,3379.0,3379.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-W3-AA1R,False,United States,c6266a82-a406-5da6-8296-aeb5e4f94ae8,not hispanic or latino,male,white,TCGA-W3-AA1R_demographic,Dead,metastasis,171bd541-9d61-4d17-acfe-655cc1a1a9b9,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-W3-AA1R_diagnosis7,Liver,TCGA-W3-AA1R_treatment18,545b49c8-2101-429f-ab77-f065fa59adb1,yes,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0534568640343304,0.3876924135875471,-1.3374433065597835,0.4565088254632871,0.3339346605272157,0.5492936433451282,-0.2068500519650383,0.9024269567152914,1.059787570510949,-0.09117635486227
EE,7563.0,0.0,54782bd7-79be-4e3c-bf99-844e7bb0e5d7,6747.0,34.0,-12474.0,19980.0,7506.0,,7563.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2MP,False,Australia,b6dfb255-fddb-5a96-902b-6d706cb61a66,not hispanic or latino,female,white,TCGA-EE-A2MP_demographic,Alive,primary,35ce55c0-fbd1-452a-95ef-7c454db61aee,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A2MP_diagnosis3,"Skin, NOS",TCGA-EE-A2MP_treatment3,b04aad7c-155d-465d-8919-dff6ead87f1b,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.5276200926618563,-0.4329820587932872,-0.4940900712157881,0.1696257005818875,1.3365178855171862,0.3710904750614987,-0.5314695149801392,0.019801876793071,0.3561731955411099,0.5940414483576668
3N,2022.0,0.0,551e071a-c290-4b48-9000-f64c2a44dfb7,1629.0,82.0,-30286.0,31991.0,1705.0,,2022.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-3N-A9WC,False,United States,282649f2-7a56-5600-a5fa-e2cf8e979386,not hispanic or latino,male,white,TCGA-3N-A9WC_demographic,Alive,primary,39de5042-9892-5297-be04-2092002fded6,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-3N-A9WC_diagnosis,"Skin, NOS",TCGA-3N-A9WC_treatment2,f0394db7-d65e-41cb-9371-3554d1da5fa7,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.4621713141053535,-0.1280441478960548,-0.9371635491052352,0.0579800546188619,1.4154733677992395,1.395917629102016,0.7711978043350596,-0.5041669206526121,0.3512821323585997,0.4465260969352076
EB,931.0,0.0,554270fb-1fb3-4aeb-81a1-f78c30b143b4,-5.0,53.0,-19645.0,19645.0,0.0,,931.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A51B,False,Ukraine,5b1e8497-83a0-5abd-9128-6a2bd00f0e1e,not hispanic or latino,male,white,TCGA-EB-A51B_demographic,Alive,primary,0cdabacd-e947-4431-8af0-9d3a40b7d1cf,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A51B_diagnosis2,"Skin, NOS",TCGA-EB-A51B_treatment3,63b74262-cf38-44fd-b86c-2878e02761a4,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.7089783897327256,-0.005991930808553,0.7574778098418741,0.3446589001828217,1.2478653990536108,-0.3835136786323406,-0.4216393991627731,-0.2668356491621271,-0.0563064661840095,0.6585490894291158
EB,278.0,0.0,555bbd13-8ad7-43b3-9087-001db30089f1,-2.0,57.0,-20910.0,20910.0,0.0,,278.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A3XF,False,Ukraine,a39cab6e-5854-5711-a51b-5a22d11a3676,not hispanic or latino,male,white,TCGA-EB-A3XF_demographic,Alive,primary,4d489fbe-0623-5a55-9dfb-85d2ae57bfc5,True,8720/3,"Malignant melanoma, NOS",No,"Skin, NOS",TCGA-EB-A3XF_diagnosis,"Skin, NOS",TCGA-EB-A3XF_treatment4,39c5befe-2927-4274-9754-1297da4f7461,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.1613424423023681,0.0539632345235626,-0.7143415764988091,0.729746236527669,0.7425834605094307,-0.3461943359680517,0.0646135068004737,1.0395644691331762,-0.0952020638735044,-0.483371709771205
3N,518.0,1.0,5564e6a7-2195-4b0d-994e-b0617b58e889,432.0,71.0,-26176.0,26663.0,487.0,518.0,518.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-3N-A9WB,False,United States,79637f56-d242-5809-97ff-227b57efb393,not hispanic or latino,male,white,TCGA-3N-A9WB_demographic,Dead,metastasis,0bee66f8-7867-406d-9799-d2a424a55284,True,8720/3,"Malignant melanoma, NOS",No,Skin of trunk,TCGA-3N-A9WB_diagnosis2,"Skin, NOS",TCGA-3N-A9WB_treatment4,76b12e37-59de-4fd5-9168-c3c42347c81f,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.2010959800694975,-0.3646199049923317,-0.7081275392844105,0.1133636482437571,-0.2361921289550965,-0.6887578376737733,-0.5186765790304084,-0.0703293813683669,0.0979949318356922,3.333507284140068
WE,274.0,1.0,56d4ca9b-c050-45b4-b636-03fe2251fa1a,29.0,49.0,-18051.0,18177.0,126.0,274.0,274.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-WE-A8ZR,False,United Kingdom,5c6585bf-58ac-5a3a-8a8a-3332a321edbf,not hispanic or latino,male,white,TCGA-WE-A8ZR_demographic,Dead,metastasis,259872d3-be75-46b3-aa08-042fff6ff70f,False,8721/3,Nodular melanoma,Yes,Not Reported,TCGA-WE-A8ZR_diagnosis5,"Lung, NOS",TCGA-WE-A8ZR_treatment10,4d0447c2-2a55-4d92-92b6-7ec4d3c84ccd,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.7915984541691445,2.5504106202355725,-0.2773383975707021,0.5919989653197425,-0.8131884625285158,-0.2561721476599329,0.7855072742855984,0.3484144065491297,-0.6467276646443006,-0.351769278391238
D9,678.0,0.0,56ee81ed-242a-48ca-92a8-49973469a697,11.0,39.0,-14489.0,14500.0,11.0,,678.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D9-A3Z3,False,Poland,36ad1734-3638-5c08-9326-c670a6aa3c1a,not hispanic or latino,female,white,TCGA-D9-A3Z3_demographic,Alive,Progression,1e0964a5-63b6-46bf-bd29-cd26366b73eb,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-D9-A3Z3_diagnosis2,"Skin, NOS",TCGA-D9-A3Z3_treatment5,bb904543-391e-4a5c-88d8-ffcc71583b7b,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.2527100806220793,0.6667401013179096,0.04859765877504,0.3683283051344721,0.0673319101894114,0.4405721819830878,0.2404316784777163,-0.0003231250292613,-0.0050667566529382,0.4112883477346631
FS,1617.0,0.0,57882f61-4a32-49f1-afd4-61c70b184d8b,457.0,55.0,-20284.0,20665.0,381.0,,1617.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A1ZT,False,Germany,f0545e91-58f7-5787-9b1b-1c6d1127ec0d,not hispanic or latino,male,white,TCGA-FS-A1ZT_demographic,Alive,metastasis,58213825-f602-41cb-8c1c-c4be9b6d19be,True,8720/3,"Malignant melanoma, NOS",Yes,"Lymph node, NOS",TCGA-FS-A1ZT_diagnosis2,"Skin, NOS",TCGA-FS-A1ZT_treatment4,17fa16f9-802c-44c5-8c8e-437736937d67,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3072468849011891,-0.1032734214492799,0.575527508191192,0.5359337450605011,-0.2910005021713772,0.7708606126595141,1.033290068766664,1.3565332478348855,1.1771730868912194,-0.3480085968458763
FS,6598.0,1.0,57dd4d65-cfad-4533-92b4-90742289603b,,52.0,-19078.0,23715.0,4637.0,6598.0,6598.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A1YW,False,Germany,f346b512-725c-5ba8-ad56-b152c2dabb79,not hispanic or latino,male,white,TCGA-FS-A1YW_demographic,Dead,primary,793f17b0-5b96-4f7a-b3d9-726271bbea67,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-FS-A1YW_diagnosis3,"Skin, NOS",TCGA-FS-A1YW_treatment3,7ce07fd3-899e-4ae9-866d-ccdd9cb07570,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2969129189238527,-0.2689164292527905,0.5868993080081278,0.211155865505626,-0.6530168553395381,-0.809146800901838,0.5139024770753888,-1.6452545239787697,1.8537701604719476,0.0408760963066594
EE,1814.0,0.0,585a8d2e-cd09-4a61-b7c9-e8f70ce39e69,43.0,71.0,-26048.0,26064.0,16.0,,1814.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2A2,False,Australia,ae1ce55e-170b-5c77-98e8-345b8dff51b8,not hispanic or latino,male,white,TCGA-EE-A2A2_demographic,Alive,primary,8789061b-060b-496f-89c8-11538ef340e1,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A2A2_diagnosis3,"Skin, NOS",TCGA-EE-A2A2_treatment3,1b9a6efc-1774-494a-aaed-c1204f687228,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.905815965338154,0.3311350311844209,-0.0698993635779415,0.6401861540891162,-0.487519680875957,0.126971845993661,0.0013557977087524,0.46628941722278,2.190671250638738,-0.0116434926434824
D3,3564.0,1.0,588a48f7-947c-463e-8991-9a4ee82683aa,2677.0,52.0,-19127.0,21975.0,2848.0,3564.0,3564.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Small intestine,TCGA-D3-A8GS,False,United States,a2dec7a1-2b8d-51d9-9f05-ba46a72f0c23,not hispanic or latino,male,white,TCGA-D3-A8GS_demographic,Dead,metastasis,0741f836-308d-459a-93da-1317d9944bc5,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A8GS_diagnosis4,Not Reported,TCGA-D3-A8GS_treatment7,13ebcc75-8f70-4076-a089-c47dc6f5f1be,yes,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.5600673744363922,-0.2928559820073551,0.3049469403183545,-0.0992093466763589,0.7600134137870626,0.6140240876130386,-0.5884393899837478,0.4296331639035358,-0.784958426492894,-2.101802458248124
EE,3932.0,0.0,58f0ae89-e277-4dff-bb73-777cdf602dc7,3470.0,61.0,-22564.0,23507.0,943.0,,3932.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2M6,False,Australia,c93c06f3-ff47-50d4-a514-5d5fd8f15290,not hispanic or latino,male,white,TCGA-EE-A2M6_demographic,Alive,not reported,0a84b5e8-81d8-52cb-9208-68fd34021ded,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-EE-A2M6_diagnosis,"Skin, NOS",TCGA-EE-A2M6_treatment2,86cf3049-9e40-475f-a7c7-5bdb86b80aec,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.6737709276276755,0.540794048359158,0.158864619532717,-0.1598347756967384,-1.619614825488564,-0.2626138989067209,0.0897588621920759,0.0853518827286632,-1.154699512313687,0.0527706245918278
Z2,839.0,0.0,590b5e18-d837-4c0e-becf-80520db57c0f,453.0,42.0,-15342.0,15811.0,469.0,,839.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-Z2-A8RT,False,Italy,d328d08b-075f-5825-9d7c-2b0201b15b96,not hispanic or latino,female,white,TCGA-Z2-A8RT_demographic,Alive,not reported,1d06a202-c51a-52e2-805f-eeb5f7fac14e,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-Z2-A8RT_diagnosis,"Skin, NOS",TCGA-Z2-A8RT_treatment,90f2ff0c-e22e-5322-94ce-5bc8de456686,yes,Targeted Molecular Therapy,0.0,0.0,0.0,0.0,0.0,1.0,0.0,Primary,0.4820904120849572,0.0260768388094653,0.2972263248315173,0.4608989956682535,0.6407354199816826,0.524544398784427,-0.0430658463444245,-0.2047356435389341,0.2512482448877133,0.0862304311011055
WE,359.0,0.0,5a4d93c3-8116-4555-b19d-d7acd4b4eeed,10.0,25.0,-9379.0,9448.0,69.0,,359.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-WE-A8ZT,False,United Kingdom,c335f56b-3578-575e-856a-c80820ba23de,not hispanic or latino,female,white,TCGA-WE-A8ZT_demographic,Alive,primary,29dadf7a-e74e-4e20-a258-5c962ea5d674,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-WE-A8ZT_diagnosis3,"Skin, NOS",TCGA-WE-A8ZT_treatment3,b9ed2026-a456-491c-92c1-c3390d4ef61e,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.3389871094507034,-0.4753904234425257,0.6232304703378314,0.4863918541400778,-1.0799478430184966,-0.3115641818914546,0.3843251644127685,-0.2267293955304811,0.2266764750898584,-0.2100725152435508
Z2,486.0,0.0,5b10234b-6189-449f-8886-d0d44a729ced,163.0,57.0,-20937.0,21112.0,175.0,,486.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-Z2-AA3V,False,Italy,3b31ccdf-a4a1-5f3c-b1df-55c168d7b8f9,not hispanic or latino,female,white,TCGA-Z2-AA3V_demographic,Alive,primary,749ddabd-8915-4091-aa67-b9944457ac15,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-Z2-AA3V_diagnosis3,"Skin, NOS",TCGA-Z2-AA3V_treatment3,94b0e0fc-2829-440e-b2ef-f7518eb97adb,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.5225742052346896,0.6047649510705215,-1.259852965905193,0.2772207257060385,0.6460032395148257,0.9782118535253312,-1.139112689544973,0.0177893766108375,-0.9276144359828052,-1.2859071650441631
GN,988.0,1.0,5bc515c8-7727-4d69-98e9-31bbcb748550,,63.0,-23288.0,24196.0,908.0,988.0,988.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-GN-A26A,False,United States,a9ef12e9-8aa4-59f3-bdaa-64f5afaad53c,not hispanic or latino,female,white,TCGA-GN-A26A_demographic,Dead,primary,0d86e49f-2bbb-43e7-a22b-73e2c58081bc,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-GN-A26A_diagnosis3,"Skin, NOS",TCGA-GN-A26A_treatment3,aa7a6500-da76-461a-b830-6bb7a3a079f5,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.2109312717333021,0.1739440656036054,-0.0755716618121238,-1.2534813848209054,0.4999090368424794,0.4670313905636433,-0.0190009161264699,-0.0923231333599164,-1.4812362066889646,-0.2912521318658883
EE,818.0,1.0,5bdadeb6-a1fb-477d-877b-034bfd52294e,,48.0,-17788.0,18488.0,700.0,818.0,818.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A183,False,Australia,f890ebbe-7014-5316-9088-92d883eb8050,not hispanic or latino,male,white,TCGA-EE-A183_demographic,Dead,metastasis,17b9870c-3fe5-4d67-a40c-fbba48f0f9f3,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A183_diagnosis6,"Brain, NOS",TCGA-EE-A183_treatment14,60d78416-050c-4f0a-92a5-7d666560ffb7,yes,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.1580301212869718,0.5813535828880483,-0.3084143941142261,0.5355292632087739,0.416223231834432,0.1850328484228279,-0.3260317064532618,0.6880956873074701,0.6199412457408255,-0.6729072107237897
EB,608.0,1.0,5bf40b29-d722-430a-91bc-cad941ee3694,-2.0,58.0,-21367.0,21367.0,0.0,608.0,608.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A6R0,False,Ukraine,aca3cfae-2e4a-5289-9680-29db72597f48,not hispanic or latino,female,white,TCGA-EB-A6R0_demographic,Dead,primary,08749085-8fce-5458-9fdb-990315caf8c9,True,8720/3,"Malignant melanoma, NOS",No,"Skin, NOS",TCGA-EB-A6R0_diagnosis,"Skin, NOS",TCGA-EB-A6R0_treatment4,10e42f54-4657-4f35-b742-fd60b958fde1,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.4069889008565384,0.0822545643329679,0.4201345870942064,0.6253303286706086,1.0985793577662724,0.907801241712887,-0.530899077966776,-0.8142356987295231,1.2619515153880807,-0.6851009964130753
EB,315.0,1.0,5c091729-7b87-4046-bfa4-41c26c32837a,301.0,52.0,-19298.0,19601.0,303.0,315.0,315.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EB-A44R,False,Vietnam,0c5bd4de-f1b1-5934-bcbf-6242d91b8083,not hispanic or latino,male,asian,TCGA-EB-A44R_demographic,Dead,Progression,9563f055-0e65-40e4-9b46-432d83a060ed,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of inguinal region or leg,TCGA-EB-A44R_diagnosis2,"Skin, NOS",TCGA-EB-A44R_treatment4,e125adde-35ae-4804-8e87-fb40338dbe45,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.6806156743827111,0.3978641291426679,-0.3289821507612306,0.333678719714405,0.3381305534217386,0.2308806960644047,0.0680535722716332,0.1402643877010226,-0.7750598462425718,1.300676384525526
EE,10346.0,1.0,5c567ee6-bd57-448b-ad17-b74eb695b6f5,9021.0,58.0,-21526.0,31669.0,10143.0,10346.0,10346.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A2GD,False,Australia,bbd43cc5-65ee-5256-a474-627fe1a40908,not hispanic or latino,female,white,TCGA-EE-A2GD_demographic,Dead,recurrence,021a07ea-1c94-4340-a276-1b1ba09c6a03,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A2GD_diagnosis7,Not Reported,TCGA-EE-A2GD_treatment18,3fb1fc80-ee18-4303-bd1b-c27ff8d1052d,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.5586670058737797,-0.307367693236484,0.5580035758340215,-0.0437072692668467,0.3734672446401038,-0.2281787690276352,-0.0558942796939717,0.7060644389345502,0.2922400125125695,-2.27088267233544
EE,1864.0,1.0,5dec1b6a-5d60-463c-9655-fc7ed79ca19d,1404.0,79.0,-29087.0,30787.0,1700.0,1864.0,1864.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A29S,False,Australia,1850a8d6-6f5b-544d-aa68-3369b463de68,not hispanic or latino,male,white,TCGA-EE-A29S_demographic,Dead,metastasis,04ea9887-db46-455f-8b0b-5493d93fbfb6,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A29S_diagnosis9,"Lung, NOS",TCGA-EE-A29S_treatment23,2de71e6b-89dc-4a11-af3b-648663ed0cda,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,-0.1112063905393498,0.420827085817154,-0.5736706857059933,-0.3164963371245078,0.8807508739232223,-0.0882569463249771,-0.5007644725458948,0.4664331672357963,1.3899343353304612,-0.9471837245798892
EE,601.0,1.0,5eda189c-2de3-429a-80d2-fc644623b37f,,54.0,-19808.0,20306.0,498.0,601.0,601.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2M8,False,Australia,fbfb084c-85c3-53dd-a7c3-ccccdda80b62,not hispanic or latino,female,white,TCGA-EE-A2M8_demographic,Dead,Progression,7e5cf096-f5c3-4786-83cd-cfef0845fa3e,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of inguinal region or leg,TCGA-EE-A2M8_diagnosis2,"Skin, NOS",TCGA-EE-A2M8_treatment4,842be055-402a-4fed-9c60-fa74bd2b64bd,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4128896577516933,-0.2371759428693042,0.4157323222991674,0.3105851980544741,1.486415735048939,1.512635658799445,0.5628244064726504,-0.4488231656412038,-0.6839929079396248,-0.3586985059655945
BF,454.0,0.0,5f07d78a-44a1-4002-a55c-5fe01b35d669,0.0,40.0,-14773.0,14773.0,0.0,,454.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-BF-AAP0,False,Russia,15325bd3-e330-5893-a069-8f2c835e0ea9,not hispanic or latino,female,white,TCGA-BF-AAP0_demographic,Alive,Progression,791e170c-9650-5794-81df-14c25b9de655,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-BF-AAP0_diagnosis,"Skin, NOS",TCGA-BF-AAP0_treatment5,0ee24893-c34f-4697-9c21-1727004865dc,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1874985065310585,-0.2074423559530352,0.0033674823468216,0.0189598621656545,0.7912116415030125,1.0038030790792762,0.0254325706329578,0.6377831827516429,-1.2174681564892489,-0.3482926934725858
WE,1506.0,1.0,5f39db5b-e5c6-4b7c-acbc-a7c73b556829,1230.0,62.0,-22676.0,24065.0,1389.0,1506.0,1506.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-WE-A8ZY,False,United Kingdom,2818294a-b3e4-52f6-97da-073c07e42966,not hispanic or latino,male,white,TCGA-WE-A8ZY_demographic,Dead,primary,11c9b1ec-4d71-4855-b20f-1de6142b0772,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-WE-A8ZY_diagnosis3,"Skin, NOS",TCGA-WE-A8ZY_treatment3,ea9ec890-6d22-4096-9bc9-03823094379d,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.7549220598275375,0.7111693536349957,-0.095025298380837,0.3166537863677992,-0.0932387027211762,-0.0657791728881406,-0.0126569187453805,0.2132893943134784,1.7514071952951047,-1.0324964677841406
ER,4000.0,1.0,5f6df69c-4ebf-4811-8b28-ad393dfbe1a3,,35.0,-13061.0,16750.0,3689.0,4000.0,4000.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-ER-A19L,False,United States,74aca22b-5a33-5fae-94a2-74f0e1e01a10,not hispanic or latino,male,white,TCGA-ER-A19L_demographic,Dead,not reported,352e6949-813b-5b05-8745-d411e94ba63d,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-ER-A19L_diagnosis,"Skin, NOS",TCGA-ER-A19L_treatment2,12f8f505-7e8d-432a-9f65-efeb5bd5900b,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0171117623512747,-0.2049184888413117,0.4829330013521611,0.1359172735058037,-1.1399649413010893,-0.9147533985154376,0.9177570490355732,-0.9289482091168092,0.0855343661088183,-0.0148042406000427
EE,907.0,1.0,5f8cc8d6-8a1c-41d0-bad6-fedd2948f40a,,54.0,-20021.0,20576.0,555.0,907.0,907.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-EE-A17X,False,Australia,0396cc50-6d55-5c24-bab8-fa918bd1ab3a,not reported,male,white,TCGA-EE-A17X_demographic,Dead,not reported,42ee9a23-6356-549f-b66d-40d0733bb7aa,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-EE-A17X_diagnosis,"Skin, NOS",TCGA-EE-A17X_treatment,3f61d8a8-1f5b-564c-ac5a-de1fe2042f2d,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.0599447714401999,-0.2074104698662819,-0.1213446637576263,0.5716713429139884,-1.1969831665342785,0.0019771396441832,-0.5515252589822487,0.3826269096470915,1.3957570295953543,-0.1593233857223337
GN,2948.0,0.0,61b777f6-a59a-4500-ad33-107e2c9254c1,60.0,53.0,-19712.0,19811.0,99.0,,2948.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-GN-A265,False,United States,0d52ec82-4d91-5406-b31f-cb4f1e6d4131,not hispanic or latino,male,white,TCGA-GN-A265_demographic,Alive,metastasis,561e2575-bc57-4ff8-9495-9e8e75513ece,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-GN-A265_diagnosis2,Not Reported,TCGA-GN-A265_treatment5,217e22a9-2b41-49be-88eb-07d703736a14,yes,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.7569530576559206,-0.3130045025507608,-0.3003156849816097,-1.0283481604051108,0.6872740405391989,0.8591435751853029,0.0966443489787302,0.7558019434383121,-0.6487073806943642,-0.6145589197111994
BF,464.0,0.0,62393dab-ab41-4785-9a57-aa4c25d223e9,0.0,36.0,-13332.0,13549.0,217.0,,464.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-A3DJ,False,Russia,fc723511-2952-5d1d-882a-6220b30f605d,Unknown,female,white,TCGA-BF-A3DJ_demographic,Alive,metastasis,0e52e5cf-8497-44ea-ad1f-27b7b98d1ae2,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-BF-A3DJ_diagnosis3,Liver,TCGA-BF-A3DJ_treatment8,a0b7f796-cf14-493f-94db-6509bb804980,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Primary,0.325684129122302,-0.0109471327577744,0.4019928773043508,-0.179140652569394,1.0112439769154102,-0.1655438963393228,-0.2148988235862127,-0.3218919041475028,0.1106884053331614,-0.100146843791899
D3,487.0,0.0,6250b800-f72e-4c8e-a0e0-206049398ba7,25.0,43.0,-15935.0,16226.0,291.0,,487.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-D3-A5GT,False,United States,58e67aa9-f8ae-582d-b8f8-ef7cf62a019a,hispanic or latino,male,white,TCGA-D3-A5GT_demographic,Alive,metastasis,0b08a1a2-af8b-45a4-a6a9-3017ab6555f9,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A5GT_diagnosis6,Not Reported,TCGA-D3-A5GT_treatment13,751affed-bc34-46d5-a339-3f4729956904,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.4051919088759871,0.3114384849184325,0.2577686719238075,0.3991256723050788,-1.5627018783545223,-1.9834226406725268,-1.007470909587161,-0.7370419417395839,-0.0918249011998652,0.883333559682101
BF,831.0,0.0,633ddc04-c424-42c8-8e54-673968b130a7,0.0,80.0,-29380.0,29380.0,0.0,,831.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-A1Q0,False,Russia,71e13c3e-d603-59b4-959d-a64d19d81f34,not hispanic or latino,male,white,TCGA-BF-A1Q0_demographic,Alive,primary,1cff8fb1-e149-4849-8995-6d345d10a53e,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-BF-A1Q0_diagnosis2,"Skin, NOS",TCGA-BF-A1Q0_treatment3,6b38e267-cb62-40ea-9550-323ffe088964,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.1915550684983329,0.2739417629979264,-0.6329598278098606,-0.8175737505661568,0.4340541837839664,0.2387045333292247,0.5632165638717994,-2.158010820409155,-0.4776366231917663,1.428912838760353
GN,650.0,1.0,638eb185-fe03-4632-a969-9655e3339b2e,39.0,68.0,-25000.0,25209.0,209.0,650.0,650.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-GN-A8LL,False,United States,8be5fce4-e521-566a-ac2b-1f7e5f1399e5,not hispanic or latino,female,white,TCGA-GN-A8LL_demographic,Dead,not reported,3a01d3eb-0a0f-5504-8a5c-116da5c27c77,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-GN-A8LL_diagnosis,"Skin, NOS",TCGA-GN-A8LL_treatment,86c88e58-59fe-5246-bde9-5594a17a779e,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.3601395815287884,0.1868284566690017,-0.3889332594624505,0.8698922058882694,1.2685693940143727,-0.7966701254035574,-0.8747099328527558,1.1420582284140453,-2.9145506269353687,-0.413619107685932
EB,590.0,0.0,63db0da6-f451-436f-9b1c-211b55947770,7.0,78.0,-28671.0,28671.0,0.0,,590.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A551,False,Ukraine,f917e9c5-82b8-5a5f-b09d-c9648e996bcc,not hispanic or latino,female,white,TCGA-EB-A551_demographic,Alive,primary,b2e93253-0a0c-4e4e-a34c-a4b0dff537f2,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A551_diagnosis2,"Skin, NOS",TCGA-EB-A551_treatment3,c868a9fd-7aa3-4120-a98a-432fe0769d08,unknown,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.0779862305066226,-0.3736790629665622,0.2327457254816368,0.1344823473294783,0.8521081951118452,1.350030413261923,0.4420446881941913,1.2569144888143478,0.2456584583934153,-0.701502574521907
XV,392.0,0.0,64690c6f-80cf-4a87-932c-7d7b3d0fbf6f,-1.0,51.0,-18739.0,18739.0,0.0,,392.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-XV-A9W5,False,Russia,4a57573e-2412-5d95-9e40-24b50290d4fd,not hispanic or latino,male,white,TCGA-XV-A9W5_demographic,Alive,primary,458ab0f9-dca3-4e91-ac6a-38030281b9af,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-XV-A9W5_diagnosis2,"Skin, NOS",TCGA-XV-A9W5_treatment3,824d8f75-d283-4e28-ba80-78c4306058a6,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.7233768105488851,-0.1088549096906726,-0.1857293331351501,-0.1782102448902339,0.4304038695746561,-0.25790141020955,-0.3642233092789751,-0.1541356389570742,-0.6551123443857476,0.7610105728643008
FS,813.0,1.0,64d46463-8039-41d1-9bbb-0ca0504356c2,,46.0,-16896.0,17527.0,631.0,813.0,813.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A4FB,False,Germany,d55beaf3-a98c-57d4-ab12-52bd6656b690,not hispanic or latino,female,white,TCGA-FS-A4FB_demographic,Dead,Progression,05a9b49c-68ce-47de-afec-93e8832b99fe,True,8720/3,"Malignant melanoma, NOS",No,"Lymph node, NOS",TCGA-FS-A4FB_diagnosis2,"Skin, NOS",TCGA-FS-A4FB_treatment5,119aea19-4259-4438-8127-dee86bfaf288,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.055489306696588,0.1405699560781834,0.0631043460219716,-0.3193834810720334,-1.4422941608444582,-2.1538595721936926,-0.1768182647700033,-0.833066950434706,0.1415486849371021,-1.0357217907946334
DA,2071.0,1.0,6625ce3f-3a1f-45f9-aa42-ab1931d6daf4,,81.0,-29859.0,31789.0,1930.0,2071.0,2071.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-DA-A1IC,False,United States,e1761d18-8a79-57c1-9521-b2c463f1293a,not hispanic or latino,male,white,TCGA-DA-A1IC_demographic,Dead,primary,c91503e7-f3c2-5417-a338-e55a8ef3b332,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-DA-A1IC_diagnosis,"Skin, NOS",TCGA-DA-A1IC_treatment2,4d0f17bc-0e09-4f0f-89b2-8362df6d624f,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.163180271908409,-0.2067848430510979,-0.0212501259125491,0.1750264908295105,-0.0631621198210923,-0.218201476625189,-0.0897849779830047,0.8798582046716792,1.3185481036428548,-0.1633730245106048
HR,2004.0,1.0,6668acfe-1594-42c0-b839-8a592702675f,-40.0,46.0,-16910.0,18433.0,1523.0,2004.0,2004.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Other and ill-defined sites,TCGA-HR-A2OH,False,Canada,995cc5c3-51dd-5a41-9d32-9a984cb93971,not reported,female,not reported,TCGA-HR-A2OH_demographic,Dead,primary,28267768-8068-5b8c-aed8-ce9f27ad8f82,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-HR-A2OH_diagnosis,"Skin, NOS",TCGA-HR-A2OH_treatment,2211b048-f02f-51b9-824b-8147ff880219,yes,"Radiation, External Beam",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0681850158315098,-0.5236689306946184,0.3661045338763873,0.35729122351603,1.6122712889238615,1.7404033601365996,0.0854496125522722,0.1251706363342739,-0.2288911241954784,0.1203394625766296
EB,779.0,0.0,667d5c5e-abc0-4fb8-b6c4-739f7cb3f0fe,0.0,48.0,-17867.0,17867.0,0.0,,779.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A5UM,False,Ukraine,807be6f4-d842-5aa4-85ac-ac54570f8240,not hispanic or latino,female,white,TCGA-EB-A5UM_demographic,Alive,primary,40bc3a07-5870-4af3-97f2-89bb946fd241,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A5UM_diagnosis2,"Skin, NOS",TCGA-EB-A5UM_treatment3,a59181ef-8ed5-437b-a195-c65d3d84b23d,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-1.3647398620778606,0.602651932103883,0.3860420115909133,0.3202768040948366,0.3924138296542687,0.384793428129885,-0.6317456313587505,-1.224785735905072,-0.3583878446467299,0.0715575875887577
DA,396.0,0.0,668701cf-9c73-4caf-8482-3f478235909a,,87.0,-31837.0,31837.0,0.0,,396.0,TCGA-SKCM,Consent Waiver,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-DA-A95Z,False,United States,23ae43b3-10f4-5876-aa9e-656a1d966f87,not hispanic or latino,male,white,TCGA-DA-A95Z_demographic,Alive,Progression,ebd42888-08e7-5be5-b48d-70b39edd5f34,True,8720/3,"Malignant melanoma, NOS",No,"Connective, subcutaneous and other soft tissues of trunk, NOS",TCGA-DA-A95Z_diagnosis,"Skin, NOS",TCGA-DA-A95Z_treatment2,0cf417e9-01a4-435b-900b-f8b3cdf13868,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.1740065471713028,0.5204848861756454,0.0532723640372255,0.2305143545071519,-1.0808872478550902,-0.6449325263933198,-0.1652109914331024,-1.2532482384823684,-0.6088801519224863,-0.2454317338411258
BF,409.0,0.0,6783fb7d-f509-47c6-b39f-535a9026f6bc,0.0,86.0,-31666.0,31666.0,0.0,,409.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-AAP1,False,Russia,bd4729a3-6368-5f24-86dc-22584d02dd2a,not hispanic or latino,male,white,TCGA-BF-AAP1_demographic,Alive,primary,a742d54c-67ec-5c0b-b5d7-071e515a0124,True,8771/3,Epithelioid cell melanoma,No,Skin of upper limb and shoulder,TCGA-BF-AAP1_diagnosis,"Skin, NOS",TCGA-BF-AAP1_treatment4,00bb8aa2-a6ca-4f0c-a8b8-819af1de8e26,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.2274491768711851,0.0133016169840828,0.5088771003110301,0.3359141787232737,-0.0987803347113972,-1.159581828431926,-0.0897189422285443,-0.2129293942808844,0.5095429624784287,1.296327900696626
FR,685.0,0.0,68567581-0be3-48f1-8dcd-487bc0c1e6f6,8.0,69.0,-25271.0,25949.0,678.0,,685.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-FR-A3R1,False,United States,3dc8b458-c51d-50c0-a5f8-d58ccd48cdc0,not hispanic or latino,male,white,TCGA-FR-A3R1_demographic,Alive,primary,1ea81643-53be-46f0-b5bf-fef1317e0dbf,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-FR-A3R1_diagnosis2,"Skin, NOS",TCGA-FR-A3R1_treatment3,2039bccb-003a-44bf-96d5-b6fc23ab1ad0,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.2575755843683175,0.0311645032404591,0.2232125743810021,0.3704907287924328,0.7525040229708425,0.9289766367469448,-0.9458700271831386,-0.280923150437759,0.5357450866704524,0.7210769663774108
DA,620.0,1.0,68f75ab5-9d77-40c5-a8ce-f56016bbe9e4,,63.0,-23157.0,23756.0,599.0,620.0,620.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,Skin,TCGA-DA-A1I0,False,United States,9e54ae7e-8611-5939-a1a3-2c82825e36d0,not hispanic or latino,male,white,TCGA-DA-A1I0_demographic,Dead,primary,3309a73f-b5f4-438f-8e2c-80aad9876187,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-DA-A1I0_diagnosis3,"Skin, NOS",TCGA-DA-A1I0_treatment3,7fb601f9-8013-462c-ae5f-a351cba26c26,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-1.0036521266076,-0.4132212588604952,-0.6135242406283319,-0.0097658944775664,0.1504484776899114,-0.3622969681603794,-0.6143371053963581,0.0139081262593868,-0.4508522295732525,0.514844897328539
ER,394.0,1.0,691a5156-281d-4fd6-b44a-299a3e8dc3e3,3.0,40.0,-14628.0,14834.0,206.0,394.0,394.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-ER-A42K,False,United States,ca8cce67-97d5-58c3-8ea3-74e68370fba2,not hispanic or latino,female,white,TCGA-ER-A42K_demographic,Dead,not reported,0ed60508-f0c9-577a-8fad-d0c7e127d88d,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-ER-A42K_diagnosis,"Skin, NOS",TCGA-ER-A42K_treatment,3d45b362-3844-5d7e-9847-b8f329c4afe4,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2836889737927058,-0.9867680890138568,-0.5747138482097971,-0.7244841178513334,-0.231284068241551,-1.102971217033044,0.6936548328127332,0.9327582094618052,-1.0129751339061566,0.1397897192757594
DA,6768.0,0.0,6993bc23-cd58-4761-bb77-3a3dcc2f7a1b,,55.0,-20399.0,25990.0,5591.0,,6768.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,Skin,TCGA-DA-A1I1,False,United States,d7e7079e-acd1-5f65-9b3f-759f50d190e7,not hispanic or latino,male,white,TCGA-DA-A1I1_demographic,Alive,metastasis,af40e007-2192-4b71-8c4f-baf87700c6e0,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-DA-A1I1_diagnosis3,Jejunum,TCGA-DA-A1I1_treatment7,0174e664-f14b-4d2e-9647-6e836a12d693,yes,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Primary,0.4274140918141646,0.0633371668071613,0.130828648008678,0.1796312283748382,0.8588264319436277,0.6791212652495274,-0.040133978900394,-0.1805856413521372,0.5917594054987362,-1.1725946068523336
EE,2166.0,0.0,69a17647-493f-46d2-9cf0-6596e56289a0,588.0,45.0,-16768.0,17332.0,564.0,,2166.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2MT,False,Australia,937bb6e3-db6e-509d-ae2f-e1bd1deaf6e2,not hispanic or latino,male,white,TCGA-EE-A2MT_demographic,Alive,primary,2c22dc5a-dca5-4c14-9099-f0c0f81f9ae4,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A2MT_diagnosis3,"Skin, NOS",TCGA-EE-A2MT_treatment3,a33d7232-5171-4f14-acfe-185ff581aae8,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.2921781219545168,0.3820483510481175,-0.10237541330896,-0.0450705884925389,-0.1200133039538829,-0.5171963631559449,-0.3440038341463632,0.6251331816061767,0.8541300090748783,0.0860533338469482
ER,349.0,1.0,69c0ef46-3117-46f3-b36e-581eb03eb829,132.0,56.0,-20740.0,21089.0,349.0,,349.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-ER-A19O,False,United States,c305712b-81c9-5ea1-8ec8-b07ef0b3174f,not hispanic or latino,male,white,TCGA-ER-A19O_demographic,Dead,metastasis,76fe415f-6dd5-45c2-b967-8ece34d2bee1,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-ER-A19O_diagnosis5,Liver,TCGA-ER-A19O_treatment10,37af1dd2-40fe-4b6f-9a61-3efd007bc994,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.6906290669538128,0.4405473147378773,-0.0884627239284652,-0.2641276907861989,1.1429099850922806,0.6075446085480616,-0.781515491328033,-0.3571106573365813,-0.6738614199187073,-1.1363983130391904
EE,2030.0,1.0,6a1818f9-9303-41b0-b3b7-07faf5055c86,905.0,70.0,-25847.0,27647.0,1800.0,2030.0,2030.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A29Q,False,Australia,c50ec5be-2b83-50d0-a608-88e009c4e2de,not hispanic or latino,female,white,TCGA-EE-A29Q_demographic,Dead,primary,5f0325a4-e020-4c50-8193-61695c284dd0,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A29Q_diagnosis3,"Skin, NOS",TCGA-EE-A29Q_treatment5,fa234d61-4ed5-456c-8af0-8a94c23f2de0,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0545385062851944,-0.9904025870082184,0.2054410042244586,0.2332227287458231,-0.9529733153646526,-0.5955228077688425,-0.3409783607549273,1.2221269856643182,1.1466621689431735,0.3757861450164728
FS,6164.0,1.0,6a1966c3-7f01-4304-b4a1-c4ef683b179a,,32.0,-11815.0,17318.0,5503.0,6164.0,6164.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-FS-A1Z0,False,Germany,2f7a2ebb-6033-5757-9219-19a73dfac07e,not hispanic or latino,female,white,TCGA-FS-A1Z0_demographic,Dead,metastasis,31a25270-d174-4e6c-87a0-3cf4fe325d42,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-FS-A1Z0_diagnosis4,"Lung, NOS",TCGA-FS-A1Z0_treatment3,100ee2ba-b427-4bd5-a082-233581253de6,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.1684395838097429,0.472566756780599,0.8850563508667363,0.205510365757024,0.3526240284082846,0.6450544849193707,0.3582093498733364,-0.5915669285667351,1.1211587680629356,0.0872784700521562
D3,3808.0,0.0,6ac4e3df-6c43-4c73-8f4c-f89c3626f2d5,3181.0,36.0,-13296.0,16554.0,3258.0,,3808.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A5GU,False,United States,c14ee770-7b06-5691-a432-e767113a06e9,not hispanic or latino,male,white,TCGA-D3-A5GU_demographic,Alive,metastasis,0bb47ce9-17d9-4930-8938-9a29dd8a842a,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A5GU_diagnosis11,"Brain, NOS",TCGA-D3-A5GU_treatment28,41a5a799-8c8e-4d16-88b2-4e18ef20e585,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.059934124919225,-0.2915846870650114,0.8037592085277189,0.3308539673136626,1.10924781386766,-0.0108547005825569,0.0269889718685819,-1.1672857306984137,-1.1045078877502983,-0.6601471057373236
EB,741.0,0.0,6b02def4-04ca-4ba0-bc48-262c4d8a294c,-6.0,58.0,-21519.0,21519.0,0.0,,741.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A44P,False,Ukraine,17451d7d-9f1a-53c3-96dd-d490aae9f504,not hispanic or latino,female,white,TCGA-EB-A44P_demographic,Alive,primary,7eb57f34-2fb0-5deb-a759-6099f1871977,True,8720/3,"Malignant melanoma, NOS",No,Skin of trunk,TCGA-EB-A44P_diagnosis,"Skin, NOS",TCGA-EB-A44P_treatment2,3e2c9912-ecac-41c8-acd4-020d69777193,unknown,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.0445525224739191,0.2048924980079284,0.6787252596842376,0.6560664802926276,0.0068500941873725,0.2825541225642554,-0.5270530006358529,-0.0454606291164884,0.1983781809624714,0.3187940547436683
ER,1264.0,0.0,6c353b35-4f6d-4a36-bc8b-8a21dd0beecb,728.0,49.0,-18220.0,18838.0,618.0,,1264.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-ER-A2NH,False,United States,bc70b17d-bee9-5bc9-b930-138f4fb25edd,not hispanic or latino,male,white,TCGA-ER-A2NH_demographic,Alive,primary,94051267-54a3-4ca4-93ee-db0c9bda6e62,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-ER-A2NH_diagnosis3,"Skin, NOS",TCGA-ER-A2NH_treatment3,ecf85d92-971a-4e5d-aabc-25a65845d0e5,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.7466082896675722,-0.0845945300911689,0.1621960813752297,0.0491674080295576,1.0386920322959796,1.6364534883168436,0.0043303706734741,0.481526918602545,0.1200047161569934,-0.6208839462800921
GN,1197.0,0.0,6dc9c5b0-77e6-4c53-a75c-8f01731c54e8,27.0,73.0,-26761.0,26978.0,217.0,,1197.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-GN-A4U4,False,United States,c8b39959-7b27-5d3b-9de2-72bcd8b66c76,not hispanic or latino,male,white,TCGA-GN-A4U4_demographic,Alive,primary,0b7c481c-1331-4958-891c-602ff1e0c1f0,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-GN-A4U4_diagnosis3,"Skin, NOS",TCGA-GN-A4U4_treatment4,3dbc2750-4c7c-40a2-96de-6d5817c3e349,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.7282334058877513,0.2519818385748194,0.3038390096416368,0.4204790112552404,-1.9697003251192535,-0.4421032935992508,-0.5851152897653108,-0.4179169128426249,1.4445512075351694,-0.2494730186321268
EE,6138.0,0.0,6e1040d2-dee0-43c9-8462-fc0859d7d2af,6128.0,60.0,-22150.0,28259.0,6109.0,,6138.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A3JB,False,Australia,4b8ad493-e33d-590c-89a0-79eccdc4650a,not hispanic or latino,female,white,TCGA-EE-A3JB_demographic,Alive,Progression,08324aac-5bb0-4655-8796-6e79bab3d60e,True,8720/3,"Malignant melanoma, NOS",No,"Connective, subcutaneous and other soft tissues of upper limb and shoulder",TCGA-EE-A3JB_diagnosis2,"Skin, NOS",TCGA-EE-A3JB_treatment5,0250476f-cc5d-48b6-930b-afeee5445a0c,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3363465876740673,0.424875204322502,0.1963684638354786,-2.192341965860732,-0.9990035185156304,0.0916858209098243,0.3658498962270043,1.63598327313925,-1.51628882616363,-0.3850853299400749
EB,977.0,0.0,6e2d8818-b377-45f5-97f4-f905de22c487,-2.0,65.0,-23773.0,23773.0,0.0,,977.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A4OY,False,Ukraine,5393d2f7-ffe3-5dbb-882d-8139e0a104e7,not hispanic or latino,female,white,TCGA-EB-A4OY_demographic,Alive,not reported,328c191b-d7e4-56e7-b3d2-c85c64b8e75b,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-EB-A4OY_diagnosis,"Skin, NOS",TCGA-EB-A4OY_treatment3,35fb5b87-60ae-4463-9527-f0092f94f8c5,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-1.5091044703549257,-0.2915251996357104,-0.6687442311798284,0.469148142868154,0.4033474827942309,-0.7307353470104306,-0.6249648338240796,-0.4584544165133198,-2.4302189179814526,-0.1255884440538835
D3,5177.0,0.0,6ec931e1-7a6f-47a8-8b30-f37271a50881,4393.0,45.0,-16569.0,18437.0,1868.0,,5177.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-D3-A8GK,False,United States,a7bd6f94-a65d-51f9-b004-b0440077e26e,not hispanic or latino,male,white,TCGA-D3-A8GK_demographic,Alive,primary,29438d1f-aab1-4eff-b9a5-a023788002b8,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-D3-A8GK_diagnosis3,"Skin, NOS",TCGA-D3-A8GK_treatment3,11feeb02-ce4e-4a83-a669-2854732de60d,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4514775495272136,0.2245853462306795,0.1956316083438279,0.4191413554839805,-1.8552675107755927,-1.0861860614234644,-1.0837665124516405,1.535502014040612,1.072248136237823,0.5536686638971265
FS,1486.0,1.0,6f2ef983-0a22-4a65-9e53-8742ac89a1c4,,57.0,-20963.0,22424.0,1461.0,1486.0,1486.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A1ZB,False,Germany,73f75934-7ea7-5c45-bb35-ee93ac7b8f72,not hispanic or latino,male,white,TCGA-FS-A1ZB_demographic,Dead,primary,0766d5d1-c4ea-40c8-9799-3978d28a3db7,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-FS-A1ZB_diagnosis3,"Skin, NOS",TCGA-FS-A1ZB_treatment3,d6ce7de4-d773-4643-89e8-411a39f5adf1,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4005646954527358,0.6196377452562329,0.3986384022347453,0.1542841459397308,-0.2886312885335534,-0.388608121033477,0.4760126781455791,0.4093644120681871,0.1097567742507784,-0.1703942857868868
D3,1321.0,1.0,6f5157b8-d43a-4fbc-b7da-23629f5b53da,1017.0,65.0,-24066.0,25355.0,1289.0,1321.0,1321.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A2J6,False,United States,f8fce00f-238d-545a-b89d-a880b7debeaf,not hispanic or latino,male,white,TCGA-D3-A2J6_demographic,Dead,metastasis,1657cb8a-4183-45b2-8653-f94dcd2bec34,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A2J6_diagnosis6,"Connective, subcutaneous and other soft tissues of abdomen",TCGA-D3-A2J6_treatment13,2819c0ab-359e-41cf-a71d-8cb7db3199b8,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.1058990660355294,1.3601666880574963,-0.0993030207762693,0.6589700696521902,-0.1819089913135728,0.1602332606623555,-0.0535544788575147,1.324764494958206,1.7385972679123358,-0.0980203785188175
EB,1160.0,0.0,6fe664cc-e66b-4abf-a7d2-08bb4ce8eba3,-6.0,53.0,-19431.0,19431.0,0.0,,1160.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A3XD,False,Ukraine,d360ce2a-25a5-5a15-bfba-540c2f470646,not hispanic or latino,female,white,TCGA-EB-A3XD_demographic,Alive,primary,174ac313-468b-5fed-a3b3-578252b18c6a,True,8720/3,"Malignant melanoma, NOS",No,"Skin, NOS",TCGA-EB-A3XD_diagnosis,"Skin, NOS",TCGA-EB-A3XD_treatment,7d5d9a81-4c3c-5211-a0a6-1052eb1d6adc,unknown,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.334132579195091,-0.620549841770296,-0.2697929166792971,0.0612507101002447,0.1255972823022912,0.1014933960966964,0.1350398017951454,-1.0691044718080418,-0.6784031214453268,0.9421666140914358
D3,4897.0,0.0,7038de05-4e26-49af-b78a-5a00ce9a120b,1155.0,27.0,-10185.0,11296.0,1111.0,,4897.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Small intestine,TCGA-D3-A8GN,False,United States,dd018c2a-189a-566b-b134-84188534c611,not hispanic or latino,female,white,TCGA-D3-A8GN_demographic,Alive,metastasis,30da51da-74a3-4b65-a33e-bd93187b13bf,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A8GN_diagnosis3,"Lung, NOS",TCGA-D3-A8GN_treatment6,20ec696b-9c71-449c-9e2c-a761f373307f,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.1845401976417435,-0.1267658706132541,-0.9823935669223222,0.1700855585029957,1.3044003996569098,0.8099230570046944,-0.2568989184480821,0.0678143811406321,0.9016431942764176,0.1156266847224673
EE,2785.0,0.0,70f52403-b4d0-4e77-96c5-68ce7265e312,2320.0,53.0,-19372.0,21675.0,2303.0,,2785.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A20F,False,Australia,a091ee24-cca5-58ae-ab2d-b85ac30afe5e,not hispanic or latino,male,white,TCGA-EE-A20F_demographic,Alive,primary,432fe963-a93e-4d26-8ce7-9ed7eda1933c,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A20F_diagnosis3,"Skin, NOS",TCGA-EE-A20F_treatment3,c5574083-7e5d-4293-8634-3f500c5ba052,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1920810484126706,-0.163607674052097,-0.3689806546536616,0.6765169088574886,0.2905529718911399,0.4289973549428159,0.1955958825666788,0.2753893999366714,0.8219887367326618,0.0416667232434
WE,731.0,0.0,71115011-ff31-45a1-9949-dd69a51cac2a,551.0,70.0,-25884.0,26255.0,371.0,,731.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-WE-A8JZ,False,United Kingdom,be324bd9-53cf-5d1b-bc0d-c533a53b8498,not reported,male,not reported,TCGA-WE-A8JZ_demographic,Alive,primary,12afb329-5a50-491b-96ea-5ad2be09b952,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-WE-A8JZ_diagnosis3,"Skin, NOS",TCGA-WE-A8JZ_treatment3,fe9f10d6-3253-4cf0-9c5b-cdd64630c2cf,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.1229147424487286,-0.5952175871149101,-0.3413408998620644,0.279424472329447,-0.6672724726416922,-0.4287594384388961,0.468029134168734,-0.9942107150263688,1.7554830812805315,-1.2375678583201366
EE,447.0,1.0,714b4003-959a-47d5-8912-a250b90d7cd4,,84.0,-30718.0,31124.0,406.0,447.0,447.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A182,False,Australia,4a479bb4-fe20-5d0b-833e-42665969434e,not hispanic or latino,female,white,TCGA-EE-A182_demographic,Dead,metastasis,00c1a0a8-7ae2-4a74-8646-56103cb9d5fd,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A182_diagnosis9,"Head, face or neck, NOS",TCGA-EE-A182_treatment22,39cde1cc-07b1-4f82-b65f-e296d44891ee,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-2.141793716731536,0.0098087881203729,-0.877832683506606,-0.0399573333222145,1.039204552940876,-0.0446362759943793,-0.5864431451916416,0.2089768939229788,-1.2571789313758293,-1.662595495869227
D3,1209.0,0.0,714f58d6-14bf-4e60-96ac-104d4abd45ed,54.0,53.0,-19423.0,20486.0,1063.0,,1209.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A3MU,False,United States,4d04d51a-8df8-53d3-8a78-0aa87318c475,not hispanic or latino,male,white,TCGA-D3-A3MU_demographic,Alive,Progression,08da9687-5e07-43a2-8e84-9acc2331cd59,True,8720/3,"Malignant melanoma, NOS",Yes,Lymph nodes of axilla or arm,TCGA-D3-A3MU_diagnosis2,"Skin, NOS",TCGA-D3-A3MU_treatment5,3a595771-f93f-45b4-800c-cdf5b4a4b1a2,yes,Immunotherapy (Including Vaccines),0.0,0.0,0.0,1.0,0.0,0.0,0.0,Metastatic,-0.3641619017410343,0.1701148218645884,0.3731403135648949,0.3030034904081947,0.4915665129593742,-0.0289136241407412,0.0508610889320096,-1.628004522416771,1.686658835069479,0.6881463365596249
Z2,2950.0,0.0,71b347ac-6ac6-475d-8e21-754764180948,2611.0,58.0,-21318.0,24164.0,2846.0,,2950.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-Z2-AA3S,False,Italy,e379f14d-4d94-50f2-b196-06d9ccc359ad,not hispanic or latino,male,white,TCGA-Z2-AA3S_demographic,Alive,metastasis,03c84e27-19b1-4af9-b8e6-520402b7b2a4,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-Z2-AA3S_diagnosis5,"Skin, NOS",TCGA-Z2-AA3S_treatment10,87382393-4ffd-4014-a1f3-1286301e9f3c,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.139114779953592,-0.5118467416369094,0.6077664182794732,0.8974410860550082,-1.0490688664900238,-0.3717770881001517,-0.1259883160801823,-1.1369544779519,0.5024392754752575,-0.4509972822671567
BF,335.0,0.0,727a7579-bd82-4141-973f-794424f4d111,0.0,61.0,-22303.0,22303.0,0.0,,335.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-AAP4,False,Russia,208eab22-221d-5ecc-92d2-0db13d4d0388,not hispanic or latino,male,white,TCGA-BF-AAP4_demographic,Alive,primary,0e4605ef-254c-5410-88c1-07ed7ae1586e,True,8771/3,Epithelioid cell melanoma,No,Skin of trunk,TCGA-BF-AAP4_diagnosis,"Skin, NOS",TCGA-BF-AAP4_treatment,02953e3f-fb44-5ad3-a322-89de1c7f4669,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.0776008450282083,0.7427987332501237,-0.5918308487064804,0.4449401803680611,0.6559758716575556,0.8235504991634427,-0.4847725585476287,2.2020708243988127,1.42137688436089,0.2567651304854415
D3,1832.0,1.0,730f7400-e94a-4f41-b081-5227fa1a9c18,1412.0,74.0,-27355.0,28922.0,1567.0,1832.0,1832.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A3CE,False,United States,ba4bfe0d-ddcf-5010-9c72-c39e953c6437,not hispanic or latino,female,white,TCGA-D3-A3CE_demographic,Dead,metastasis,12c18079-dcc8-4f1c-870b-9df9795bba8e,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A3CE_diagnosis3,Not Reported,TCGA-D3-A3CE_treatment6,1a28cd71-a306-407e-a3da-2eb769fe6d35,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,1.043248408757926,-0.3439732820227691,0.2853045519188007,0.4127660000833604,-0.0702903405736699,0.7054658255416238,0.7966033958769858,0.283726900691638,0.262544271761609,-0.8456266226887037
XV,393.0,1.0,7436a28f-01a3-4148-b38e-63c57b5d86c4,-2.0,62.0,-22778.0,22778.0,0.0,393.0,393.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-XV-AAZW,False,Russia,10f6f37e-3676-5c49-8f6f-faa3a2525edc,not hispanic or latino,female,white,TCGA-XV-AAZW_demographic,Dead,primary,ab9a8d7c-42ef-5656-a22f-749442259598,True,8720/3,"Malignant melanoma, NOS",No,Skin of lower limb and hip,TCGA-XV-AAZW_diagnosis,"Skin, NOS",TCGA-XV-AAZW_treatment4,360c660d-6a18-437c-b816-bf2442b3b6b2,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.3388117086459247,0.4375876187414034,-0.768885270604127,-0.1121238510236036,-0.9181210505878526,-1.0767403938304478,-0.562522812180603,0.352583156926613,-0.6820131918895611,-0.1366098180177911
FS,2028.0,1.0,74596c13-8b5d-4289-a3c0-446fa968b241,,64.0,-23663.0,25467.0,1804.0,2028.0,2028.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-FS-A4F4,False,Germany,9a583247-3772-5a2b-86e8-59e3bbf8221b,not reported,male,white,TCGA-FS-A4F4_demographic,Dead,primary,2c6d58f7-6c37-5f76-a852-91b4bb81f342,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-FS-A4F4_diagnosis,"Skin, NOS",TCGA-FS-A4F4_treatment2,5944b4e3-5149-4054-9bf9-e3086e21c352,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.1554130907221083,0.2119362887460318,-0.1314080952351407,0.4709797507228627,0.7410612140898079,-0.3681897817629994,-0.5348182901870182,-0.7997169474148422,0.0920557836854993,0.2700316452245722
FS,2454.0,1.0,745c699b-8ecf-4653-b41f-6620f11bcf39,2267.0,39.0,-14426.0,16741.0,2315.0,2454.0,2454.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A4FD,False,Germany,8f706631-8e18-5ce3-a921-01f449c8a516,not hispanic or latino,male,white,TCGA-FS-A4FD_demographic,Dead,metastasis,06822ea1-0cd7-4164-b9fa-3ae4e5466db4,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-FS-A4FD_diagnosis5,"Lung, NOS",TCGA-FS-A4FD_treatment10,3c45e87c-924b-4d4f-91f8-26329c4d5396,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.3068586558679723,-0.4757176937966867,0.6756530913856439,0.1992224116446261,-0.3391920238832551,-0.1195087983021413,-0.3061832850384748,-1.2729419902656494,-0.5202587452107933,-1.2262099439808478
D3,718.0,0.0,74dc56e9-0076-458b-a12c-d50d7f057c47,42.0,63.0,-23109.0,23256.0,147.0,,718.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A8GD,False,United States,09e9b748-e063-5de3-9d6e-69574f497552,not hispanic or latino,female,white,TCGA-D3-A8GD_demographic,Alive,Progression,007971f9-52c4-4b63-8006-96e91c4c6f07,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of inguinal region or leg,TCGA-D3-A8GD_diagnosis2,"Skin, NOS",TCGA-D3-A8GD_treatment5,6724ae02-0bc8-424b-961d-c484b7d94bf6,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0992958146021697,-0.432164561946069,-0.0477253295647544,0.2648952523050033,1.339611608518464,1.406445684796801,-0.5052119320431874,-0.2980294019867386,0.8422517127744946,-0.4511373432022668
GN,3587.0,1.0,76cc1d42-acec-46b3-9663-5e4de2550353,,60.0,-22254.0,25475.0,3221.0,3587.0,3587.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-GN-A264,False,United States,c7a889d1-dc01-568c-9984-43227a3f0264,not hispanic or latino,male,white,TCGA-GN-A264_demographic,Dead,primary,2ac6c162-2782-4371-ae52-c507268457e7,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-GN-A264_diagnosis3,"Skin, NOS",TCGA-GN-A264_treatment3,25560dd3-5635-4026-8101-a84869dc657d,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.7125973911340517,1.2589387370284453,0.6645525698118787,0.648081993375268,-0.7850893543059811,-1.2752465915963171,-0.4552505362878703,-1.1576544798262978,0.8531983779924954,1.1547618983483874
WE,1923.0,0.0,77052f40-374e-4dae-bc17-908b52db0f08,1479.0,48.0,-17824.0,19581.0,1757.0,,1923.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-WE-A8ZQ,False,United Kingdom,9d003348-f636-53a7-bda8-17ee6cd75c46,not hispanic or latino,male,not reported,TCGA-WE-A8ZQ_demographic,Alive,primary,54215354-cfb0-4410-8390-d29c4bd57922,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-WE-A8ZQ_diagnosis3,"Skin, NOS",TCGA-WE-A8ZQ_treatment4,e9f0b0ed-69f7-4406-9fb6-3f79ec00012f,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2727047929828682,-0.6237634983248335,0.1652012149988489,-0.1978327820648137,-1.255365302836304,-1.7757287786683351,0.5594294144079132,-1.2253607359571397,0.1793961976589164,0.2533475867180922
EE,3857.0,0.0,783eb662-7d7a-4637-8500-e2d86d73ec7b,2170.0,66.0,-24159.0,27875.0,3716.0,,3857.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A2GO,False,Australia,eb52df88-7c7e-5ff5-bf58-9910d1ed128a,not hispanic or latino,female,white,TCGA-EE-A2GO_demographic,Alive,Progression,48377cf7-b945-4cbf-9947-18006f0a83f7,True,8730/3,Amelanotic melanoma,No,"Connective, subcutaneous and other soft tissues of lower limb and hip",TCGA-EE-A2GO_diagnosis2,"Skin, NOS",TCGA-EE-A2GO_treatment6,607f1ab9-487b-45f6-9007-7356b04023c9,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.1989721253068385,-0.6975723529755126,0.2385785051226792,-1.70777162569674,-1.1213118851504305,0.5277563153318249,-0.0095943847335573,-1.0678107216908923,-0.4820618708330861,0.3788981289789611
EB,390.0,0.0,78f3d4db-a1ff-4ea2-aaa0-cbf0278b915e,7.0,58.0,-21239.0,21249.0,10.0,,390.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A82B,False,Vietnam,c29972df-6f0c-52c2-bb10-cd3d42c4a2fb,not hispanic or latino,female,asian,TCGA-EB-A82B_demographic,Alive,primary,0aee8509-614b-452e-b3e0-c39f9b6a5f22,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A82B_diagnosis3,"Skin, NOS",TCGA-EB-A82B_treatment3,3e6f1c64-1056-4c7b-9d1d-7ddddff7921b,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.3912459899308901,1.1604179869787554,-0.1755363046387602,0.2419668548751651,0.9503851800028492,0.4490180561795847,-0.7950940924198729,0.0629268806980646,-0.6785195753306243,1.324459442430257
D3,818.0,0.0,791d3824-890f-43f2-b545-c7266506d716,51.0,59.0,-21823.0,22033.0,210.0,,818.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A51T,False,United States,3ee4d224-ca1c-54de-8f1a-d0c2ecad602c,not hispanic or latino,female,white,TCGA-D3-A51T_demographic,Alive,Progression,0d1f308d-f533-4f05-b18e-80c27c66c8d0,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-D3-A51T_diagnosis2,"Skin, NOS",TCGA-D3-A51T_treatment4,87319a29-0d20-4310-bba2-70b0c3ef630f,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2409718265195121,-0.1272678282669663,-0.98644725182643,0.7461312126395747,0.7567706564429534,0.2094206127931164,-0.6691572263387071,-1.4143920030740311,1.0838935247676114,-0.0715383224632311
D3,961.0,1.0,798074d3-0b84-4dd5-aa88-91feda9ac8c6,34.0,72.0,-26471.0,26974.0,503.0,961.0,961.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A1Q9,False,United States,1a687a00-eed2-5019-a8b7-2866ba6d454f,not hispanic or latino,male,white,TCGA-D3-A1Q9_demographic,Dead,primary,127d02ad-cf65-403e-b08e-4495d01c9069,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-D3-A1Q9_diagnosis3,"Skin, NOS",TCGA-D3-A1Q9_treatment4,247b7173-1333-42e8-b307-3d1943a4bd4b,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4794913395116295,0.5122848061863715,-0.8282421572855516,0.5701798205381242,-0.7496710726855317,0.2539465983555677,0.2272562855380078,3.223127166856065,0.7394229320564594,0.7994928496211637
ER,1857.0,1.0,7a918706-c697-4cef-9661-346c5a612ff8,1005.0,36.0,-13300.0,15030.0,1730.0,1857.0,1857.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-ER-A19M,False,United States,c3aee83d-4b37-564a-90f2-ddc5a98ab9b2,not hispanic or latino,male,white,TCGA-ER-A19M_demographic,Dead,not reported,004f5c1f-2299-54b9-9efb-388aaef54df5,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-ER-A19M_diagnosis,"Skin, NOS",TCGA-ER-A19M_treatment2,8370623d-3db6-4014-9832-496f28e8a169,yes,"Radiation, External Beam",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.6743084319432703,-0.0134636169060542,-0.0133257615281941,0.3918087158476036,1.14818516738516,1.6281357236585556,-0.02450913105655,0.5026581705159942,0.902109009817608,0.0743777053935607
EE,877.0,1.0,7b4bcf0e-ec55-489b-870f-a4360a6bea2f,,66.0,-24371.0,25170.0,799.0,877.0,877.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2M7,False,Australia,6e346da2-0f3a-59fe-996f-56f382258d00,not hispanic or latino,male,white,TCGA-EE-A2M7_demographic,Dead,Progression,8f4c5d67-b817-4798-9620-3215d2cbb31a,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-EE-A2M7_diagnosis2,"Skin, NOS",TCGA-EE-A2M7_treatment4,14850166-f31c-4142-bc51-5ec7ab212c6a,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3182789448878396,-0.5335115800648491,0.5255415136632501,-1.3321987115724214,-0.6633057123629855,0.3819509880276576,0.6945841896026927,0.8746832042030791,-1.5643842807916573,-0.0740164460769135
YD,210.0,0.0,7b617d72-ae16-4829-a1d9-274d1d30617f,202.0,43.0,-15804.0,16006.0,202.0,,210.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Liver and intrahepatic bile ducts,TCGA-YD-A89C,False,United States,29ba5f37-a41c-5140-a4d6-787b8744057c,not hispanic or latino,female,white,TCGA-YD-A89C_demographic,Alive,metastasis,20243bb8-c641-40b7-8291-fca48c235865,True,8720/3,"Malignant melanoma, NOS",No,Liver,TCGA-YD-A89C_diagnosis2,"Skin, NOS",TCGA-YD-A89C_treatment4,8555c982-acf2-4bd0-9340-89296dd6fc26,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.2283849764879805,-0.0926974281490287,0.3387881512480838,-0.0162265218675651,-2.388527506109809,-1.461585291501228,-0.4309408314780807,-0.2878231510625573,1.2220078327309052,0.4929952298175477
D3,854.0,1.0,7b7a49b5-5be8-4966-8f3a-e6e01e694f86,574.0,33.0,-12330.0,13109.0,779.0,854.0,854.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A1Q8,False,United States,92f20ef8-fe7f-5110-b815-5700d38e36d7,not hispanic or latino,male,white,TCGA-D3-A1Q8_demographic,Dead,metastasis,268401b4-6fd7-439a-8930-ae37cdc0e2c6,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A1Q8_diagnosis7,Liver,TCGA-D3-A1Q8_treatment22,51a0625b-9493-4209-9651-29f7500d62f1,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,0.5477413040686758,-0.1205022362364729,0.4962801309065361,-1.6163182057364929,-1.1847210868890554,-0.9057103677574228,0.2416592454262344,0.2430456470079268,0.1021872717064167,-0.685003256705712
DA,1640.0,1.0,7b92fcd4-f9be-4b97-94a2-b2e8348aeaba,,63.0,-23286.0,24594.0,1308.0,1640.0,1640.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,Skin,TCGA-DA-A1I8,False,United States,7b658e4b-6542-5006-9acd-76d9ab8d6bb9,not hispanic or latino,female,white,TCGA-DA-A1I8_demographic,Dead,metastasis,1e2c8d3a-8f12-4c5d-a09f-23117adcef86,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-DA-A1I8_diagnosis5,"Brain, NOS",TCGA-DA-A1I8_treatment4,5f701fe7-7887-426d-b953-5322703e3a53,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.4804664272516717,-0.2399221909289975,-0.457297921118182,-0.8743107737431046,-1.0183694255739628,-0.6606767366819896,0.2087837743791883,0.2686331493248893,-0.4994134997424724,-0.1294586040565922
BF,405.0,0.0,7c6e2fe9-d1ff-4bf4-bda1-cc3615eb3584,0.0,62.0,-22734.0,22734.0,0.0,,405.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-AAP2,False,Russia,597c5bd3-600d-5b23-8356-30eaae5f4050,not hispanic or latino,male,white,TCGA-BF-AAP2_demographic,Alive,primary,0396cff6-31ce-4165-9195-057a76bd769f,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-BF-AAP2_diagnosis2,"Skin, NOS",TCGA-BF-AAP2_treatment3,085a80b7-ce9f-41c2-8ff5-3b54615657e0,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.1764895283941434,0.1884195006706583,0.2172528233709225,0.41700830635335,0.6907303554837093,-0.0306595646830044,-0.1760213155391148,-1.160385730073613,-0.2666221830319951,0.4352997745138721
FS,808.0,1.0,7ce09a09-074e-4f38-bed7-98ab34347fbe,,70.0,-25856.0,26535.0,679.0,808.0,808.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-FS-A1ZU,False,Germany,cebe950c-e550-5640-b57d-59d56bc24fc8,not hispanic or latino,female,white,TCGA-FS-A1ZU_demographic,Dead,primary,21866bc4-cd74-42cc-8133-3f04cd3d6444,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-FS-A1ZU_diagnosis3,"Skin, NOS",TCGA-FS-A1ZU_treatment3,d6cc1e70-aec0-4241-a456-6f2dad867cd9,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.0517954366235034,0.6397757037177113,-0.2079783810784605,0.4033523722423101,-1.7117351215441534,-1.7876805029253842,-0.0120251477185076,0.6977269381795861,0.522818705402388,-0.6236566300512485
EE,2889.0,1.0,7ee2f8d5-6c31-4f5f-a779-b43979e66d0b,,69.0,-25523.0,28249.0,2726.0,2889.0,2889.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-EE-A180,False,Australia,8bcf56f3-8077-5942-badf-f03f7b0e0cdb,not hispanic or latino,male,white,TCGA-EE-A180_demographic,Dead,metastasis,03a97b8a-b3c7-4560-bf03-2eb3abab8883,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A180_diagnosis6,"Mediastinum, NOS",TCGA-EE-A180_treatment15,2eff126e-497f-4dd7-aa1b-da89170981a2,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.0014225394218352,0.5269643605339278,0.8634045681367869,0.7083340628130126,0.1774289500756224,-0.0024689844767205,-0.0946623137898072,0.0071518756476048,1.8576131386867791,0.2114140313448861
GN,772.0,0.0,7f7bc51f-7f75-4796-9ce5-a4735c3c0807,15.0,68.0,-24872.0,25309.0,437.0,,772.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-GN-A8LN,False,United States,6722b974-c340-5103-8640-b316a31e4564,not hispanic or latino,male,white,TCGA-GN-A8LN_demographic,Alive,metastasis,165bfcbd-0bb0-43dc-81dc-caa19cbfa8af,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-GN-A8LN_diagnosis6,"Lung, NOS",TCGA-GN-A8LN_treatment11,3cda4050-9608-44ed-9422-4f64ba5a22c8,yes,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0997076427379707,-0.3208005066068975,0.7368061665508691,0.2671922585650746,-0.8768449616906958,-0.648831837966306,-0.6185885841248032,-1.5653295167415129,0.7154334316850944,-0.4396260843024675
DA,1093.0,1.0,7fb87427-9b19-4378-86d5-f4f775f97805,,51.0,-18961.0,19850.0,889.0,1093.0,1093.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,Skin,TCGA-DA-A1I4,False,United States,1f426814-e5b1-5df9-a233-77c37fc7fc43,not hispanic or latino,male,white,TCGA-DA-A1I4_demographic,Dead,Progression,1b0f0021-7201-4a12-b8b5-319aabe1af6b,True,8720/3,"Malignant melanoma, NOS",No,"Skin, NOS",TCGA-DA-A1I4_diagnosis2,"Skin, NOS",TCGA-DA-A1I4_treatment5,c1e3b869-974c-4cef-bdda-6e11eb2fa785,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.1107041366493027,0.1707846014215958,-0.0466595483310868,0.2836676648739989,-0.4725126195993445,-0.7416031256909869,0.429324719934523,1.6165770213820017,0.9293592189773144,0.1129249814968601
DA,1096.0,1.0,800d3a17-269f-4d97-94ff-8585f20038d8,,37.0,-13585.0,14437.0,852.0,1096.0,1096.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-DA-A1HW,False,United States,cfe2c1b3-02a4-59ef-ac35-2a222ef0d9bb,not hispanic or latino,female,white,TCGA-DA-A1HW_demographic,Dead,not reported,aaf57293-d870-4fe7-9c00-867ac908e062,False,Not Reported,Not Reported,Yes,Not Reported,TCGA-DA-A1HW_diagnosis4,Not Reported,TCGA-DA-A1HW_treatment6,4b736828-ddbb-4e93-9151-d6d8a81e647b,yes,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,1.0106388578572163,0.3286592575976727,0.4977060508525506,0.5446779025403613,0.3060010147957751,0.9337673017074816,0.3652296546298473,-0.2668356491621271,-0.4097440080630988,1.91713459314942
EB,352.0,1.0,800f3039-97e0-441e-8292-4ccf1bb4797a,-3.0,76.0,-28078.0,28419.0,341.0,352.0,352.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A6QZ,False,Ukraine,097660e3-c5a9-56f4-9159-d26b76cbcb64,not hispanic or latino,female,white,TCGA-EB-A6QZ_demographic,Dead,metastasis,90e3d27c-35ce-4b9b-9da9-aee5a4863a81,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EB-A6QZ_diagnosis4,"Brain, NOS",TCGA-EB-A6QZ_treatment12,06f6cc2c-dd4c-433c-92b6-7c8c678443c6,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Primary,-0.0391556931032451,-0.2514172849887053,-0.4210402653890127,0.5202579573900868,0.1032216495716673,-1.3377831609328552,-0.4645839877810745,-1.0576044707667112,-0.8886023844080126,0.116969857222321
W3,2101.0,1.0,81807b84-da9c-4847-a303-5a8c7297127c,882.0,57.0,-21033.0,23042.0,2009.0,2101.0,2101.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Adrenal gland,TCGA-W3-AA1Q,False,United States,281e38da-23ed-5bb2-9c04-6b6b3b5147a6,not hispanic or latino,male,white,TCGA-W3-AA1Q_demographic,Dead,metastasis,00b3d892-2ff8-406c-b475-1a9e72d1381d,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-W3-AA1Q_diagnosis3,"Lower limb, NOS",TCGA-W3-AA1Q_treatment11,97c1daca-0c24-4d1b-8580-dfa96f496b54,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.2243073452669895,0.4024374311835409,0.4453215463414747,0.505817867607103,0.872365074991083,0.5736589933365978,-0.3096339885464458,-1.1983357335100089,0.037438911480791,-0.1960277372544296
EE,1424.0,1.0,81cedb9e-ee43-476b-9ed9-8d0fdb346065,1092.0,77.0,-28319.0,29566.0,1247.0,1424.0,1424.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2A0,False,Australia,b6cb8421-a89c-5017-8be9-5a68f43ad4e3,not hispanic or latino,female,white,TCGA-EE-A2A0_demographic,Dead,metastasis,0ff5da26-15e4-46a2-9438-312c9aecf1e6,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A2A0_diagnosis4,Eyelid,TCGA-EE-A2A0_treatment7,5757e961-0ddb-4491-ac3e-77a17a888b01,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.6774071820424856,0.3342801732584268,0.916625889771999,0.3361899500605679,-0.4531622650542894,0.0314819369799054,1.3484066301122724,1.2457019877990498,1.0367297012219672,1.348086502245161
EB,382.0,0.0,82e85ac9-8e3e-4c2e-ae0b-a32ceeb8115d,-6.0,71.0,-26216.0,26252.0,36.0,,382.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A6QY,False,Ukraine,e3c18d60-2974-533e-b9cf-b4450afbcc53,not hispanic or latino,male,white,TCGA-EB-A6QY_demographic,Alive,metastasis,05ef605e-723d-48e0-8d40-d0b3e6d1f30e,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EB-A6QY_diagnosis3,Not Reported,TCGA-EB-A6QY_treatment10,0e6b9be2-8f78-4886-a402-20eb9aa4280e,yes,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.6920892450845081,0.6310133088564784,-0.429788387765696,0.3104179178520584,-1.0884690095629337,-0.1355115843619741,0.7183586974756099,0.5416144240435045,0.0013382070384451,0.1274795309873827
BF,703.0,0.0,8352cbb0-10e7-40bd-96f0-1e982ab4c07b,-1.0,65.0,-23940.0,23940.0,0.0,,703.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-A5EO,False,Russia,e0d023af-2b1a-5776-8045-6eacaada4f97,not hispanic or latino,male,white,TCGA-BF-A5EO_demographic,Alive,primary,7a8bcd33-531b-4e8d-a5e7-fd0ee5a61102,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-BF-A5EO_diagnosis2,"Skin, NOS",TCGA-BF-A5EO_treatment3,fabb8853-a800-4fc9-a7da-df43158bf822,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.7980869918609367,0.6669114557966275,-0.8785691078960346,0.1574708579243431,0.1543163150548694,0.0165808381549281,-1.2131259502896936,-1.7522045336631544,-0.957543084504363,0.4005234143009776
EE,1940.0,0.0,83d05b9a-f409-4169-bef9-e772d2cfbfaf,16.0,54.0,-19961.0,19991.0,30.0,,1940.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A29E,False,Australia,86f58812-7741-5e39-9213-94f65b3245b1,not hispanic or latino,male,white,TCGA-EE-A29E_demographic,Alive,Progression,28ce6beb-d628-4383-9e34-17e0bb4761a5,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-EE-A29E_diagnosis2,"Skin, NOS",TCGA-EE-A29E_treatment4,77ba6131-e219-4b34-8017-b59f0fad2300,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4099969073713586,-0.3003628269873882,-0.0180637218651057,0.3057799566561385,-0.4670884379309177,-0.6966801612964292,-0.7630778378150623,-0.1749793908444882,0.4310530437876511,-0.2716466709207362
FS,854.0,1.0,8465257b-7212-44a3-bd9f-1f7d017499ad,,62.0,-22932.0,23314.0,382.0,854.0,854.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A1Z4,False,Germany,b220a30e-72e5-5de7-a64b-ad199d732cf7,not hispanic or latino,male,white,TCGA-FS-A1Z4_demographic,Dead,primary,07a4515b-f739-552a-a8eb-96aad986908b,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-FS-A1Z4_diagnosis,"Skin, NOS",TCGA-FS-A1Z4_treatment2,3cd84843-0c6c-4a92-9f93-ab70995674f7,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2984560266590566,-0.6145445680826502,-0.0731366133324126,-0.2602347478360436,-0.018345657180559,0.7632158014646567,0.7634490812182821,-0.3578294074016654,-1.6162062597492166,0.1521492932992022
EE,2927.0,1.0,8509f10a-c454-45a5-9c22-853fda423b9f,,60.0,-22050.0,23305.0,1255.0,2927.0,2927.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2MJ,False,Australia,db113fb6-d73b-5952-b615-8290a87bbf24,not hispanic or latino,male,white,TCGA-EE-A2MJ_demographic,Dead,primary,27ea5ef3-f60b-4c34-aae9-47342b2525ad,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A2MJ_diagnosis3,"Skin, NOS",TCGA-EE-A2MJ_treatment3,91f4a649-d424-44a0-a98b-f6dcf5e2bc37,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.4086841304433487,-0.3724533640000916,0.3702503769235074,0.3231275390233139,0.9787227962531232,1.0919821934320295,0.7433402295268059,0.0708331314139797,0.1272248570454622,-0.2983923493754662
D3,284.0,1.0,85400bf1-23e0-4e0f-8df7-f0d108641aee,22.0,47.0,-17220.0,17472.0,252.0,284.0,284.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-D3-A3MO,False,United States,28ddb5b2-688c-5c78-af06-bdbcdad3f55e,not hispanic or latino,male,white,TCGA-D3-A3MO_demographic,Dead,metastasis,0af25dc0-bcb7-49fe-878b-ff5316b87461,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A3MO_diagnosis10,Vertebral column,TCGA-D3-A3MO_treatment26,40e8b8ed-e611-4962-af6d-a8fbb7cb4537,yes,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4372028763874559,-0.7294536900129838,-1.0334077582664083,0.1221842227692865,-1.6557256462469718,-1.3597820260104758,0.7745356080057965,0.8437769514045002,0.00168756869434,-0.5280890286498505
D3,4195.0,0.0,854466bf-b943-4acb-b4f1-6b285cb813e3,32.0,61.0,-22287.0,25026.0,2739.0,,4195.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-D3-A5GO,False,United States,74f32bd0-0ec7-52da-ae6e-f71ff143ff6c,not hispanic or latino,male,white,TCGA-D3-A5GO_demographic,Alive,Subsequent Primary,1612327f-45fe-439a-a369-d302e1d11f50,False,8070/3,"Squamous cell carcinoma, NOS",Yes,Not Reported,TCGA-D3-A5GO_diagnosis5,Other ill-defined sites,TCGA-D3-A5GO_treatment9,5f70b817-b65d-41f9-8256-07bc238fdb36,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.0127050164727928,-0.094736894545659,-0.0585591093441795,0.355945770458406,1.842186029448784,0.0580965763674238,-1.4339584853043037,-1.2459169878185186,-0.4309386151873146,-0.1014657417522126
EE,1195.0,1.0,865128c9-2e8e-4683-9232-174282ae984d,906.0,43.0,-16041.0,17158.0,1117.0,1195.0,1195.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A2A5,False,Australia,69ebc21d-9a47-52bd-a76c-f8da6b77fde3,not hispanic or latino,male,white,TCGA-EE-A2A5_demographic,Dead,Progression,28ea3eb3-089b-49ef-b1f5-7a980f6e5899,True,8720/3,"Malignant melanoma, NOS",No,"Connective, subcutaneous and other soft tissues of upper limb and shoulder",TCGA-EE-A2A5_diagnosis2,"Skin, NOS",TCGA-EE-A2A5_treatment9,211867d9-5545-486a-a025-ec10ce2b8b67,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.2813325102211369,-0.7157849643735019,0.6771978274380155,0.4084457154914663,-1.2254733840718812,-1.067517102349062,1.1600896499232527,-0.5692856765491554,0.4546931825031231,-0.7312355548921832
FS,874.0,1.0,87dc5c05-3121-46bf-adba-061f45cecf27,,77.0,-28412.0,28412.0,0.0,874.0,874.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-FS-A4F5,False,Germany,bff1557d-94a5-5904-af1d-6d9798f12294,not hispanic or latino,female,white,TCGA-FS-A4F5_demographic,Dead,primary,b50840df-f034-426b-960e-570cfb0c1665,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-FS-A4F5_diagnosis2,"Skin, NOS",TCGA-FS-A4F5_treatment3,44153fcb-de93-4190-bbaa-844123711466,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3060579882006201,0.475363286144739,-0.9203203670593986,0.3151910825483593,-0.2463044901686622,-0.8513474402996767,-0.2717150914736763,-0.5921419286188029,0.1866163385473852,-0.902713554829052
EE,2470.0,1.0,880bb701-f1d3-4bf2-bfc8-143ad8d07b6a,1309.0,28.0,-10421.0,12876.0,2455.0,2470.0,2470.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A2GS,False,Australia,fdf07dc0-737a-5d3d-9ed2-51db9041c9fc,not hispanic or latino,female,white,TCGA-EE-A2GS_demographic,Dead,metastasis,3b0260e5-60d4-4ea3-88a2-e9ccfc95cf4a,False,8730/3,Amelanotic melanoma,Yes,Not Reported,TCGA-EE-A2GS_diagnosis9,Heart,TCGA-EE-A2GS_treatment27,8387cfe1-2f88-47b8-ab8c-888f9c65ff82,yes,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,0.4819653977802868,-0.3676257562160578,0.6177823864949191,0.3417262880385955,0.1073964466811026,-0.2568334456315789,0.3367498217274119,-1.203510733978609,0.3129688040955928,-0.9845845400050972
ER,1010.0,0.0,88314f23-3446-4102-a117-b65a8520d8e6,954.0,30.0,-11032.0,11990.0,958.0,,1010.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-ER-A3PL,False,United States,11472a7f-ab92-5723-91aa-71d6dc2ecf23,not hispanic or latino,male,white,TCGA-ER-A3PL_demographic,Alive,not reported,0bce2e8c-ac1a-5a9b-b215-b99b0a15a557,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-ER-A3PL_diagnosis,"Skin, NOS",TCGA-ER-A3PL_treatment2,8abd20c0-8e81-4e4d-b8c5-fcdb0c153531,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.5068498260509758,1.2461911029078458,0.405387648312614,0.4014702693395915,0.2480941007073019,-0.5546239505613132,-0.7099032250747195,-0.6144231806363826,0.7320863372826929,-0.3443488819285208
BF,335.0,0.0,888ef0fc-fc84-4afb-a369-695fee5ae4f6,-4.0,75.0,-27622.0,27622.0,0.0,,335.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-A5EP,False,Russia,194a43a8-8b33-5baa-90b4-727504080c9b,not hispanic or latino,female,white,TCGA-BF-A5EP_demographic,Alive,primary,6e619257-a9ac-578a-afb6-0b16d5290758,True,8720/3,"Malignant melanoma, NOS",No,Skin of trunk,TCGA-BF-A5EP_diagnosis,"Skin, NOS",TCGA-BF-A5EP_treatment,2e2b30a1-44cc-5cee-86d3-a95b01256a0d,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.3221017972598419,0.0219531674945325,-0.3853313306112092,0.3185629828887436,-0.94262211046673,-0.5622596141318476,-1.005932868830932,0.5293956729370898,-0.4836922252272569,-0.3645096942606888
FW,640.0,0.0,889ae822-add8-4a10-abe0-50176c858f80,41.0,71.0,-26056.0,26067.0,11.0,,640.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-FW-A5DX,False,United States,7b951af1-497c-5c7a-9118-e5befa11247a,not hispanic or latino,male,white,TCGA-FW-A5DX_demographic,Alive,primary,5d2db7b8-e512-581a-ab46-2c9766393019,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-FW-A5DX_diagnosis,"Skin, NOS",TCGA-FW-A5DX_treatment2,a76e9e22-a035-42c1-a474-8c0965746aa0,unknown,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.6660859655028994,-0.1939154799686795,-0.8266761039277242,0.3480846469001148,-2.5537305806178376,-0.7843694211379914,-0.0603621996415806,-1.6246982721173882,-0.2562577872404824,0.5106086835101615
EE,566.0,1.0,8aad9690-d1ad-424b-9a80-d7980760d093,313.0,78.0,-28805.0,29352.0,547.0,566.0,566.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A29N,False,Australia,3c216c5f-4963-5094-a569-52e9ff117353,not hispanic or latino,male,white,TCGA-EE-A29N_demographic,Dead,not reported,2d3f2e29-e7fe-5fe5-bc64-6b1f60314573,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-EE-A29N_diagnosis,"Skin, NOS",TCGA-EE-A29N_treatment2,023a4fe0-79cd-4ab6-bed7-b6123df50262,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3296520349638987,0.5988439876202993,0.1261292987966565,0.3181491158659265,0.0035765423556565,0.6987707515779519,0.7233780873237915,0.837883200870816,0.9708168021433612,-0.0064130333913616
ER,955.0,1.0,8ab09143-daf6-40a9-85d3-0fe9de7b3e06,-226.0,62.0,-22702.0,23508.0,806.0,955.0,955.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-ER-A193,False,United States,0bd642cc-53ea-5130-b235-77b6ee3a1fdc,not hispanic or latino,male,white,TCGA-ER-A193_demographic,Dead,metastasis,0998c454-0cb3-4802-a461-5ce1408efdea,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-ER-A193_diagnosis3,"Brain, NOS",TCGA-ER-A193_treatment8,2a4c8f6a-7892-4b4d-b3dc-f33980f30224,yes,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,0.4864441852696296,0.2593704507467742,0.309666650556933,-0.1897376278556433,0.1839718612109842,0.9627548112207706,0.7266186034819088,-0.0433043789212386,0.9373945370628686,-0.8625619256368457
XV,417.0,0.0,8b6b1cbf-dedb-4c99-8f75-eafbe5c43592,-1.0,81.0,-29836.0,29836.0,0.0,,417.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-XV-A9W2,False,Russia,6fba0475-2228-5cd5-93c4-badaa2864dae,not hispanic or latino,male,white,TCGA-XV-A9W2_demographic,Alive,primary,0e18b7ca-4800-44e1-8591-a33ed7377568,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-XV-A9W2_diagnosis2,"Skin, NOS",TCGA-XV-A9W2_treatment3,5bd16a83-9032-404b-a8dc-623c150f1649,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.8905237973168314,-0.0237371095398003,-0.2175923194622253,0.1366467929003232,-0.1160307228699051,-0.3467741940952694,0.1290026276135357,-0.5771919272650705,-0.7922950212666604,0.1830651259216436
EB,126.0,0.0,8b93bdb4-b64b-4940-a814-f5b3f5ae56cc,16.0,56.0,-20605.0,20605.0,0.0,,126.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EB-A3Y6,False,Ukraine,694f855c-f806-5e3f-a946-cd7bb26994bc,not hispanic or latino,female,white,TCGA-EB-A3Y6_demographic,Alive,primary,c10ef3ea-29be-4144-a133-5468fc187996,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A3Y6_diagnosis2,"Skin, NOS",TCGA-EB-A3Y6_treatment3,0f2ef396-4dd4-4257-af11-55642158212e,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.1642526687534212,0.1457982454857563,-0.4527858359748456,0.3556003914333387,0.6864914130707399,-0.1099518932345102,-0.3074848356474763,-0.1271106365099435,0.4952191345867887,-0.2088150455034247
D3,504.0,1.0,8c54fcfd-999f-43c5-b31f-26d006f5fff3,43.0,79.0,-29212.0,29681.0,469.0,504.0,504.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A1Q1,False,United States,678c4a9d-5270-58dc-80e2-48b540d31a74,not hispanic or latino,female,white,TCGA-D3-A1Q1_demographic,Dead,metastasis,2cb33232-951d-48a0-956a-d40a9dc1cbb7,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A1Q1_diagnosis7,"Connective, subcutaneous and other soft tissues of abdomen",TCGA-D3-A1Q1_treatment18,0fe72257-a37c-448a-a203-cd1c9878eb89,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4877522891402867,0.793592189151807,0.3479600617435852,0.4602064860852712,-1.5209927418260392,-1.4068005410578834,0.7066426539287036,2.1024520653782752,1.012507293080005,-0.5241313918262804
WE,546.0,0.0,8d7f8f4d-aef9-4d1b-bfb4-7ed85b0797b3,60.0,79.0,-29216.0,29488.0,272.0,,546.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-WE-A8K6,False,United Kingdom,d3de021d-d8d1-51a4-9f18-4a57991495f9,not hispanic or latino,male,white,TCGA-WE-A8K6_demographic,Alive,primary,1b387332-07e4-44f6-8ccb-a4f61f4ea52d,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-WE-A8K6_diagnosis3,"Skin, NOS",TCGA-WE-A8K6_treatment3,18e0b9bf-1906-47f5-8bbf-615001afa291,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.6091341782709596,-0.6332187266547925,-0.0707918314366306,-0.6122813739147708,-0.1461374823260029,-1.3448478641408237,-0.4145656634988168,-1.7637045347044875,0.9937582175470452,0.1145036817361345
EE,2192.0,1.0,8ee500d6-c7b3-46e9-86d0-933695934707,1931.0,53.0,-19664.0,21769.0,2105.0,2192.0,2192.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EE-A29G,False,Australia,94708ac0-2b10-5e4a-befe-876fdcf3d7bf,not hispanic or latino,male,white,TCGA-EE-A29G_demographic,Dead,not reported,1fe97638-18e6-53f8-8469-3e1a20ca54ac,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-EE-A29G_diagnosis,"Skin, NOS",TCGA-EE-A29G_treatment,62c00264-300d-5a52-b908-00a28846f0f5,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.3369091027717948,-0.4740818311882819,0.5679788042656305,-0.1335167122107667,0.4372471825074472,-0.3049508994907101,0.9993094585298116,1.3780957497873836,-0.1721780820554068,-0.3495655389051156
DA,1235.0,1.0,8fc9cc74-f388-49f0-b957-debb62638634,,69.0,-25219.0,25462.0,243.0,1235.0,1235.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-DA-A1IB,False,United States,c0708f19-083c-5aee-a1ff-9fcf8534024d,not hispanic or latino,female,white,TCGA-DA-A1IB_demographic,Dead,Progression,393c7569-5686-4f26-872c-022cfe4aa61f,True,8720/3,"Malignant melanoma, NOS",No,"Lymph node, NOS",TCGA-DA-A1IB_diagnosis2,"Skin, NOS",TCGA-DA-A1IB_treatment4,545b9429-a7ef-44a3-9de8-b1a2b33c054e,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0388070663289591,-0.2015138900327032,0.4292196829091195,0.1476441240610526,0.9013698846514364,1.3318735419679826,0.7191336805533253,0.1414143878051557,-1.014139672759137,-0.0007937621179925
EB,378.0,0.0,90402c32-9548-432e-85b8-a4f80e14401e,-1.0,63.0,-23322.0,23322.0,0.0,,378.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A299,False,Russia,486a1b4a-e245-5b8b-925a-7ed1287638b0,not hispanic or latino,male,white,TCGA-EB-A299_demographic,Alive,primary,5b745982-1073-45db-9469-9de0cc115b5d,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A299_diagnosis2,"Skin, NOS",TCGA-EB-A299_treatment3,ae7fdfd9-467f-403e-b3b2-fe6479a8bf5f,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.2792652451191054,-0.6628485726340211,0.2007977783092007,-0.1130449502559865,0.2423809440063329,-0.23135060921035,0.0706385651443081,-0.5094856711342286,-1.2819836089442795,0.4201995377858118
EE,2588.0,1.0,905ea29f-588a-497b-9f06-2eef3bdc9442,1156.0,67.0,-24618.0,27064.0,2446.0,2588.0,2588.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EE-A29B,False,Australia,347f4ce1-efb8-558c-9a85-40e1c9bbb5ef,not hispanic or latino,male,white,TCGA-EE-A29B_demographic,Dead,Subsequent Primary,05ea71dc-66a1-477e-b00f-241f53fbfbd2,False,8720/3,"Melanoma, NOS",Yes,Not Reported,TCGA-EE-A29B_diagnosis4,"Skin, NOS",TCGA-EE-A29B_treatment6,21ca037c-8476-44cf-a97c-43ee1f01922b,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.3815161054738605,0.3977563733062603,0.1443633034987793,0.4909399281273486,0.1372771743007027,-0.3151672968283188,-0.6438552329218691,0.3396456557551142,0.760035269754185,-0.1031086474941232
GN,3708.0,0.0,909335d0-bb4b-4ea3-869a-93e4d91c2154,2224.0,30.0,-11294.0,14050.0,2756.0,,3708.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Brain,TCGA-GN-A4U3,False,United States,0b2706e0-e16c-507e-99e6-84f75d0e8a6e,not hispanic or latino,male,white,TCGA-GN-A4U3_demographic,Alive,metastasis,36a17a6a-9384-465f-a269-e464f4d35be8,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-GN-A4U3_diagnosis6,"Brain, NOS",TCGA-GN-A4U3_treatment15,3c9705ca-4d2e-4a52-b5d6-caae0a6f7fe1,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,0.7947451546185663,-0.7756480242982049,-0.5029147639992447,0.1807057824707398,-1.193022726689155,-0.4227564760434166,-0.959812167118184,-0.672210685869076,0.4747232507743606,-0.5103960913155905
ER,9188.0,0.0,90aa7540-93e7-4ffa-9e77-879198be1e7b,4652.0,48.0,-17820.0,22528.0,4708.0,,9188.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-ER-A19G,False,United States,016d846e-5db6-55f1-ba43-e6a85a4b538c,not hispanic or latino,female,white,TCGA-ER-A19G_demographic,Alive,Progression,9623e4d4-11da-459f-a9f6-323fe8e44688,True,8720/3,"Malignant melanoma, NOS",No,Skin of trunk,TCGA-ER-A19G_diagnosis2,"Skin, NOS",TCGA-ER-A19G_treatment5,8c9827e3-a858-4654-a3c7-f9cb1a68c569,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.7188810488802304,-0.1563689337898988,0.5229445388917513,0.1894754765692406,0.4877443683089126,0.760686998715574,0.1066647065912804,0.1457268881956553,0.6908616618872395,0.5847807983195553
EE,6699.0,0.0,913f21a9-f727-4983-ab3a-61b5b3fc7f5e,4897.0,34.0,-12727.0,17619.0,4892.0,,6699.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2GH,False,Australia,41f94306-bac1-5876-ba51-f98924249da5,not hispanic or latino,male,white,TCGA-EE-A2GH_demographic,Alive,Progression,52c2dc47-5f94-4e69-b96b-c6c81e9835ea,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-EE-A2GH_diagnosis2,"Skin, NOS",TCGA-EE-A2GH_treatment6,074838ac-00da-431e-bd55-d1715416035c,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.5240715778013205,-0.130810809392577,0.3322208198932788,0.1581985914392067,0.3466880590481145,0.7899437871997751,-0.521484212994243,-0.1848981417426368,-1.6096848421725356,0.900601167326189
EE,1301.0,1.0,919dfc28-6b55-452e-884c-48cb86802ac2,29.0,78.0,-28510.0,28910.0,400.0,1301.0,1301.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A2GR,False,Australia,6a22e7ee-1315-58ea-9952-836d63d33a74,not hispanic or latino,male,white,TCGA-EE-A2GR_demographic,Dead,Progression,1da532db-e2c1-4147-820e-844a9ff62b26,True,8720/3,"Malignant melanoma, NOS",No,"Connective, subcutaneous and other soft tissues of upper limb and shoulder",TCGA-EE-A2GR_diagnosis2,"Skin, NOS",TCGA-EE-A2GR_treatment4,05382629-2b0b-4de7-9eb3-254dbd47fc23,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3218299652755111,-0.6859399537054811,0.9969756368129248,0.7751832803572241,-0.902541013048296,-2.214364822684255,-0.0333978598465921,-1.0136169667836146,1.961490004372495,0.0459084939683861
XV,412.0,0.0,92116b0b-e614-4a27-a3c2-207e561c788b,-1.0,56.0,-20545.0,20545.0,0.0,,412.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-XV-AAZV,False,Russia,6fc585ed-2f9f-58ef-84e9-72b91a97d081,not hispanic or latino,female,white,TCGA-XV-AAZV_demographic,Alive,primary,623ed717-ddd1-5310-84a9-998d81c6f94e,True,8720/3,"Malignant melanoma, NOS",No,Skin of trunk,TCGA-XV-AAZV_diagnosis,"Skin, NOS",TCGA-XV-AAZV_treatment4,277f434a-31fb-4393-aa70-6138e6b6d827,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.6599350987628819,0.1573330885716777,-0.020877248878471,-0.3144623294962382,1.0522753624006291,0.2753636789055421,-0.5864452522327425,-0.1749793908444882,-2.2957146804623934,-0.0799419219001169
EE,4222.0,1.0,92d79156-9139-487b-8582-ce0e87b4ecd0,3835.0,30.0,-10988.0,15172.0,4184.0,4222.0,4222.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A3AH,False,Australia,3b87585b-5e0f-5759-9561-9267a689c25e,not hispanic or latino,male,white,TCGA-EE-A3AH_demographic,Dead,metastasis,03d90a1a-3887-4251-b5ad-2cc1d375bc38,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A3AH_diagnosis8,"Abdomen, NOS",TCGA-EE-A3AH_treatment19,644a7f7a-819d-4bef-9d69-f3e8e79c7935,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.6854684362733539,-0.5774689107714553,0.199179415497387,0.3293685646146102,-0.9607615754004688,-1.1933457391120574,0.6649383107506824,0.228383145680227,0.428258150540502,0.5813716030119903
DA,804.0,0.0,931e39cd-b0c4-437f-b6c5-9358d74ea533,,73.0,-26708.0,27104.0,396.0,,804.0,TCGA-SKCM,Consent Waiver,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-DA-A960,False,United States,1dde1ad7-e45b-52b7-8a69-0b6618acd2f8,not hispanic or latino,male,white,TCGA-DA-A960_demographic,Alive,Progression,87d23d88-e480-4224-84e7-bbef669b69f6,True,8720/3,"Malignant melanoma, NOS",No,"Connective, subcutaneous and other soft tissues of upper limb and shoulder",TCGA-DA-A960_diagnosis2,"Skin, NOS",TCGA-DA-A960_treatment4,1d495392-30da-4d04-b8d7-259152d595cd,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.9345309237281512,0.695532698007084,-1.3512856201711891,0.2597589551059749,-0.0980849820956102,-0.4492207151457692,-0.9873223712008284,-0.3424481560088842,-1.4488620265761527,0.159843383136548
EE,1658.0,0.0,93a31e9f-6557-4f15-a49f-5dfea2c588b2,13.0,52.0,-19216.0,19957.0,741.0,,1658.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A3AE,False,Australia,aedcb0c5-1c23-58af-b755-7e38b835f0c7,not hispanic or latino,female,white,TCGA-EE-A3AE_demographic,Alive,primary,594e5fe7-46ba-4ef0-a588-4d8828a06c9e,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A3AE_diagnosis3,"Skin, NOS",TCGA-EE-A3AE_treatment3,2b7fccb9-5fbb-44de-b29e-0d278a82b5bb,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.4359100934912584,0.0170816686891592,-0.4176219318847852,0.6767257315150197,0.4730735371365623,0.5839557746778559,-0.1890068181797037,-0.6375669327320627,2.518023122211101,0.1902963136331513
D3,4638.0,0.0,95f469b1-e109-4d0e-b9aa-2060207f8a03,567.0,77.0,-28234.0,29760.0,1526.0,,4638.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Colon,TCGA-D3-A8GP,True,United States,9d91319c-4aa2-5db0-a1b0-7cff05f5c206,not hispanic or latino,male,white,TCGA-D3-A8GP_demographic,Alive,metastasis,15c54237-00bb-4bd1-b9ec-9e0c9d700a10,True,8771/3,Epithelioid cell melanoma,No,"Colon, NOS",TCGA-D3-A8GP_diagnosis2,"Skin, NOS",TCGA-D3-A8GP_treatment4,97898bf1-a6e1-4122-b36b-0bb627479f9c,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.3252350344151392,0.3851121484056202,0.2455645685636871,0.5121765957925192,0.8205449553839909,-0.8577404047586179,-0.9786058107137838,-1.839173291538228,-1.2112961005684608,-0.8719040482927312
EB,226.0,0.0,960899ed-b61b-4b20-b16d-e37dffb01aa3,12.0,62.0,-22972.0,22972.0,0.0,,226.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A553,False,Ukraine,47d4a113-6470-5f92-a7e0-c4441872bf28,not hispanic or latino,male,white,TCGA-EB-A553_demographic,Alive,primary,0de6600c-025d-424f-a093-4e6c0481dfe7,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A553_diagnosis2,"Skin, NOS",TCGA-EB-A553_treatment4,0fcab086-bd17-4db7-afa8-eafc191bc301,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-1.0852143157164087,0.7209670278112364,-0.2209643847094629,0.0898743589338831,-1.0157758915000958,-0.2294284340623346,-0.1565264257991802,1.1946707331781383,-1.3534862945171815,-0.4794299157447263
GN,1524.0,1.0,962ff090-16c0-438b-8213-86b2bd306e4c,27.0,70.0,-25725.0,27193.0,1468.0,1524.0,1524.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Bronchus and lung,TCGA-GN-A8LK,False,United States,4abf4174-7766-5dce-9f45-d5435bc02b11,not hispanic or latino,male,white,TCGA-GN-A8LK_demographic,Dead,primary,055824db-81d1-56d4-971e-b04029d8c232,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-GN-A8LK_diagnosis,"Skin, NOS",TCGA-GN-A8LK_treatment3,2cd5b775-1fec-4ef1-a53b-f449737baf77,yes,Chemotherapy,0.0,0.0,1.0,0.0,0.0,0.0,0.0,Metastatic,-1.0752604333322346,0.4805013808982854,-1.3032009122209265,0.4181263776281138,-0.491236407239402,-0.7206783659044728,-0.4548321121008712,1.4377520051892916,-0.1365431931542534,-0.1058574064688289
D3,5318.0,0.0,963858b8-a8b6-498e-989a-271654713772,4341.0,39.0,-14305.0,16788.0,2483.0,,5318.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-D3-A51E,False,United States,2b32c73a-a0aa-5cc0-9d46-69ab4f369fed,not hispanic or latino,female,white,TCGA-D3-A51E_demographic,Alive,Progression,670ac2cd-3b4d-4a93-ba61-e9d87b2c9a99,True,8720/3,"Malignant melanoma, NOS",No,"Connective, subcutaneous and other soft tissues of lower limb and hip",TCGA-D3-A51E_diagnosis2,"Skin, NOS",TCGA-D3-A51E_treatment6,521cb75a-abba-4121-82a8-8980f48e0486,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0370825614657166,0.9554282348817956,0.0736482463926482,-0.1009129280764503,1.5925783955800747,0.7320591757713375,-0.0190983109928623,0.390245660336974,0.0840204655999451,-0.1124876891074493
EB,568.0,0.0,96fc529a-6ad3-456f-a41a-63238ecbb9c4,-1.0,34.0,-12484.0,12484.0,0.0,,568.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A431,False,Russia,847376ca-18f4-569b-b810-3050d5e9db70,not hispanic or latino,male,white,TCGA-EB-A431_demographic,Alive,primary,369c2e36-e1e8-411b-8063-b52263899bce,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A431_diagnosis2,"Skin, NOS",TCGA-EB-A431_treatment3,4eab7f47-d2f7-4f4f-9afe-b3c7acf8e970,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.5864720366288416,0.1294895574418731,-0.8448237865037669,0.5338930653036299,-0.0613832884486119,-0.1101115121340107,0.2024080927129773,0.8383144509098676,0.8366619262801945,0.5470123271203484
BF,447.0,0.0,97991c80-c4aa-4ede-9fd9-bbaff9c4a472,0.0,58.0,-21414.0,21414.0,0.0,,447.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-AAP8,False,Russia,12bf3735-fd8d-51d7-836e-cf134ed42a34,not hispanic or latino,male,white,TCGA-BF-AAP8_demographic,Alive,primary,7b003b25-d974-55d0-ad8a-82876def5a09,True,8771/3,Epithelioid cell melanoma,No,Skin of upper limb and shoulder,TCGA-BF-AAP8_diagnosis,"Skin, NOS",TCGA-BF-AAP8_treatment2,14d1e9ab-fefa-44e7-8fac-c256966537bc,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.3870451754783984,-0.1977259945354658,0.4401291212990235,-0.3331862785596921,0.3890156928917923,-0.1914764886889628,0.3160206625523406,-1.2539669885474525,-2.876004390901767,0.0450505979779266
EE,1365.0,0.0,97d9dfc9-c937-48b4-b453-df081950419f,315.0,77.0,-28364.0,29721.0,1357.0,,1365.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2GT,False,Australia,81daf07f-b1db-539c-a43e-747574c31f7d,not hispanic or latino,male,white,TCGA-EE-A2GT_demographic,Alive,Progression,1ca2c182-8e39-4cc6-9a36-c2d335e2e837,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-EE-A2GT_diagnosis2,"Skin, NOS",TCGA-EE-A2GT_treatment5,7bcfe3f6-4de6-4c61-a8d6-5e9c189f6f32,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2583059053525666,-0.2980171546772178,-0.6102337794563727,0.2940689351044797,-0.0565439242466269,0.005057056079689,-0.7320589873570219,-1.0715482220293242,0.5872177039721188,0.3785034761241774
W3,1280.0,1.0,9817ec15-605a-40db-b848-2199e5ccbb7b,946.0,63.0,-23314.0,24533.0,1219.0,1280.0,1280.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-W3-AA1V,False,United States,e14da4bf-9d01-5248-84db-2ac3228994aa,not hispanic or latino,male,white,TCGA-W3-AA1V_demographic,Dead,primary,553efa14-214f-4738-aae6-e4cdf76b5426,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-W3-AA1V_diagnosis3,"Skin, NOS",TCGA-W3-AA1V_treatment3,988b9c9c-ef5b-4642-a0cb-9c4007d0a507,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0287771125183073,0.3192602432279438,-0.6890530453921347,-3.31401033412748,0.5377400484051603,0.6499030823005526,0.6185306920769935,0.0992956339912762,-0.8896504693756954,-0.2556065810132594
FS,3080.0,0.0,9937259a-9d47-483c-8773-b3c60e02a653,469.0,74.0,-27210.0,28849.0,1639.0,,3080.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A1ZM,False,Germany,723c4dcc-ebea-5636-94e9-dc98017c3f5e,not hispanic or latino,male,white,TCGA-FS-A1ZM_demographic,Alive,primary,8b74dba2-0f4c-5e4e-8de1-62397a19dcbd,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-FS-A1ZM_diagnosis,"Skin, NOS",TCGA-FS-A1ZM_treatment,aa2c2dc9-1947-5085-b9cf-6231089c4e9e,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4072617688103775,0.110934071158131,0.0860284855857114,0.129671170218748,0.5160342997743625,0.5913474220343442,0.2917724022793207,-0.0642918808216689,-0.7261492144174592,-0.3484822202296582
WE,760.0,0.0,99706ad3-5cf4-45f8-815e-51e78f2e9f79,360.0,56.0,-20708.0,21231.0,523.0,,760.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-WE-AAA4,False,United Kingdom,907dc8f0-2833-57f1-a506-349ea098f222,not hispanic or latino,female,white,TCGA-WE-AAA4_demographic,Alive,metastasis,46ff54e8-6bbf-41b3-a088-b8eae8deaf2a,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-WE-AAA4_diagnosis4,"Brain, NOS",TCGA-WE-AAA4_treatment9,b1be0195-1c52-484a-9359-a6ea90f60d19,yes,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.8357760649622221,0.0898440807159804,-0.8630678456541286,0.4284137209823496,2.0748573696209767,1.2068193286865547,-1.139225238309926,0.7514894430478124,-0.997952582702731,-0.6142084049574883
FW,587.0,0.0,9a7656cf-75a4-4b1f-a2d2-25e3ec147e63,66.0,48.0,-17730.0,17790.0,60.0,,587.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FW-A5DY,False,United States,93eded39-8a1b-5545-83cd-3d58d78abe10,not hispanic or latino,female,white,TCGA-FW-A5DY_demographic,Alive,Progression,4d8b0433-5b7e-4a24-a404-e05e307fa182,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-FW-A5DY_diagnosis2,"Skin, NOS",TCGA-FW-A5DY_treatment4,b630f917-7284-47ff-9afa-e5ba8a0ff7e5,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0402331261700534,-0.2910506171118149,0.2709862036140204,-0.0932860507003082,0.5303107394233296,0.5671552561248475,0.0234476293622895,-0.5254419225790776,-1.1706536945994976,0.2445309007204159
D9,111.0,0.0,9a903fc2-57d7-4a02-94e7-9b9b7ee99276,68.0,82.0,-30142.0,30152.0,10.0,,111.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D9-A1JW,False,Poland,38f66910-9968-5666-9b76-260cb6a3375e,not hispanic or latino,male,white,TCGA-D9-A1JW_demographic,Alive,not reported,38a0a5b5-dd0e-5a22-9a1b-b6ff8cac7546,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-D9-A1JW_diagnosis,"Skin, NOS",TCGA-D9-A1JW_treatment2,13e4fabd-dda8-4696-99e4-eb5f2a67fc20,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.3637229443200837,-0.0466957578873637,-0.4414523439899809,0.5671890628475174,0.5274677341731029,0.5469761524006648,-0.181423224262631,0.3668144082152613,0.1745051344764041,-0.3278398143384678
EE,11252.0,0.0,9b99ffee-fe9f-4be5-a00a-ef86627282a4,10320.0,51.0,-18779.0,29785.0,11006.0,,11252.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A29T,False,Australia,2325d925-0ef8-5460-abec-5ac27c3f8ee8,not hispanic or latino,female,white,TCGA-EE-A29T_demographic,Alive,metastasis,12716746-12df-4bb5-b181-2c0d584e18c7,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A29T_diagnosis4,Not Reported,TCGA-EE-A29T_treatment6,666aa87d-5c44-497a-8b4b-4b42f17782f6,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0904287811285381,-0.531284990832935,0.2115313709525262,-0.5920643571139562,-0.3865442890054717,0.4335729820598632,0.5784212521654202,1.5247207630643629,-0.0316182425008568,1.3026241418528708
EE,2423.0,0.0,9c0240d6-8b75-41ae-8fe8-269831fd1e41,1359.0,40.0,-14701.0,17068.0,2367.0,,2423.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2GL,False,Australia,9d3d255f-0704-5732-a046-3f5364d0d592,not hispanic or latino,female,white,TCGA-EE-A2GL_demographic,Alive,metastasis,2ca86d2a-9384-44b0-8c72-200496cfc0b0,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A2GL_diagnosis7,"Lymph nodes of head, face and neck",TCGA-EE-A2GL_treatment18,044551e8-d298-4bfd-abae-4c7f71d21ba1,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,0.5958196977181959,0.0147452096191389,0.7618460292699876,-0.1413277593883035,-0.1170232190174754,0.3158835555693276,0.0707994704462953,-0.716629439891219,-0.5292256943787305,-0.2280548253799724
EB,777.0,0.0,9c47ab1d-e3bd-4191-bd60-4a2123de534e,-1.0,56.0,-20486.0,20486.0,0.0,,777.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A4XL,False,Russia,ef2ea813-3459-5d77-8e4d-db73c46198c0,not hispanic or latino,female,white,TCGA-EB-A4XL_demographic,Alive,primary,39172651-5212-4931-9a2e-2b0acd515d82,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A4XL_diagnosis2,"Skin, NOS",TCGA-EB-A4XL_treatment3,5e8ab103-cc35-4d0e-905d-eb8a3c4f06c8,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.297334856103871,-0.1755296202998083,0.7074780038295292,0.3970570067205511,-0.2658947668996665,0.0735825585799329,0.2520577978944891,-1.3660919987004374,1.0304411914158813,-0.6280294455026079
FS,730.0,1.0,9d86940d-50fb-4d2f-8b1e-539196885f46,,43.0,-15890.0,16251.0,361.0,730.0,730.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-FS-A1ZN,False,Germany,e5c2b828-f99f-56f6-8e0a-5733bce8c1f5,not hispanic or latino,male,white,TCGA-FS-A1ZN_demographic,Dead,not reported,1945a1f9-2cf9-47a1-882b-a2577b8da4f4,False,Not Reported,Not Reported,Yes,Not Reported,TCGA-FS-A1ZN_diagnosis3,Not Reported,TCGA-FS-A1ZN_treatment,12a72fa9-7a10-5db8-ab10-bc5af0ffd2a3,yes,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.0335012220166865,-0.0654672890391077,-0.4860513976893097,0.7210042597510858,0.1254744452255865,-0.7459415815153134,0.773250087048242,0.1349456372194062,0.2697644126500778,0.0307726365060794
EB,205.0,1.0,9e5a0b7e-9682-4f29-8e4a-7af968ca93fc,-1.0,59.0,-21623.0,21785.0,162.0,205.0,205.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A44N,False,Russia,17963bd3-8940-584e-8521-174cdf303f1a,not hispanic or latino,male,white,TCGA-EB-A44N_demographic,Dead,primary,387abcd0-7286-5680-b292-22ebc0f899ca,True,8721/3,Nodular melanoma,No,"Skin, NOS",TCGA-EB-A44N_diagnosis,"Skin, NOS",TCGA-EB-A44N_treatment2,2e2166cb-7dca-45cb-a032-bb67da751ca6,unknown,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.0285505245425909,-0.3819753812306549,0.2258167054222916,0.1179589385220684,0.0803808969394192,0.0378328631313308,0.1604253042520051,-0.4351669144046208,-0.7001799979960307,0.4031037139457189
D3,3826.0,0.0,9e5b6bee-0e10-4559-8d0e-2dc9677cc90c,2961.0,74.0,-27095.0,28187.0,1092.0,,3826.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A5GL,False,United States,838d618f-df77-509f-82e1-6fba5835c462,not hispanic or latino,male,white,TCGA-D3-A5GL_demographic,Alive,metastasis,34647396-4fed-487c-b1ed-45c398cd26ed,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A5GL_diagnosis4,"Colon, NOS",TCGA-D3-A5GL_treatment6,30a56448-be71-47c3-8e20-bcb26ea8d08b,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.3264866403985079,1.2303746949725394,-0.554046618651479,0.6024066811352332,-0.1935023943437134,-1.0319121036405667,-0.4637617865026869,1.3788144998524652,-0.6982002819459671,-0.8208797265294204
ER,1341.0,1.0,9ee83669-d7a4-476e-8857-304600b4917a,16.0,47.0,-17443.0,17480.0,37.0,1341.0,1341.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-ER-A19N,False,United States,c368653d-d170-58d4-8e20-0ff2bb5960b8,not hispanic or latino,male,white,TCGA-ER-A19N_demographic,Dead,not reported,19b74072-f0b2-5726-bb54-f68445f5ac44,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-ER-A19N_diagnosis,"Skin, NOS",TCGA-ER-A19N_treatment2,7e304e4b-acb2-40f0-801f-9f838cad532b,yes,Immunotherapy (Including Vaccines),0.0,0.0,0.0,1.0,0.0,0.0,0.0,Metastatic,-0.4779088739014239,-0.3518835435192892,0.3166581612233142,-0.6253785969831742,0.2706848089082663,0.6587022376792007,0.2148804221073567,0.4451581653093334,0.2901438425772083,-0.4238288562979241
LH,11217.0,0.0,9ef30567-6e19-4cd0-8ec8-69194136418d,10837.0,24.0,-9058.0,19905.0,10847.0,,11217.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-LH-A9QB,False,United States,bc44b6a1-74f2-5bfa-b183-95bdd17e9ef1,not hispanic or latino,female,white,TCGA-LH-A9QB_demographic,Alive,metastasis,2d9b8ce7-639e-4fba-8ab7-94f9071a2107,True,8720/3,"Malignant melanoma, NOS",No,Skin of trunk,TCGA-LH-A9QB_diagnosis2,"Skin, NOS",TCGA-LH-A9QB_treatment4,6b740d4d-df6d-49f8-ba63-5832c228eb46,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.1454876718377715,-1.1477051563264318,0.0319404612113205,-1.5217217175234232,-0.517946458436144,-0.3079310720918931,0.7547536341617472,-0.1112981350781132,0.5928074904664189,-0.3531708813763572
FS,347.0,1.0,9f4dde50-fa0c-43bf-8d5d-70b76cc35793,,36.0,-13325.0,13477.0,152.0,347.0,347.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A1ZR,False,Germany,b332f490-0754-59d7-bf3e-753da3dab344,not hispanic or latino,male,white,TCGA-FS-A1ZR_demographic,Dead,not reported,0505e5d3-e0d9-42d8-a7a6-75b7e8101200,False,Not Reported,Not Reported,Yes,Not Reported,TCGA-FS-A1ZR_diagnosis4,Not Reported,TCGA-FS-A1ZR_treatment4,2a44fd87-f21c-4e67-b873-ea9d37c3ed62,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1127002111997284,-0.0151003472580752,-0.1439602274253016,0.4800275753892783,0.3237850104021622,-0.1907572683173558,1.168584170999819,-1.286454491489213,0.924468155794802,-0.5526837008315338
FS,996.0,1.0,9f5bd948-dc3d-4b17-a114-d2f5c46fe10c,,71.0,-26232.0,26809.0,577.0,996.0,996.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A1ZH,False,Germany,706ba8ab-f238-5efe-89fd-530a703679fb,not hispanic or latino,female,white,TCGA-FS-A1ZH_demographic,Dead,primary,0fddc02c-601b-4ec0-8b45-4cd0935d02e7,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-FS-A1ZH_diagnosis3,"Skin, NOS",TCGA-FS-A1ZH_treatment3,582b8b39-e1a3-47a9-aadd-d4716c2fc7d7,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.450552115207823,-0.5992949700383112,0.5899505182014589,-1.9515354519931516,0.0644271131708954,0.6992953045538114,0.5477197292259355,-0.0512106296371537,-0.1629782251168744,0.3808431352236023
EE,151.0,1.0,a01a350d-64be-4af3-91c3-7d681c3db11d,,55.0,-20235.0,20320.0,85.0,151.0,151.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-EE-A185,False,Australia,e426865f-16c1-5880-a5fb-2744b7cbb12a,not hispanic or latino,female,white,TCGA-EE-A185_demographic,Dead,primary,03d12ccf-d2b5-4353-afc8-2b9d44aeaf1b,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A185_diagnosis3,"Skin, NOS",TCGA-EE-A185_treatment3,6ed982d4-a277-446c-afb6-1e431a72350c,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.4490595503246738,0.3291639480398342,-0.4336840771408307,0.6681698524570897,-1.0090922225804189,-1.61802047469809,0.4135836239490798,2.042220809924299,1.2872220084977235,-0.1088726254038103
FR,3176.0,0.0,a0bb7e56-85e1-4bc7-9515-f4279356e6d1,2787.0,41.0,-15159.0,17930.0,2771.0,,3176.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FR-A8YE,False,United States,8bc9c125-d7d0-5543-860a-8c7300dfcd18,not hispanic or latino,male,white,TCGA-FR-A8YE_demographic,Alive,Progression,000cde4e-7967-438b-b00a-006cfbe3243f,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-FR-A8YE_diagnosis2,"Skin, NOS",TCGA-FR-A8YE_treatment5,426d5f81-900f-45fa-b2d8-e11a38c218bc,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0046493023975006,-0.9636375374314456,0.3198576114068596,-0.9917653086904202,0.2002145091575785,0.7586488650399582,0.1547867487889561,-1.597098269618192,-0.4630798875295312,0.149422447140838
DA,1032.0,1.0,a20aeafc-9a68-4af0-87ea-532ee835ebb2,,55.0,-20365.0,20795.0,430.0,1032.0,1032.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-DA-A3F2,False,United States,d7adce23-c12d-5001-a4ee-06b95e09bdff,not hispanic or latino,male,white,TCGA-DA-A3F2_demographic,Dead,primary,260c2254-0f76-5f04-adff-e94f7ea5c4f5,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-DA-A3F2_diagnosis,"Skin, NOS",TCGA-DA-A3F2_treatment2,129e5b6a-42a4-4813-b9b3-935a40894097,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.2857872039617688,-1.091394804327134,-0.3618174578404691,-2.070608818416351,1.528884431388632,0.8343334404797395,-0.7587434236813582,0.0548768799691332,-2.6979464002812974,0.0664498531446783
WE,1492.0,0.0,a25b293b-e019-4890-b44d-bec4dedf46fb,1006.0,74.0,-27191.0,28197.0,1006.0,,1492.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-WE-A8K1,False,United Kingdom,b51b14b0-c1b2-52e5-bbb2-ffe07e63f802,not hispanic or latino,male,white,TCGA-WE-A8K1_demographic,Alive,Progression,3f5da186-3de7-403e-9989-8c976dff0e47,True,8743/3,Superficial spreading melanoma,No,"Connective, subcutaneous and other soft tissues of lower limb and hip",TCGA-WE-A8K1_diagnosis2,"Skin, NOS",TCGA-WE-A8K1_treatment4,18a2eec7-566f-462d-a426-37835591bee9,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0924898624489915,1.4166579780253696,-0.1888842280309715,0.31994979758656,0.6314239724732791,0.9072125035287644,-0.4274722625448337,0.199633143076898,1.0895997651472071,0.1309713194956304
D9,561.0,1.0,a276671a-02dd-4b94-9408-1c47710791fe,220.0,54.0,-20072.0,20285.0,213.0,561.0,561.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D9-A4Z6,False,Poland,f3471ff4-2b77-5755-9ee9-d28243902557,not hispanic or latino,male,white,TCGA-D9-A4Z6_demographic,Dead,primary,5501be87-5360-4359-8096-e15a1912cfa3,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-D9-A4Z6_diagnosis3,"Skin, NOS",TCGA-D9-A4Z6_treatment3,e4ab3785-d9ce-4463-b89f-cf478dbaf188,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0657742449107217,-0.2150193474865103,0.1381214847894948,0.7928880782286443,-0.5653172195249443,-0.0298232288413866,0.0864822344041677,1.8202707898265928,0.17205960288515,0.7947470649456475
3N,395.0,1.0,a29a20e3-5c2c-4f37-b93e-ae9ebc46ec53,189.0,82.0,-30163.0,30469.0,306.0,395.0,395.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-3N-A9WD,False,United States,c0f6cee0-ed72-5490-ab2a-7178e4d6afa2,not hispanic or latino,male,white,TCGA-3N-A9WD_demographic,Dead,Progression,35c96410-b81a-4a79-94b0-ae64922bc46c,True,8720/3,"Malignant melanoma, NOS",No,"Lymph nodes of head, face and neck",TCGA-3N-A9WD_diagnosis2,"Skin, NOS",TCGA-3N-A9WD_treatment4,d0b3518b-7909-4779-9019-4ed7305cd751,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.3157252209452305,-0.2693816830487299,-0.1429384799013725,0.1186909745851904,0.2064310370789902,0.2444674139022514,1.0955994665442357,-0.7258294407242859,-0.6128395840226156,0.7491046095642804
FS,824.0,1.0,a3df4ba6-538e-4b53-a356-eb1ef743b2ab,,71.0,-26197.0,26996.0,799.0,824.0,824.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-FS-A1ZY,False,Germany,19b5b7f4-2a8d-530c-9f22-ea4743f895ba,not hispanic or latino,male,white,TCGA-FS-A1ZY_demographic,Dead,metastasis,2c9bf2b2-85ed-486e-855a-a0e2b61bdcce,True,8720/3,"Malignant melanoma, NOS",Yes,"Skin, NOS",TCGA-FS-A1ZY_diagnosis2,"Skin, NOS",TCGA-FS-A1ZY_treatment4,5b09cf92-9db1-4e20-b7d8-89eecfea6624,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.1864911074676867,-0.036992038567571,0.1527448441217682,0.6735233702230788,-2.0312766509587283,-1.6759139887359666,-0.1067100196135158,-0.7767169453321784,0.1103390436772685,0.5307446281032517
D9,218.0,0.0,a4e5a8ba-dbb2-4ee9-8ab3-cc5bab152cc2,0.0,68.0,-24979.0,24979.0,0.0,,218.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Nasal cavity and middle ear,TCGA-D9-A4Z5,False,Poland,90795e20-b64c-5b38-8fc8-53c631c3e993,not hispanic or latino,male,white,TCGA-D9-A4Z5_demographic,Alive,not reported,43223822-0f40-5180-a221-6edd033400f5,True,8720/3,"Malignant melanoma, NOS",No,Nasal cavity,TCGA-D9-A4Z5_diagnosis,"Skin, NOS",TCGA-D9-A4Z5_treatment2,13406d3e-351e-4fcc-b4ac-9b2a5e35cfb3,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.4255014213181901,-0.1835514051826073,0.8786893826725789,0.1771419919577172,-0.3081493681555267,-1.0841726624552093,0.388527620000291,-0.7567356935228648,-0.4478244285555083,0.1896804539645982
EE,2270.0,1.0,a5286cd0-403a-421b-ab58-11e250740b00,2146.0,83.0,-30602.0,32872.0,2270.0,2270.0,2270.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2GJ,True,Australia,d76cf5d7-5b7e-5eec-a300-d71ba0904c05,not hispanic or latino,male,white,TCGA-EE-A2GJ_demographic,Dead,metastasis,166f724e-8784-4ff5-aed9-5e12abdc8ed2,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A2GJ_diagnosis9,Intrathoracic lymph nodes,TCGA-EE-A2GJ_treatment23,207c6cdd-3a01-48f0-b6c5-fa1384dc80f7,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,0.5255057787199965,-0.1667270024468737,-0.1932934523706246,0.0876121856338734,-0.4800328791378023,0.3814340295366937,1.3450367408470214,0.3446769062106953,0.4227848179315017,-0.5848364314131438
IH,524.0,0.0,a5930bc2-d0e4-454f-b60d-5dd1148d4669,140.0,61.0,-22577.0,22891.0,314.0,,524.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-IH-A3EA,False,United States,bb7eb437-7526-5d8e-a2fa-5796b051d72d,hispanic or latino,male,white,TCGA-IH-A3EA_demographic,Alive,not reported,2db65d3f-83ad-58de-ae00-7ade4f078b5d,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-IH-A3EA_diagnosis,"Skin, NOS",TCGA-IH-A3EA_treatment2,1e4fac3d-7651-47dd-bbee-fd23412a2ec9,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.7858444124859231,0.6533707787807173,-0.4100735183618587,0.1597658084033429,0.274562349043524,-0.4188756871410815,-1.6474559971198537,-1.0117482166143998,-0.8961718869523764,-0.1453821652701321
BF,325.0,0.0,a5ab4498-8721-40ea-8ee4-fc1a6d05721d,0.0,55.0,-20384.0,20384.0,0.0,,325.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-AAP6,False,Russia,de668345-5b2d-505c-960f-dc1130a392d3,not hispanic or latino,male,white,TCGA-BF-AAP6_demographic,Alive,primary,38927727-2ea7-56c6-aae7-f0a50a4c446f,True,8771/3,Epithelioid cell melanoma,No,Skin of lower limb and hip,TCGA-BF-AAP6_diagnosis,"Skin, NOS",TCGA-BF-AAP6_treatment,5a9e91ab-4477-59b4-9cd3-614020058f08,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.5821977441355812,0.4998074302225274,-0.3241312194245776,0.7315684244456483,-1.7490252662358683,-0.7292322797876074,-0.5979870931854131,0.3965706609097071,0.4424655245468443,-1.1044631665996631
D3,361.0,1.0,a5f95c6c-e25a-4ad8-bd5d-fcfd8a31933c,17.0,58.0,-21440.0,21639.0,199.0,361.0,361.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A2JD,False,United States,2f674640-3d84-5044-8444-83abf16d3ae6,not hispanic or latino,male,white,TCGA-D3-A2JD_demographic,Dead,metastasis,1e291400-346d-4569-8112-3839fd5656eb,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A2JD_diagnosis4,Liver,TCGA-D3-A2JD_treatment8,216bdd20-3605-4c1a-85ef-29552b1f8856,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,-0.3394829336180532,-0.2980314926390681,-0.2809597553422274,0.4584300381227635,-0.2601859592354488,0.5824748633273368,-0.5785644665945695,0.7701769447399766,-0.0493192330661359,1.0552500555729365
EE,412.0,1.0,a67fd5bb-b6b6-4e00-9acd-68d0a59b5e55,154.0,79.0,-28883.0,29268.0,385.0,412.0,412.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EE-A20I,False,Australia,dd43b34e-e2a5-5857-984d-46397ed2f45f,not hispanic or latino,male,white,TCGA-EE-A20I_demographic,Dead,Progression,096aead4-ef7a-4ef4-a733-045831598f89,True,8720/3,"Malignant melanoma, NOS",No,Skin of lower limb and hip,TCGA-EE-A20I_diagnosis2,"Skin, NOS",TCGA-EE-A20I_treatment4,34f07375-926b-42a0-9563-2df307737e66,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.9261712052620148,0.5859495346683679,-0.7190654803211799,0.4802629644586352,0.2809426695112,0.1140644998657047,-0.2759504631056752,0.1074893847332265,1.3448666817201782,-0.920712794266538
EE,79.0,1.0,a6c0bfce-0adb-4dd0-bbe7-3f9e7dcdf7bf,34.0,78.0,-28824.0,28879.0,55.0,79.0,79.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A29L,False,Australia,3b53d05d-281a-5072-b770-717f0930d6f3,not hispanic or latino,male,white,TCGA-EE-A29L_demographic,Dead,Synchronous primary,02c155ee-9dd4-4f05-8f11-64f0d3fb8e3a,False,8090/3,"Basal cell carcinoma, NOS",Yes,Not Reported,TCGA-EE-A29L_diagnosis10,Skin of other and unspecified parts of face,TCGA-EE-A29L_treatment23,33086cec-60fb-4491-8209-ee837a8ff80c,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,-0.0305142009311869,-0.3667038253983328,0.0054564779545051,0.5431932291222428,-1.3432063058418742,-1.2798300517087726,-0.3093137367110638,0.3673894082673265,1.5828984232690606,0.4335940677791652
EB,796.0,0.0,a9255dcb-b236-4777-ac43-555e3a5386c3,-1.0,63.0,-23091.0,23091.0,0.0,,796.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A3XB,False,Russia,d46d5f96-5408-5331-9cc6-8da16981793d,not hispanic or latino,male,white,TCGA-EB-A3XB_demographic,Alive,primary,570ab698-814a-4954-8a4c-78ee5e483010,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A3XB_diagnosis2,"Skin, NOS",TCGA-EB-A3XB_treatment3,27cb8e9f-530e-4c0e-93bf-a05eeab34caf,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.604225057204045,0.5675211818233696,0.3027528866385744,0.4607236129705428,0.7732082563490638,0.2194713945077598,-0.2278142323021157,0.6113331803565799,0.9775711274906392,-0.381163482757789
EE,3527.0,0.0,a92e70e1-c57d-45ef-a822-33b361c22291,1643.0,46.0,-17109.0,20597.0,3488.0,,3527.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2A1,False,Australia,fbe95aea-762b-5127-aaf1-c1af906e86b6,not hispanic or latino,male,white,TCGA-EE-A2A1_demographic,Alive,Progression,0c7a0f30-c8c1-4b03-9227-07ebee4adaff,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-EE-A2A1_diagnosis2,"Skin, NOS",TCGA-EE-A2A1_treatment5,0745c0c5-0f61-4480-996b-f7bef40a5c90,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1836957090303237,-0.0430815701463844,0.4693671250110887,0.3626429809802227,0.6789255074598115,0.792883176753738,0.5598049711986943,0.6945644378932195,0.6183108913466548,0.0825607657656294
ER,1785.0,0.0,a9eb1022-ffd3-42de-a39d-2126fc7ec0ce,-30.0,64.0,-23533.0,23533.0,0.0,,1785.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-ER-A196,False,United States,924c0c94-8240-5efb-ab8a-727615955c63,not hispanic or latino,female,white,TCGA-ER-A196_demographic,Alive,primary,07f748b7-6401-534e-a606-61ff418294f0,True,8744/3,"Acral lentiginous melanoma, malignant",No,Skin of lower limb and hip,TCGA-ER-A196_diagnosis,"Skin, NOS",TCGA-ER-A196_treatment4,5d0e627e-21cc-4605-9115-17ff4ea00f64,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.3280233211140656,0.082412950681966,0.804486623250121,0.0431715942718886,-0.7460029943448467,-0.5789301807581276,0.1537778654719626,-2.369179589530612,0.7557264759981629,0.2685588467789142
EE,3781.0,0.0,aa55097f-4fd6-45e7-a394-f4122ceafc51,-21.0,47.0,-17196.0,17196.0,0.0,,3781.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A3AA,False,Australia,73930170-5def-5321-9216-cd80653f9ae1,not hispanic or latino,male,white,TCGA-EE-A3AA_demographic,Alive,Progression,ac8c66d2-e015-55db-bd3f-64299a4932e6,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-EE-A3AA_diagnosis,"Skin, NOS",TCGA-EE-A3AA_treatment3,056f6f34-7ae2-45d1-8df3-109cf058079d,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.8255323512727895,-0.3831578526128399,0.0751597844893472,-0.1835877191689307,0.8671198985534666,0.2067083862018325,0.4117616644470611,-0.3428794060479331,-0.9414724483332546,-0.2619065479320596
EB,1643.0,0.0,aa597e8b-7813-4837-b778-4dafe3b091bb,1064.0,60.0,-21920.0,22985.0,1065.0,,1643.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EB-A5SH,False,Russia,ce3fa398-860e-5bc8-8e2f-42112e915e3b,not hispanic or latino,female,white,TCGA-EB-A5SH_demographic,Alive,Progression,007a07a8-1044-4356-9781-9f88da02df16,True,8720/3,"Malignant melanoma, NOS",No,"Lymph node, NOS",TCGA-EB-A5SH_diagnosis2,"Skin, NOS",TCGA-EB-A5SH_treatment6,1a4cccee-b1ac-4a41-bae3-de5fe2c0c0f3,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.6727992195189495,-0.6058897295433314,-0.5128990070939573,0.7631916588752015,-0.6542591621364434,-0.8705791878717264,-0.973357412572424,-1.4565107568879103,0.5500689145620923,-1.0656937724771898
GN,1960.0,1.0,ab74d6ed-880e-4470-bfd5-2974a4c3a0d7,491.0,38.0,-14055.0,15784.0,1729.0,1960.0,1960.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-GN-A267,False,United States,e036ed8b-c53b-5c7a-a01d-ba4a502f73c0,not hispanic or latino,male,white,TCGA-GN-A267_demographic,Dead,metastasis,0effc79c-335a-4071-aa61-1af44847d6c4,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-GN-A267_diagnosis11,"Brain, NOS",TCGA-GN-A267_treatment28,3b992604-a38e-4c91-a681-67d45288bc0e,yes,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.3526868491852081,0.8122486550347808,0.0176794396672638,0.446019234925334,0.4903000447861766,-0.0830170245961755,-0.0855734554292272,-1.7379732823745089,-1.1973216343327138,-0.4503532906641786
GN,673.0,1.0,ab7eb3ec-bd87-4e49-9010-b51b17148f7c,40.0,71.0,-26118.0,26697.0,579.0,673.0,673.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-GN-A4U9,False,United States,aaed5306-4dd9-533c-95b1-9d6200379454,not hispanic or latino,male,white,TCGA-GN-A4U9_demographic,Dead,metastasis,177ad17f-5c69-4155-b0b5-ab14896c5501,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-GN-A4U9_diagnosis5,"Lung, NOS",TCGA-GN-A4U9_treatment14,24b6ced1-38c8-4b1f-9a22-01d0be91d9da,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,0.1843400484926818,-0.4805037788971206,0.6158533580992213,-2.9523803619239994,-1.0834651738259808,-0.4330986848156468,0.6912245711335767,-1.4773545087753246,-1.9501960027835583,1.1381374741927437
EE,1562.0,0.0,acd3deaf-39df-4996-b6ce-2b295b9315a1,56.0,75.0,-27463.0,28465.0,1002.0,,1562.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A3JE,False,Australia,af2dd024-0be7-5be6-b30f-e38dbb69f841,not hispanic or latino,male,white,TCGA-EE-A3JE_demographic,Alive,metastasis,159a8069-5570-4658-a45d-aa511966f1d5,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A3JE_diagnosis4,Not Reported,TCGA-EE-A3JE_treatment8,44af88e6-33a3-4e24-9475-95a3c4c19882,yes,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,0.1323769989528282,-0.1939724035566103,0.5635022377172975,0.0222812071296885,1.2602640680944963,1.537300373804694,0.9618303221221488,-0.2789106502555254,0.1563383283699346,0.2450974864780236
WE,1229.0,0.0,adfa6beb-1aa3-4a2a-afe7-8d036a80b20d,311.0,47.0,-17261.0,17911.0,650.0,,1229.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-WE-AAA0,False,United Kingdom,8800101e-ce1e-57d6-af34-63705cbdd7b2,not hispanic or latino,male,white,TCGA-WE-AAA0_demographic,Alive,metastasis,63f72da9-76de-4054-975b-f855289e5a0b,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-WE-AAA0_diagnosis5,"Brain, NOS",TCGA-WE-AAA0_treatment11,a1d5a2b4-a2ba-42e1-939c-5cb02fac623e,yes,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.2398070270219088,-0.019152896176255,-0.7030945751903306,0.4383086204623518,0.8269504295084901,-0.032077714294295,-0.2588216842908935,-0.3093856530150554,1.5670606948685477,0.0032146847586922
GF,1070.0,1.0,af852862-f01e-4ddd-82c6-9781c93ef20b,1058.0,39.0,-14304.0,14304.0,0.0,1070.0,1070.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-GF-A769,False,United States,bf6be8d9-ee67-5108-ab74-67223b1e65a9,not hispanic or latino,male,white,TCGA-GF-A769_demographic,Dead,primary,1c73d48a-e025-5cf9-9930-50ca58665d7e,True,8721/3,Nodular melanoma,No,Skin of lower limb and hip,TCGA-GF-A769_diagnosis,"Skin, NOS",TCGA-GF-A769_treatment5,8f28b627-83c8-45b5-9d22-cde14a57baa9,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.3468881672796536,-0.4576241044150811,-0.8914821663680104,0.2382382992816945,-0.764516338123893,-0.4032242667113287,-0.4227448862934585,2.649420864906622,0.3992611331013294,-0.2708778537094681
D9,2359.0,0.0,af915978-c5e1-4dd4-ab0e-d2be5ac0ae4f,1606.0,56.0,-20493.0,22106.0,1613.0,,2359.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D9-A6EC,False,Poland,8dfe7055-9489-55ca-ac6e-8f3d84bed7c0,not hispanic or latino,male,white,TCGA-D9-A6EC_demographic,Alive,Progression,5da9e77e-c73c-495b-a976-d6121b2dead4,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-D9-A6EC_diagnosis2,"Skin, NOS",TCGA-D9-A6EC_treatment5,54041fa0-207d-4bc0-8c93-181f4ef79ddc,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.001930341116744,0.0167633631307984,-0.4502466414690324,0.0922621126395715,0.0777048954744685,-0.4800632588264434,-0.2323886708678844,1.2652519895693144,0.6715303169277896,0.3565132147572213
D3,4129.0,0.0,afbc376b-524d-4ecd-b79f-d8be770591a7,2188.0,15.0,-5684.0,8387.0,2703.0,,4129.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A5GN,False,United States,00331849-fc99-50db-bbbb-9b5d7a5cf152,not hispanic or latino,female,white,TCGA-D3-A5GN_demographic,Alive,metastasis,0fab1459-5636-457e-b393-d90e313ea0a2,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A5GN_diagnosis9,Liver,TCGA-D3-A5GN_treatment22,1a1649ee-0418-4c24-88fb-48dc80aaf2d1,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.023999397991566,-0.3736260754777875,0.34041256702809,-0.2893275073192947,0.7803095431582633,0.5572183647682225,-0.2042789605847608,0.2775456501319212,-0.488932650065662,0.9078915793667648
D3,1992.0,1.0,affb02c3-ec15-465e-8296-6a32132d542e,22.0,48.0,-17626.0,19440.0,1814.0,1992.0,1992.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A2J8,False,United States,9f6f6e91-e5da-5940-9654-29983fecd73c,not hispanic or latino,male,white,TCGA-D3-A2J8_demographic,Dead,metastasis,04e65286-7a34-4ecc-b158-c679e7349094,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A2J8_diagnosis11,Specified parts of peritoneum,TCGA-D3-A2J8_treatment29,53ee42fb-83f6-4d11-bf6f-6b4b34965d35,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,-0.4380449882250151,-0.0744504992982188,-0.2461172805031709,-3.026971933129593,1.0605457020665907,1.324764763572296,0.6825345988001347,0.1254581363603066,-1.3391624666255415,-0.0907605314895075
FS,10870.0,1.0,b1739cb5-09bc-414a-8f05-c66d2cb9868d,,51.0,-18843.0,29177.0,10334.0,10870.0,10870.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-FS-A1ZC,False,Germany,c02f4fe6-21ff-5e91-8806-8d4086af3e90,not hispanic or latino,male,white,TCGA-FS-A1ZC_demographic,Dead,primary,22528957-0295-51d6-a9c4-8e3d53182cc5,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-FS-A1ZC_diagnosis,"Skin, NOS",TCGA-FS-A1ZC_treatment2,8ffbc7b5-d07a-4e93-993c-7bdd1afc696d,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.5782161919568932,-0.3399407330252997,0.2083690257443075,-1.240898740631118,-2.4580822124410706,-1.7303568777020095,-0.6669139087711947,-1.837592041395044,-0.2222532527334998,-0.5690533696979453
XV,405.0,0.0,b2fbea07-eede-4ab1-994a-da26583a5106,-1.0,76.0,-27938.0,27938.0,0.0,,405.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-XV-AAZY,False,Russia,56e8b1fa-e9dc-59f1-90d3-7be50c72db57,not hispanic or latino,female,white,TCGA-XV-AAZY_demographic,Alive,primary,26850fe8-ea00-45e7-8316-ec58b4aa0b22,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-XV-AAZY_diagnosis2,"Skin, NOS",TCGA-XV-AAZY_treatment3,0fcbf3fe-aab9-4777-8cdb-5ab2a97767f6,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-1.5403485606510978,0.606674297256762,-0.5948066638398571,0.4467380647086066,1.0387187664280428,-0.2950840119613186,-0.905248664513476,-0.5574981754817896,-0.9871223713700258,-0.6268839705793295
EE,5237.0,1.0,b34e2ac6-0661-4f7c-97f5-f1f3b54aa0e4,,42.0,-15446.0,20589.0,5143.0,5237.0,5237.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A3J3,False,Australia,86130fe2-9a1f-5c7c-b40d-3c7d5d450ec4,not hispanic or latino,male,white,TCGA-EE-A3J3_demographic,Dead,recurrence,10b6f7e0-f3b0-479a-9c3e-b4af84f6ef09,False,8730/3,Amelanotic melanoma,Yes,Not Reported,TCGA-EE-A3J3_diagnosis5,Not Reported,TCGA-EE-A3J3_treatment11,1b39e941-2a9e-4173-8ac0-7a63bc8ae0e3,yes,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,0.3378495610224798,-0.3447313308915121,0.4965166639716765,0.3109069559272732,0.718152654414951,-0.3707759605255964,0.4331826223848035,-0.8658419534025021,-0.3168138075953836,1.2413316267215777
EE,1482.0,0.0,b4079a49-bb11-430a-9a1e-19bd46d87fbe,575.0,39.0,-14498.0,15065.0,567.0,,1482.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2GI,False,Australia,c11f8907-89f7-5165-b211-69d22bbdd609,not hispanic or latino,male,white,TCGA-EE-A2GI_demographic,Alive,Progression,91a976d2-7105-4c1d-8d2c-c624c14d733d,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-EE-A2GI_diagnosis2,"Skin, NOS",TCGA-EE-A2GI_treatment6,6a83c5ec-e717-4039-b0bd-f4b2c2d97f36,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.2409343014310823,0.001826406121706,0.4734709926739797,0.2910465027992385,0.684128269235408,0.6741290901245609,0.0360227670463744,-0.2044481435129014,0.0842533733705424,0.3067523439331555
BF,327.0,0.0,b44cced8-88db-4769-a1b0-b09d28558277,-1.0,63.0,-23199.0,23199.0,0.0,,327.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-A5ER,False,Russia,fdc065a6-3e8a-5788-9053-e302628a5001,not hispanic or latino,male,white,TCGA-BF-A5ER_demographic,Alive,primary,7a07ac01-ad50-581f-807e-2e93f8e9fc94,True,8720/3,"Malignant melanoma, NOS",No,Skin of trunk,TCGA-BF-A5ER_diagnosis,"Skin, NOS",TCGA-BF-A5ER_treatment,70816a16-a894-5ee5-8856-0fb66d3c28a5,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,-1.1496387739951754,0.3120409502631117,-0.7631155115813693,0.3630142440551612,-1.0662938818199048,-0.8937930996130873,-1.282622543670755,0.0415081287585854,0.335327950072789,-0.7147628844136835
EB,39.0,0.0,b53cf25c-929c-4f1a-870e-13f260c5cf7d,-1.0,37.0,-13712.0,13712.0,0.0,,39.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A3HV,False,Russia,73b5aa24-9171-5af3-94fa-42c7b155ce96,not hispanic or latino,male,white,TCGA-EB-A3HV_demographic,Alive,primary,34a86f61-f52f-4842-951d-2f88dd1c5c32,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A3HV_diagnosis2,"Skin, NOS",TCGA-EB-A3HV_treatment3,a26aa0e4-999d-403d-b51f-823ef806db4a,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.6148831048291232,-0.1065644683052951,-0.2303039867456172,0.1307187039479007,0.07784453772207,-0.3409498983477444,-0.1984774791893396,-1.1700169809457288,-0.6363632688527879,-0.233261672304026
FS,1655.0,1.0,b5abfbd1-8f92-4ba3-8f2b-801fb600397a,1302.0,75.0,-27482.0,28791.0,1309.0,1655.0,1655.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-FS-A4FC,False,Germany,e4e0235a-9229-5bd8-aa15-1fdc39355424,not hispanic or latino,female,white,TCGA-FS-A4FC_demographic,Dead,Progression,1dee670d-b45f-4e4d-a667-20cd09bc1ae1,True,8720/3,"Malignant melanoma, NOS",No,"Skin, NOS",TCGA-FS-A4FC_diagnosis2,"Skin, NOS",TCGA-FS-A4FC_treatment5,646d7baa-b6fa-45f8-ba32-3e30bf74ebef,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.1828744243704551,0.2246577735939594,0.3846007211930632,0.3524047827794602,0.402840061168127,-0.0098820967364332,0.6224944977876563,-0.120641885924194,0.8648437665222839,-0.9196539650456124
EE,659.0,1.0,b5e37b9b-6264-4cc8-9b44-1d8ac0692d6c,,49.0,-17950.0,18529.0,579.0,659.0,659.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2M5,False,Australia,0fcfdf92-ff36-56e7-9a6d-84f747e41e73,not hispanic or latino,male,white,TCGA-EE-A2M5_demographic,Dead,Progression,303a4e7c-95db-4f8d-a776-b023163a964f,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-EE-A2M5_diagnosis2,"Skin, NOS",TCGA-EE-A2M5_treatment4,3c45b202-5623-4f9a-9279-eb8b215f901b,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3084838353114899,0.6179555083957907,-0.3005090429189737,-3.71218953572759,-0.2445865803189166,0.8587695425133931,0.7481493579843708,1.5204082626738633,-1.207802484009524,1.0910128258724316
DA,1319.0,0.0,b6691e3c-ee3f-49a2-8bd4-2086413e5d8d,,39.0,-14327.0,14353.0,26.0,,1319.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-DA-A3F8,False,United States,9e293c0b-bb3b-5adf-89f0-a9cdf7ed4ce2,not hispanic or latino,male,white,TCGA-DA-A3F8_demographic,Alive,primary,283410cb-3185-4ef0-8554-e3272246caa9,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-DA-A3F8_diagnosis3,"Skin, NOS",TCGA-DA-A3F8_treatment3,4f3a539a-3da1-415e-aee8-31aeeff2f969,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0045850371712741,-0.1450797977442777,-0.0633157186389567,0.1356546589830176,1.0082921693680145,1.7124920797090013,0.0371624624992411,0.5164581717655908,-0.3522157887259418,-0.3604055942061621
WE,2145.0,0.0,b6750b08-c59d-49b9-8c08-a19e17cb366f,1408.0,73.0,-26946.0,28741.0,1795.0,,2145.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-WE-A8ZO,False,United Kingdom,f25d88d1-3ba0-5c3a-ab27-82dfd354202a,not hispanic or latino,female,not reported,TCGA-WE-A8ZO_demographic,Alive,primary,3ad260f8-0682-5792-a1b7-7fc6b03e8f54,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-WE-A8ZO_diagnosis,"Skin, NOS",TCGA-WE-A8ZO_treatment,8245868e-dd7e-5921-8434-68b2762a29fe,yes,"Radiation, External Beam",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1816993027368512,-0.3743262360618768,-0.3193739130873017,0.2778261534052477,0.7495855532443377,0.5306829746932117,0.0931680825005053,-0.1653481399723722,0.4743738891184657,-1.3378175290030874
GN,1460.0,1.0,b6b51b28-bdee-4fe6-a3f3-7b128e16721c,757.0,72.0,-26494.0,27914.0,1420.0,1460.0,1460.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-GN-A26D,False,United States,c4023b76-c8d7-55ea-a0b2-0de9abe42b04,not hispanic or latino,female,white,TCGA-GN-A26D_demographic,Dead,metastasis,3356f832-d92c-434b-9be6-bc1b6ae70347,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-GN-A26D_diagnosis7,"Brain, NOS",TCGA-GN-A26D_treatment15,00b20fe7-006b-448f-8b08-9952d361d152,unknown,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.6108606657677749,2.046329008071035,0.5189059957235608,0.6855222505524333,-0.1637694827162037,-0.7445451881638867,-0.1511590093387963,-1.0180732171871305,1.4864746062424086,-0.4734036652045295
EB,321.0,1.0,b6ee9305-c935-4692-81f3-956956d5b4c4,5.0,56.0,-20610.0,20827.0,217.0,321.0,321.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A5VU,False,Vietnam,bc2472b5-834e-5c5c-a6be-5e42d9bf0a85,not hispanic or latino,male,asian,TCGA-EB-A5VU_demographic,Dead,recurrence,1f898249-45e8-4a6c-8598-1db0f2f40509,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EB-A5VU_diagnosis4,Not Reported,TCGA-EB-A5VU_treatment8,32f7e9ff-6176-48ab-9577-f730bef80bd5,yes,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Primary,0.3550836607577578,0.2219760865811736,0.2938355944372288,0.040519560524239,-1.571328984870311,-1.3550380722844666,-0.2993949910224405,0.6524456840793401,0.0169430276683629,-0.0875848979492166
D3,688.0,0.0,b770ed96-a48c-4e88-8db6-b2d1a1619da2,94.0,56.0,-20559.0,21129.0,570.0,,688.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A51N,False,United States,4fc441f8-b3c1-5abd-8d7d-9d4454b16c9c,not hispanic or latino,female,white,TCGA-D3-A51N_demographic,Alive,metastasis,252e3766-379a-40e2-878a-53ba1df0408b,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A51N_diagnosis5,"Connective, subcutaneous and other soft tissues of lower limb and hip",TCGA-D3-A51N_treatment12,8a827876-3208-4125-aa4d-ebe36619e979,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.6174491941089233,-0.4753557268293685,-0.7421953932828115,-0.4120908565289164,0.7350500617812116,0.3115274522638383,-0.4436647275934018,-0.3742169088855634,-1.5346885400406949,0.3790059396618113
D3,5065.0,0.0,b829885f-8681-4b00-b301-8b0e0c2c6684,4511.0,39.0,-14563.0,17125.0,2562.0,,5065.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A3CB,False,United States,ee8be063-49bb-5b48-906b-d2509b0734fd,not hispanic or latino,male,white,TCGA-D3-A3CB_demographic,Alive,not reported,05669195-f8aa-51f1-a54d-69ae2a1c7254,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-D3-A3CB_diagnosis,"Skin, NOS",TCGA-D3-A3CB_treatment,541595cc-26f6-5fc9-8888-da792b1e5c14,yes,Immunotherapy (Including Vaccines),0.0,0.0,0.0,1.0,0.0,0.0,0.0,Metastatic,0.2831533748821207,0.4073708279127421,0.2494246926147418,-0.3038239009381563,0.5012020900206756,1.97094452609763,-0.1093552047546295,0.614064430603895,-0.0998602192854194,0.0394142657711617
ER,270.0,1.0,b85b14d7-3b5a-4800-af12-622ec03b9fe5,21.0,51.0,-18732.0,18850.0,118.0,270.0,270.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-ER-A19T,False,United States,9c50988c-04a7-5921-b47e-c815e6aed37f,not hispanic or latino,male,white,TCGA-ER-A19T_demographic,Dead,primary,151da5d4-ec66-4ea9-ad1a-3e6738f0c039,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-ER-A19T_diagnosis3,"Skin, NOS",TCGA-ER-A19T_treatment3,485a9dd3-e932-4010-b559-105265c2a8fd,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.519499680669292,0.998686758813293,1.5176299698025628,0.0901142307141497,-0.8758751081056236,-1.877459726871804,0.1429422276851926,0.4441519152182167,-0.1409684407955732,0.1401358405179604
EE,832.0,1.0,b8a1732f-c1cb-4a02-af4f-61b63d3d52df,5.0,70.0,-25930.0,26328.0,398.0,832.0,832.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A3JD,False,Australia,6613cb1e-1a7c-5b7b-bc61-a3162a2a656c,not hispanic or latino,male,white,TCGA-EE-A3JD_demographic,Dead,Progression,23962e68-5c23-5df9-8e27-c520d7d620ab,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-EE-A3JD_diagnosis,"Skin, NOS",TCGA-EE-A3JD_treatment2,76bae6c7-ac68-4837-acd5-034f3fd01200,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2207345180360473,-0.3620283720847639,0.2722378716152143,-1.8601343975649356,0.8981353952012491,0.9207190637867546,0.2380123797484722,0.1990581430248302,-0.7851913342634893,1.196875371070385
FS,4062.0,1.0,b91af125-a024-4ba3-a5e8-99955ff9efc5,,31.0,-11599.0,15539.0,3940.0,4062.0,4062.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Bronchus and lung,TCGA-FS-A1ZQ,False,Germany,50de1694-4e19-54ae-9265-7f71570a0c09,not hispanic or latino,male,white,TCGA-FS-A1ZQ_demographic,Dead,metastasis,4c0ba9d0-daa8-453c-8426-06d56b02aa1b,True,8720/3,"Malignant melanoma, NOS",No,"Lung, NOS",TCGA-FS-A1ZQ_diagnosis2,"Skin, NOS",TCGA-FS-A1ZQ_treatment5,7cf38a78-f9ff-4065-aceb-1ef537066db8,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3118869157905882,0.3368311321968846,-0.4137118235941033,0.5188348584652976,-0.0296064347857381,0.251627284495774,0.4389043621189021,0.5088394210757083,0.2383218636196469,-0.5406079054289378
ER,7514.0,1.0,b93f703e-be51-4469-aaac-2d4a87a37639,6399.0,25.0,-9366.0,16605.0,7239.0,7514.0,7514.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Retroperitoneum and peritoneum,TCGA-ER-A3ES,False,United States,75148c59-65c6-5c5f-8c08-e52cb380f71a,not hispanic or latino,male,white,TCGA-ER-A3ES_demographic,Dead,metastasis,0584a3e0-46f5-4a40-b4d4-fbaf84cfdd83,True,8720/3,"Malignant melanoma, NOS",Yes,"Peritoneum, NOS",TCGA-ER-A3ES_diagnosis2,"Skin, NOS",TCGA-ER-A3ES_treatment4,674b1210-167c-4a7a-835c-095faa418762,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0924383616037129,-0.087531180251763,0.8545239605553471,0.2652183767455072,-1.7058622803857375,-1.723900371286552,-0.0980231946420178,-1.1920107329372758,0.5869847962015236,0.7667427818971471
ER,1333.0,1.0,b9607824-a8d3-4915-ab73-962cdcfd8dc3,759.0,50.0,-18582.0,19739.0,1157.0,1333.0,1333.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Other and ill-defined sites,TCGA-ER-A2NC,False,United States,dfeaa0c3-2f01-5936-b071-fb9fa7835c79,not hispanic or latino,male,white,TCGA-ER-A2NC_demographic,Dead,primary,2b626c94-528a-48bf-92a5-a4024ac15d23,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-ER-A2NC_diagnosis3,"Skin, NOS",TCGA-ER-A2NC_treatment3,3a6909cd-c336-4374-b689-00be0b91e94a,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.191647532763762,0.0444224925653386,-0.1511503187985738,-1.8239707750561511,-0.1779379499973708,-0.1574427316805047,0.6953751910244815,0.000539375048839,-0.5307395948876036,-0.1086663644524568
W3,3683.0,1.0,ba207d79-91c0-45dc-a784-4bcaec580eb4,1826.0,66.0,-24258.0,26115.0,1857.0,3683.0,3683.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Bronchus and lung,TCGA-W3-A828,False,United States,50844386-a436-5332-bfd3-fadf0270c962,not hispanic or latino,male,white,TCGA-W3-A828_demographic,Dead,metastasis,59d8674e-ed36-4f26-9dc9-684216191800,True,8772/0,"Spindle cell nevus, NOS",No,"Lower lobe, lung",TCGA-W3-A828_diagnosis2,"Skin, NOS",TCGA-W3-A828_treatment4,033af209-7ab7-4613-a62f-54a3b47e4a97,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0670281442487688,-0.1600180453479915,-0.1286020713578693,-3.3050476019466792,-0.6298768230051461,-0.2384596554178476,1.8042041238319224,-0.0414356287520215,-0.016945052953322,-0.3065311598223456
EE,4601.0,1.0,bc71a91d-8ad1-4bab-a4fa-89470aa4e4d0,4333.0,59.0,-21660.0,26129.0,4469.0,4601.0,4601.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EE-A20C,False,Australia,be06aa03-1b06-5da5-8bf4-b681afaac735,not hispanic or latino,male,white,TCGA-EE-A20C_demographic,Dead,metastasis,019f21c1-6704-4b91-9b94-1420c9b5bfb4,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A20C_diagnosis23,Intrathoracic lymph nodes,TCGA-EE-A20C_treatment64,059ca16a-ae2b-437d-b030-cfb749538cef,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.1130891727393315,-0.7723844480839454,0.7127473790604619,0.4087282781538232,0.2387865201626517,-0.6567869292486477,-1.0915345814978612,-0.4160481626734078,-0.4126553551955454,0.0403698411903032
EE,516.0,1.0,bd2345ed-33b8-4010-8479-4d6c67e29561,,66.0,-24125.0,24572.0,447.0,516.0,516.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2MH,False,Australia,0c58c4a8-09e7-5505-9dec-37a32de914f8,not hispanic or latino,male,white,TCGA-EE-A2MH_demographic,Dead,Progression,272f50c3-6bf2-48d6-a55f-300a70afeb6a,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-EE-A2MH_diagnosis2,"Skin, NOS",TCGA-EE-A2MH_treatment5,5b8171b8-8f43-421d-a55f-bb976e011c69,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3454104767800385,-0.2319745651854031,0.3442067308936749,0.1577725538257356,0.3511636671329736,0.1614655671752524,0.0087683451510393,-1.2713607401224674,-0.415566702327992,-0.5393182972606705
ER,857.0,1.0,bda2f09a-82c4-40ec-90e8-0bf63916a5c7,27.0,57.0,-20938.0,21399.0,461.0,857.0,857.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-ER-A2NB,False,United States,f00a3f49-ff82-57b2-bb3e-a4298e34c69a,not hispanic or latino,male,white,TCGA-ER-A2NB_demographic,Dead,primary,2afc6501-7d63-4788-a9fd-8c68dea1680a,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-ER-A2NB_diagnosis3,"Skin, NOS",TCGA-ER-A2NB_treatment3,18ae2cda-0a6a-4389-8ad0-a0e0e26340f5,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-1.2813509035874389,-0.3695178813470927,-0.6122975317439028,-0.1722510523844106,0.5826294165143936,0.2933740744609965,-0.9195184984559752,-0.5045981706916637,-2.6599824336741857,1.27051127641819
EE,3106.0,1.0,be73fde2-d843-426b-9306-a02d3f2a754b,1746.0,67.0,-24683.0,27736.0,3053.0,3106.0,3106.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A2GN,False,Australia,cf256737-137d-5c1b-b7f1-752df600cf66,not hispanic or latino,male,white,TCGA-EE-A2GN_demographic,Dead,metastasis,3f8a32da-91b6-481f-a7e5-fc2e9ec95643,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A2GN_diagnosis4,"Adrenal gland, NOS",TCGA-EE-A2GN_treatment7,16365631-4e86-4ebc-8bf6-97beb5a3eb8e,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.1398343006215098,-0.2722076764302439,0.3749756901034562,0.6832255936955826,-0.7704068674421651,-0.9778704471917556,0.6269947561611099,-0.4407731649122724,0.8217558289620666,0.346214321549871
D3,1780.0,1.0,beab616a-256e-48f3-a458-028897a6138c,1666.0,68.0,-25069.0,26808.0,1739.0,1780.0,1780.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A8GI,False,United States,b8106e0a-ef2f-5234-813f-3082619d585b,not hispanic or latino,male,white,TCGA-D3-A8GI_demographic,Dead,Progression,1c54d3dd-e180-407b-bcb1-84b8e2d152f9,True,8720/3,"Malignant melanoma, NOS",No,"Lymph nodes of head, face and neck",TCGA-D3-A8GI_diagnosis2,"Skin, NOS",TCGA-D3-A8GI_treatment11,719ae9f2-d8bb-49e2-8929-cfc82ef579e8,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.0573429672999244,0.1752811058368152,-1.6983744963734566,0.4363739588255708,-0.0962744214189443,-0.0470046955985643,-0.7219932634847334,-0.4575919164352194,-0.1875499949147294,-1.024225641126804
D3,553.0,0.0,c03152cb-c6e6-47e2-a1cb-2354260a3661,42.0,58.0,-21379.0,21540.0,161.0,,553.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A5GS,False,United States,a94b0408-a179-5e75-812e-f89efc33e34d,not hispanic or latino,male,white,TCGA-D3-A5GS_demographic,Alive,not reported,0df0a54b-b894-531c-877a-fd91d5c9382a,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-D3-A5GS_diagnosis,"Skin, NOS",TCGA-D3-A5GS_treatment2,5a9790e9-f460-4c55-af60-7f46a2113a3a,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.3568200141074533,0.156118504929004,-0.6343846786739852,0.2408096460894392,0.5472062705153715,0.3872583931693014,-0.3362803264726103,-0.5079044209910466,0.9066507113442256,1.1802110532263557
EE,6225.0,1.0,c061ae6c-7a02-47c3-aecd-a56487c01603,,43.0,-15880.0,21999.0,6119.0,6225.0,6225.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2MI,False,Australia,01582e02-0a47-50f8-92cf-858ccbdfab97,not hispanic or latino,male,white,TCGA-EE-A2MI_demographic,Dead,not reported,1a110078-9376-51ff-83a4-803e270ce069,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-EE-A2MI_diagnosis,"Skin, NOS",TCGA-EE-A2MI_treatment,0b38d0e5-7711-5574-b3c7-fb5d689dd255,yes,"Radiation, External Beam",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0774850774418216,-0.1617380175490044,0.6233909767860212,-1.9619352713713247,0.9810692299770656,0.3440206595747017,0.1473192998024675,0.247645647424459,-1.189169862361862,0.9391520629054066
D3,1766.0,1.0,c0b0255b-74fd-4af7-a2b0-5a82829f680b,48.0,54.0,-19858.0,21481.0,1623.0,1766.0,1766.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A3C6,False,United States,ec73290f-f174-5f9b-9acc-8a1863d03751,not hispanic or latino,female,white,TCGA-D3-A3C6_demographic,Dead,Progression,0ef68273-d104-43cf-a07f-9360a64b7746,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of inguinal region or leg,TCGA-D3-A3C6_diagnosis2,"Skin, NOS",TCGA-D3-A3C6_treatment4,217996cb-b64e-42b1-933f-87fbb2662351,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0191808460751387,-0.6607301836982793,1.2037508413123996,0.4435153334113431,-0.7535512807369287,-1.5185850872265263,-0.0711741246832647,-1.3601982481667558,-0.5491393087646704,0.2142281306758681
EE,1315.0,1.0,c127ffb6-2ccf-4e90-b811-0aa40ebfab17,664.0,70.0,-25926.0,27051.0,1125.0,1315.0,1315.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2MQ,False,Australia,dd1966fb-004b-51bb-9c4b-8cecd7e88a2a,not hispanic or latino,female,white,TCGA-EE-A2MQ_demographic,Dead,not reported,33c3de9b-8927-55a5-9835-d33e9c5542a8,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-EE-A2MQ_diagnosis,"Skin, NOS",TCGA-EE-A2MQ_treatment2,70193e9c-9cfd-4390-b777-c59762c668d3,yes,"Radiation, External Beam",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.6647192073380686,0.0736462852647691,-0.3290215415530769,0.4312562557389984,-0.2688600230840383,0.617627090037832,0.3296382355377964,-0.1620418896729894,0.291774196971377,-0.1462247656550902
FS,1628.0,1.0,c2948fe9-5798-43bc-a743-511e94e417f8,,63.0,-23344.0,24841.0,1497.0,1628.0,1628.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A1ZD,False,Germany,f14dc139-3a85-5c2e-8069-fe03cd4cae66,not hispanic or latino,male,white,TCGA-FS-A1ZD_demographic,Dead,primary,360931c7-14e7-4557-bd59-4c9ae896bc0e,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-FS-A1ZD_diagnosis3,"Skin, NOS",TCGA-FS-A1ZD_treatment3,31e08139-3035-4257-96c4-9afd97b1c945,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1165004615344353,-0.012475081353594,0.8023400764396601,-1.7505678815907495,-2.161225144446867,-1.7148026004597912,0.5179512670365927,1.0734894722051054,0.7511847744715455,0.4201961014876607
GN,1156.0,0.0,c35d97f8-1b70-4fbd-a603-9230b3ba7952,0.0,61.0,-22499.0,22499.0,0.0,,1156.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-GN-A4U5,False,United States,ebb7a9d5-94d6-5b22-b50a-8086133aaf16,not hispanic or latino,female,white,TCGA-GN-A4U5_demographic,Alive,primary,75c9c6e0-fdd3-4961-a7d3-2a5a038f29fc,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-GN-A4U5_diagnosis2,"Skin, NOS",TCGA-GN-A4U5_treatment3,0e0ab2a5-e3d4-4446-adad-13aaed35c631,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.086062001125912,-0.326566296418614,0.3859727538741259,0.4513719838040579,1.382936330700689,1.3042991115845173,-0.2613180327735292,-0.6132731805322494,-0.2351796340015642,-0.025474581160114
FS,6953.0,1.0,c3a8881b-70f8-402c-ac75-1cc49fca4e87,,55.0,-20396.0,27173.0,6777.0,6953.0,6953.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Other and ill-defined sites,TCGA-FS-A1YY,False,Germany,5bf4592c-52ee-5401-8fe8-6a6216e8e8cd,not hispanic or latino,female,white,TCGA-FS-A1YY_demographic,Dead,primary,121fdf06-9156-5efd-a59f-1060787ad042,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-FS-A1YY_diagnosis,"Skin, NOS",TCGA-FS-A1YY_treatment,1dd7bb28-20bc-57c9-8418-63c4736312c9,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0852752143729151,0.0722882042224177,0.1940626243214361,0.4602706602370243,-1.3734235871559817,-1.4768235216451313,0.2934903572306942,-1.526373263214,1.1372294042340438,-1.1494032514382224
D3,3976.0,0.0,c3d4caa5-eebc-4276-b1e1-ab9494867b10,3173.0,63.0,-23286.0,25626.0,2340.0,,3976.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A3BZ,False,United States,0645f63f-4367-5665-aa5c-a42d6ad4f1fe,hispanic or latino,male,white,TCGA-D3-A3BZ_demographic,Alive,not reported,18e42005-64a6-5deb-b0ff-3812f369e525,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-D3-A3BZ_diagnosis,"Skin, NOS",TCGA-D3-A3BZ_treatment2,566fb629-382e-40c1-8954-24a874925ecf,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1210852537745378,1.995849351855013,-0.214022049636015,-0.1244865973553069,0.1402142133851861,0.6498618892508448,0.7348405658723786,1.2089019844667868,3.2308373541194704,0.9732147151140323
D9,519.0,1.0,c4ed9e22-b5d7-4469-89a8-861a86791c8b,0.0,54.0,-19749.0,19941.0,192.0,519.0,519.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-D9-A3Z4,False,Poland,efae417c-d95e-5d43-afc7-9c6604e6356d,not hispanic or latino,male,white,TCGA-D9-A3Z4_demographic,Dead,primary,5402df94-1797-4a7e-a2d1-07a7eb69bf45,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-D9-A3Z4_diagnosis2,"Skin, NOS",TCGA-D9-A3Z4_treatment3,0fa011a5-ae68-4ef9-a7e8-4add0978e595,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.0176386184729117,-0.4577256660627733,0.0941272621593429,0.3195168684396476,0.4489488858612231,0.1296172188849919,-0.0346460162911664,-1.1904294827940938,-0.4584217321176162,-0.3926079769832677
EE,1948.0,0.0,c5476668-4b3f-47bb-9d67-488cef891243,16.0,47.0,-17319.0,17319.0,0.0,,1948.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A3AC,False,Australia,5e528b2d-a7fc-5d03-a91f-4d531bff03cc,not hispanic or latino,male,white,TCGA-EE-A3AC_demographic,Alive,Progression,80049880-2be4-5d16-994f-f34fec8a208b,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-EE-A3AC_diagnosis,"Skin, NOS",TCGA-EE-A3AC_treatment,6c3d57fa-c6f6-5b70-bddc-b1668ddc218d,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0787265860511039,-0.2552620252160352,0.1864391140169936,0.423298467704056,0.0651718489093636,0.5322511448274742,-0.1667447962523279,-0.1818793914692866,-0.5258485317050934,-0.6976063231063366
D3,1888.0,0.0,c58638ed-a38c-4494-a41e-6ee5283a7a59,584.0,74.0,-27255.0,28590.0,1335.0,,1888.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-D3-A2JF,False,United States,07df337b-d2f2-5041-85e5-1d71f7554a35,not hispanic or latino,male,white,TCGA-D3-A2JF_demographic,Alive,not reported,1567f2dc-c011-5fc5-a612-6d266f9af585,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-D3-A2JF_diagnosis,"Skin, NOS",TCGA-D3-A2JF_treatment,8730c048-a412-59d2-90ec-c73b5fc752b1,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.155499182547441,-0.2192012378829106,-0.289258628395523,-1.4068566645037068,1.9532543325494585,0.5776244336611794,-0.1619851237021598,-1.6021295200737755,-0.6689703567361971,0.0066771692041644
D3,2912.0,0.0,c59a5615-2dd1-4902-a62b-0e312eab5484,453.0,75.0,-27566.0,28509.0,943.0,,2912.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A1QB,False,United States,92317f8d-0fa9-5fe7-8ec2-98bde4bc50e5,not hispanic or latino,female,white,TCGA-D3-A1QB_demographic,Alive,recurrence,106c6938-42be-406b-92c8-dfee1d8247a6,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A1QB_diagnosis5,Not Reported,TCGA-D3-A1QB_treatment12,070de179-69a3-450e-b2c0-7338657f8d84,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.06993028998382,-0.2097722469270333,0.1239358100156616,0.403837369737032,1.6168219293483166,1.2674154329636993,-0.2382558279312686,0.8171831989964209,1.0232210505274126,-0.03890476916242
GN,1910.0,1.0,c6be76d4-a1ba-4dd6-84bf-3b30cabe144e,1457.0,83.0,-30430.0,32236.0,1806.0,1910.0,1910.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-GN-A268,False,United States,4ca7b50c-07ef-5a59-892c-ab781d93fd6d,not hispanic or latino,female,white,TCGA-GN-A268_demographic,Dead,primary,00c053e4-0957-5b71-a7fe-c699208e4320,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-GN-A268_diagnosis,"Skin, NOS",TCGA-GN-A268_treatment2,435b3ab9-0a7a-4bc5-a088-f7cfea2b66ff,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.5996091152608625,0.8894266555268389,0.1895975425740118,0.5972751100841576,-1.9425720648358735,-0.4763703912985126,0.344122598297274,0.4818144186285776,0.7644605173955048,-1.174039895104565
D3,5424.0,0.0,c714c48f-a18c-4110-a82d-3cc95c315afd,5034.0,23.0,-8637.0,13991.0,5354.0,,5424.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A5GR,False,United States,5220f6c0-17fa-5993-9540-8e9f2558ca2f,not hispanic or latino,female,white,TCGA-D3-A5GR_demographic,Alive,Progression,42fe61c3-e200-4a0c-87fe-16b2e32657f2,True,8720/3,"Malignant melanoma, NOS",Yes,Lymph nodes of inguinal region or leg,TCGA-D3-A5GR_diagnosis2,"Skin, NOS",TCGA-D3-A5GR_treatment5,49a83bd2-129d-462c-8dc6-c70d8c1247f9,yes,Immunotherapy (Including Vaccines),0.0,0.0,0.0,1.0,0.0,0.0,0.0,Metastatic,0.2934779878807337,-1.155314437316524,0.1113454612721446,-0.5699376009440111,-0.4697693330174808,0.4596897660141681,0.1957869436096188,0.3865081599985396,-0.4562091082969553,0.8020367806958123
EB,264.0,1.0,c757c326-6803-4451-a2d3-4368812855a7,-9.0,75.0,-27556.0,27556.0,0.0,264.0,264.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A550,False,Ukraine,5d4265fd-618a-52ae-b24c-34f2ca3fcd9e,not hispanic or latino,female,white,TCGA-EB-A550_demographic,Dead,primary,35f6aa12-5336-5099-a916-1d20dab405e2,True,8720/3,"Malignant melanoma, NOS",No,Skin of trunk,TCGA-EB-A550_diagnosis,"Skin, NOS",TCGA-EB-A550_treatment,08a19033-7f2d-5830-9b44-1fab744c685f,yes,Hormone Therapy,0.0,0.0,0.0,0.0,0.0,0.0,1.0,Primary,-0.0432517111139982,-0.2231935437765296,0.2322375653365604,0.2764347170292924,0.1263325499170976,-0.1398112015912465,0.2145614447358736,-0.0184356266693577,-0.9729149973636836,0.2254423931455868
D9,698.0,1.0,c77e1eef-ec9a-42ea-96cc-70aa437a00e6,254.0,56.0,-20570.0,20968.0,398.0,698.0,698.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-D9-A6EG,False,Poland,5e61b7b5-c7a3-5dc6-b528-5b397da7914b,not hispanic or latino,male,white,TCGA-D9-A6EG_demographic,Dead,metastasis,0ae2eb06-282e-4a9b-b4c6-0570d74cfe8a,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D9-A6EG_diagnosis5,"Bone, NOS",TCGA-D9-A6EG_treatment6,10f4071f-81d6-4285-9e63-905a9aee7bb3,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.5034744906258991,0.948310313839038,-0.4033413839119955,0.2058794702456806,-1.8339973212920129,-0.3994740154286533,0.0571412697859023,3.407558433556426,1.5839465082367412,0.4906974533826383
EB,81.0,0.0,c787c4da-c564-44f1-89eb-dd9da107acb1,5.0,69.0,-25537.0,25597.0,60.0,,81.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A44O,False,Ukraine,c64a8ac0-76c1-537c-aedb-554b679061c1,not hispanic or latino,male,white,TCGA-EB-A44O_demographic,Alive,primary,0f9c04f8-2e70-5391-a7c5-69e00000bd9e,True,8720/3,"Malignant melanoma, NOS",No,Skin of trunk,TCGA-EB-A44O_diagnosis,"Skin, NOS",TCGA-EB-A44O_treatment,2528c908-268e-51e4-a3ae-2efd25644684,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.0375378206960544,0.5007453097910515,-0.2885856822452827,0.343937716259865,-1.2454184393187229,0.6352951233217367,-0.0186991076119308,2.1070520657948077,1.8128948467323889,0.7862818136403327
RP,6.0,0.0,c7ecf63a-a412-43e6-805e-e9f49d7dfe6b,2.0,66.0,-24450.0,24450.0,0.0,,6.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Spinal cord, cranial nerves, and other parts of central nervous system",TCGA-RP-A690,False,United States,651c560d-6e8f-59ca-8c67-d9ff07d74625,not hispanic or latino,female,white,TCGA-RP-A690_demographic,Alive,metastasis,16701708-f2d8-5bff-9228-1af5994e42ab,True,8720/3,"Malignant melanoma, NOS",No,Spinal cord,TCGA-RP-A690_diagnosis,"Skin, NOS",TCGA-RP-A690_treatment2,79efc0ef-6366-49d7-b6af-95043a7c854e,unknown,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.1560082010707506,0.0367604708768568,0.6418144147399246,0.1644504596551757,-0.580252338779172,-0.5169837062575677,0.0752721927989175,-0.8924357058105814,1.175076916955858,0.9363896792954584
EE,1966.0,0.0,c8ba1856-d055-4dc6-a184-72763c76aae4,19.0,59.0,-21552.0,22789.0,1237.0,,1966.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A29H,False,Australia,54aa33f1-e6bd-5f3d-abbd-8604dbd25464,not hispanic or latino,female,white,TCGA-EE-A29H_demographic,Alive,primary,0e0c967a-4b40-45e5-a770-df2a3995df61,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A29H_diagnosis3,"Skin, NOS",TCGA-EE-A29H_treatment5,83234fc5-7b60-4b08-9d00-25f2f91d6696,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3782919241487861,0.6995939862367375,-0.1671873393302106,0.6071759736535516,-0.0654708529904347,0.1067431889106596,-0.1390159741489529,-0.2081856438513332,1.1236042996541915,0.3659535957705911
EE,5107.0,1.0,c9dea107-fc12-4559-ad27-2800ae6b42e4,,63.0,-23132.0,27730.0,4598.0,5107.0,5107.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2MM,False,Australia,7d083421-31b1-5391-979e-7e633274a0e4,not hispanic or latino,female,white,TCGA-EE-A2MM_demographic,Dead,metastasis,17e0d244-8fc3-4d35-9b9b-eb6b41694b14,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A2MM_diagnosis12,"Small intestine, NOS",TCGA-EE-A2MM_treatment32,0760a691-3a68-4eab-beb6-319aae2466ca,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1890644756293407,0.1307329326290247,0.5419243076065133,-0.6954915782314357,0.1280016706897438,-0.399988218692331,-0.0136791345897483,-0.8894169555372312,0.8861548275317974,-0.8903354955541691
EB,422.0,0.0,ca9f542c-fdac-4e58-8658-eca78e4fafca,21.0,51.0,-18910.0,18932.0,22.0,,422.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EB-A44Q,False,Vietnam,63eb641f-3e55-5cd7-9faf-e73b5d4fdb25,not hispanic or latino,female,asian,TCGA-EB-A44Q_demographic,Alive,Progression,76c34eb8-0df4-4ba7-b0a5-ffb669f23c4f,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of inguinal region or leg,TCGA-EB-A44Q_diagnosis2,"Skin, NOS",TCGA-EB-A44Q_treatment4,6c970884-8b4d-4868-90ab-05303cfcf991,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.162940176706869,1.5860671217700772,0.1413469272970755,0.0628245689828352,1.0957446411450673,0.9041747627422044,1.0520189349689704,1.0454582196668578,-0.53807618966137,0.5253347416110081
EB,180.0,0.0,caaf50a4-13b5-4003-b52f-e5f9780f9f94,-5.0,77.0,-28148.0,28148.0,0.0,,180.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A3XE,False,Ukraine,560b9793-852d-5211-b29e-a497af35251e,not hispanic or latino,female,white,TCGA-EB-A3XE_demographic,Alive,primary,1bc38f95-6443-45b2-b041-8f4b7daca014,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A3XE_diagnosis2,"Skin, NOS",TCGA-EB-A3XE_treatment2,32201945-3f7d-4455-a940-1fbff13e87ec,unknown,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.669688448505449,-0.0431018817182248,-0.4193718651456319,0.5373402638156468,0.8000326702390667,-0.6361993279199539,-0.0723765997567884,-1.5056732613396022,-1.1897521317883522,-0.468029717452395
FR,478.0,0.0,ccf8809a-cdfd-46f7-b607-001b8b91c1a4,10.0,34.0,-12679.0,12953.0,274.0,,478.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FR-A69P,False,United States,f122a6d0-1f52-5b57-b4ed-0414bcf2bad9,not hispanic or latino,female,white,TCGA-FR-A69P_demographic,Alive,metastasis,6672c33e-cbc6-45ed-8e03-fe2b88aa1c61,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-FR-A69P_diagnosis2,Not Reported,TCGA-FR-A69P_treatment6,1d847d96-d78d-493d-8fb0-c3032d2b0274,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.8958935348098624,-0.2817209477880463,0.3865592082463218,0.564771729380758,-1.581006949787948,-0.8619508107510114,0.244149046371591,-0.8099231983390234,1.1496899699609178,-0.2917343130869668
EE,2620.0,0.0,cdcf4d91-98a1-4a65-98dd-c6fc80805a0c,1535.0,43.0,-15953.0,17468.0,1515.0,,2620.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2A6,False,Australia,585a51d0-2358-52f2-9533-c38ecfdf27de,not hispanic or latino,male,white,TCGA-EE-A2A6_demographic,Alive,Progression,4854c1af-5b89-4de7-87d7-986d2179b345,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of inguinal region or leg,TCGA-EE-A2A6_diagnosis2,"Skin, NOS",TCGA-EE-A2A6_treatment5,5bbb4f1f-d949-4a57-90e1-099ef6251a3e,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.6487971430312413,0.9468538606607684,0.4018880719397755,0.3210194018233128,0.0878469548201641,0.715884312515322,0.1407491242061177,0.5051019207372766,0.3587351810176636,0.4827742325642387
ER,196.0,1.0,ce28f65d-4ae8-4e63-815f-5b8d4389e092,19.0,54.0,-19733.0,19831.0,98.0,196.0,196.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-ER-A19J,False,United States,333d4f8f-58e1-5fd8-868e-254f02bb24b9,not hispanic or latino,male,white,TCGA-ER-A19J_demographic,Dead,metastasis,6a46ae50-44ca-4f8f-8534-8d6c5a6242da,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-ER-A19J_diagnosis5,"Bone, NOS",TCGA-ER-A19J_treatment9,0e5bd6dd-7379-431d-b8c0-10cf92742231,yes,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1163630141224422,0.3845115861825968,0.327539004013754,0.4720270560206719,-1.1358613616287814,-0.4727322338134853,0.7727017121947544,-0.1669293901155568,0.1811430059383848,0.5742700642502638
RP,21.0,0.0,ce727e9e-325d-41d8-bfaf-0051418b9bef,-2.0,71.0,-26044.0,26044.0,0.0,,21.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Brain,TCGA-RP-A694,False,United States,1511d8d9-a189-5616-b6d3-3bb9a6086c87,not hispanic or latino,male,white,TCGA-RP-A694_demographic,Alive,metastasis,fd9e1b1b-7860-5f90-8f48-6640ffb63bf3,True,8720/3,"Malignant melanoma, NOS",No,Parietal lobe,TCGA-RP-A694_diagnosis,"Skin, NOS",TCGA-RP-A694_treatment3,285f8207-1821-4371-a13b-536b3adeeff4,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.3588354043591296,0.4045361463798835,-0.5182995963340867,0.6061139003499776,0.4234383421248231,-0.0462819033663761,0.2204453865109252,1.1167582261231153,0.5974656458783338,0.0255101934621281
YD,1496.0,0.0,ceb45393-54ee-4801-8c6f-c0aa66e37e60,926.0,75.0,-27498.0,28424.0,926.0,,1496.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Bronchus and lung,TCGA-YD-A9TA,False,United States,096cd246-2da9-5174-96a6-08d8c9389aa6,not hispanic or latino,male,white,TCGA-YD-A9TA_demographic,Alive,primary,18347b03-337d-4c6f-9efb-0444e240a19b,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-YD-A9TA_diagnosis3,"Skin, NOS",TCGA-YD-A9TA_treatment3,7cf7d802-cc06-4dc6-81be-89ae14a38ab4,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2582518179338895,-0.847174480013777,-0.0121327028428743,-3.521716487440762,-0.5563346160834092,0.2739597009627798,1.3898792409474046,0.0343206281077519,-0.9328548608212104,1.3501546258531183
WE,651.0,0.0,cf409c7c-ff82-4529-bda4-554310843bc5,256.0,84.0,-30843.0,31099.0,256.0,,651.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-WE-AAA3,False,United Kingdom,e0434a86-3a67-53c9-84da-c5e4652845f2,not hispanic or latino,female,white,TCGA-WE-AAA3_demographic,Alive,primary,12e7eb37-61a9-4ed6-a45a-347a4f8f48a5,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-WE-AAA3_diagnosis3,"Skin, NOS",TCGA-WE-AAA3_treatment6,c167f2b8-8004-44bc-8dfe-c9329e894832,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.5623490846745767,-0.1574770223480959,-0.7407705410580903,0.7495479731250215,0.4721568673160694,0.6094465617939694,0.1923069783115709,-0.0121106260966246,-0.3127379216099588,0.3448068119150537
EB,326.0,1.0,cf97d5ff-1cb7-434e-9ca8-c396cf960e5a,-1.0,86.0,-31622.0,31622.0,0.0,326.0,326.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EB-A3Y7,False,Ukraine,5f1d2d91-970f-5d66-bbb3-9f24bc97a880,not hispanic or latino,female,white,TCGA-EB-A3Y7_demographic,Dead,primary,072e6944-11f5-5957-9107-13d77a4f4dc0,True,8720/3,"Malignant melanoma, NOS",No,"Connective, subcutaneous and other soft tissues of head, face, and neck",TCGA-EB-A3Y7_diagnosis,"Skin, NOS",TCGA-EB-A3Y7_treatment5,5cf26eda-ba66-44df-b3c0-58b46df89e6b,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.217338937502939,0.2439118622347777,-1.2924867523843604,0.3069022356476334,-0.8036751330194534,0.0054233015051912,-1.29464222123675,-0.2904106512968561,-1.538647972140824,-0.2311305898711971
D9,766.0,0.0,cfe787b3-8297-4318-987c-bfadd743d767,415.0,70.0,-25582.0,26004.0,422.0,,766.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D9-A6EA,False,Poland,acd0b7a6-83b9-5637-932e-170632f09d1e,not hispanic or latino,male,white,TCGA-D9-A6EA_demographic,Alive,primary,20c70da4-aec1-5cea-8d3e-bb78db3d09ed,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-D9-A6EA_diagnosis,"Skin, NOS",TCGA-D9-A6EA_treatment,88e57747-9e58-57ad-8c17-c96985920bd9,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2589819606798582,-0.7512614822973763,-1.6380077947898009,0.4573380100239748,0.1641546179270216,-0.4596988396365847,-0.440255363900185,-2.4519795970282,-0.6793347525277097,0.1329098544324901
EE,5932.0,0.0,d2372037-5eea-4f98-bd72-551218e83779,4422.0,42.0,-15396.0,20350.0,4954.0,,5932.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A29W,False,Australia,bef197ea-4608-5944-803d-714ce5ca859f,not hispanic or latino,male,white,TCGA-EE-A29W_demographic,Alive,Progression,412c60d5-f86e-4f17-860d-98821debbe58,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of inguinal region or leg,TCGA-EE-A29W_diagnosis2,"Skin, NOS",TCGA-EE-A29W_treatment4,37a3f2a2-2dc9-4ec6-bd6b-98916e08ddcd,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3118394363200092,-0.1234084940041826,0.8354470202080186,-1.7192857489276747,-1.8334899327055805,-0.885083911417948,0.3167068652288218,-0.9523794612385246,-0.2477566536137357,-0.3625957891439361
DA,2249.0,0.0,d241a660-1c84-44fa-a6b3-ec9284333bd2,,62.0,-22718.0,23831.0,1113.0,,2249.0,TCGA-SKCM,Consent Waiver,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-DA-A95X,False,United States,1473b059-d448-532b-aeab-824298f47206,not hispanic or latino,male,white,TCGA-DA-A95X_demographic,Alive,primary,b87d236b-84ea-4bc5-a0bf-4ec9d4a9759a,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-DA-A95X_diagnosis3,"Skin, NOS",TCGA-DA-A95X_treatment3,d0254178-3b98-4a78-b9ab-620337571f8d,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.2268789175997525,-1.090669905302929,0.377404455179886,0.0465974634660808,0.0477239153099854,0.1469652157410964,0.0878797160394698,0.7197206901711332,0.6285588332528699,-1.2647697756819123
EE,1438.0,1.0,d28b2d64-2399-4ce1-9c9a-7538dabab862,,52.0,-19333.0,20677.0,1344.0,1438.0,1438.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2MD,False,Australia,09c14118-51aa-572d-b1ff-53db5d896c97,not hispanic or latino,male,white,TCGA-EE-A2MD_demographic,Dead,not reported,28faf539-7cef-55a8-867d-18f367e83b12,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-EE-A2MD_diagnosis,"Skin, NOS",TCGA-EE-A2MD_treatment2,2b375c83-169e-4652-aa41-37760bb00515,yes,Chemotherapy,0.0,0.0,1.0,0.0,0.0,0.0,0.0,Metastatic,0.7596497105648943,-0.0987946313345301,-0.0121225685933076,0.4281977033276695,-1.015614162623787,0.1960288905402498,0.1857118513211599,1.0727707221400211,1.1222068530306162,0.93660775354621
ER,877.0,1.0,d32a4219-4cca-470f-b6b3-11447d9f5e0b,15.0,53.0,-19499.0,19879.0,380.0,877.0,877.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-ER-A2NF,False,United States,a6e603f4-0120-58dc-bb57-d649ac82909f,not hispanic or latino,male,white,TCGA-ER-A2NF_demographic,Dead,not reported,7db135ee-0f01-46b3-8f51-7ac192d758ff,False,Not Reported,Not Reported,Yes,Not Reported,TCGA-ER-A2NF_diagnosis5,Not Reported,TCGA-ER-A2NF_treatment6,5f62fdd4-397d-4334-b403-14ec33be6b99,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.1448245708754666,-0.2694424695952913,0.4629878718852276,0.5555812954017337,1.0233168230180871,0.4484225228676848,-0.1478577649387238,0.9455519606202876,1.6026955837697008,0.8007007099779864
GN,1487.0,0.0,d3b77da8-be1d-4955-b1c7-55b7769785e8,1046.0,51.0,-18953.0,20003.0,1050.0,,1487.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-GN-A4U8,False,United States,67d9e75f-8d6a-527d-9e8b-b5e2a405f2a1,not hispanic or latino,male,white,TCGA-GN-A4U8_demographic,Alive,not reported,75f1fe4e-265c-5bc6-a676-bd6be9f2fa27,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-GN-A4U8_diagnosis,"Skin, NOS",TCGA-GN-A4U8_treatment2,0ea279a9-41cd-4720-aa9e-020374502499,yes,Immunotherapy (Including Vaccines),0.0,0.0,0.0,1.0,0.0,0.0,0.0,Metastatic,-0.1105749950281016,-0.2172198420639773,0.2411287599366793,0.5100763200045375,-0.0848956356883495,0.7068352443183407,-0.1664292710476649,0.354595657108844,-0.372362310882477,1.3760323088004418
EB,291.0,0.0,d56a707b-dbf5-481d-9d93-1e23a854a684,3.0,76.0,-27998.0,27998.0,0.0,,291.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A41B,False,Ukraine,89dd1f48-2447-580b-bbd1-f1ca1fcfe062,not hispanic or latino,female,white,TCGA-EB-A41B_demographic,Alive,primary,471c72a2-f599-5813-b8fb-21dda3aaa0b1,True,8721/3,Nodular melanoma,No,Skin of upper limb and shoulder,TCGA-EB-A41B_diagnosis,"Skin, NOS",TCGA-EB-A41B_treatment5,347569a8-7b6e-429d-9b05-8edb5c85a97b,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.1139523132605832,1.208299885370171,-1.230325421040532,0.1496623561770587,-1.2129286943470756,-0.1370712186100253,0.0658078475443936,0.0548768799691332,-0.0105400892619386,0.1754899693136147
ER,1487.0,1.0,d5f8b18c-8ae7-457a-aa3e-c4bd77b276ab,1355.0,77.0,-28383.0,29755.0,1372.0,1487.0,1487.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-ER-A19C,False,United States,2541a294-3cb0-599b-89c4-6e0d1168f5ad,not hispanic or latino,male,white,TCGA-ER-A19C_demographic,Dead,primary,1d0fd2a6-9da2-4b62-ac69-53cc62ab308e,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-ER-A19C_diagnosis3,"Skin, NOS",TCGA-ER-A19C_treatment3,4227414c-2197-480b-b72b-2a57f33a7914,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3978506297423353,0.1936465495730859,0.3466316945613468,0.7505287610599025,-0.1950885482451354,-0.2274093675950315,0.3081156529169705,-0.7633481941216306,0.5983972769607169,-0.1084075479283112
EB,1792.0,0.0,d6276407-52a3-4f0c-8332-1b3477f6d2fc,1178.0,49.0,-18226.0,19915.0,1689.0,,1792.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Small intestine,TCGA-EB-A5UN,False,United States,141ac6c9-3cb6-5beb-932f-a633df70b6e8,not hispanic or latino,male,white,TCGA-EB-A5UN_demographic,Alive,metastasis,9657a16f-8f01-40c3-8926-e2fe6995ae70,True,8720/3,"Malignant melanoma, NOS",No,"Small intestine, NOS",TCGA-EB-A5UN_diagnosis2,"Skin, NOS",TCGA-EB-A5UN_treatment5,85d2e9a6-15ed-4686-a2cf-7b2a165d79a5,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.2522531375885778,0.3386469715548341,-0.2255832628786918,0.3365321388397466,0.0014971415385707,0.147374118599779,0.0307186336053441,0.5180394219087754,-0.1132524160946763,-0.6074167877749059
EE,1124.0,1.0,d6283ab0-9019-4ad2-93aa-2e6b39cd9641,,71.0,-26226.0,27338.0,1112.0,1124.0,1124.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-EE-A3J5,False,Australia,469fc0b9-ed2a-5cf8-a9a2-1fdb66035396,not hispanic or latino,male,white,TCGA-EE-A3J5_demographic,Dead,recurrence,18a79749-9132-4e9e-afa7-bbfa77a07c9e,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A3J5_diagnosis5,Not Reported,TCGA-EE-A3J5_treatment11,0a79a1b7-d806-4eab-a75f-de001dd14c41,yes,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Primary,-0.3001786472701565,0.1697767079876714,-0.2325061608741978,0.27417779863772,0.0037780583734432,0.6692773692370846,0.3392422702408691,1.198983233568638,1.696208053663906,-0.3223914497426332
EE,3141.0,1.0,d70e0d27-7f27-4807-a36e-9fb7b00f0a70,,51.0,-18841.0,21858.0,3017.0,3141.0,3141.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2ME,False,Australia,fcbc43ea-6313-5182-b106-c3c2d13bbca4,not hispanic or latino,male,white,TCGA-EE-A2ME_demographic,Dead,primary,1ba61517-955d-482b-adfb-bef469bab3a6,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A2ME_diagnosis3,"Skin, NOS",TCGA-EE-A2ME_treatment3,2471fcef-31ed-49c6-902c-93e2fe806ad9,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2318314103901229,-0.6819658025918559,0.6685464376846824,-0.0066811890261573,0.7872898780578027,1.4732662582355287,0.5650678889262967,0.1822393915018832,0.0600309652285803,0.0849437833930518
QB,220.0,0.0,d7207811-3f9a-48ac-ab9b-3e8af1b1d9f2,0.0,49.0,-18134.0,18325.0,191.0,,220.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-QB-A6FS,False,United States,a86d237a-121e-502d-abb8-2c5c0f684060,not hispanic or latino,male,white,TCGA-QB-A6FS_demographic,Alive,not reported,073287fe-bdef-55ff-ac1d-856f6945c6d8,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-QB-A6FS_diagnosis,"Skin, NOS",TCGA-QB-A6FS_treatment2,41c4f552-23fc-4544-9fa8-68617691ce80,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.502169067215276,-0.0221922632908432,-0.95910707909878,0.1063627785295825,0.9572770671634072,0.3033633805203834,-1.2074359381945978,0.2138643943655462,-0.6768892209364535,-0.307975476590489
EE,440.0,0.0,d73d1b38-9ab4-409e-a360-e93f8c54715c,22.0,48.0,-17857.0,18284.0,427.0,,440.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A29R,False,Australia,e1e0e089-1369-5a6a-9551-f80518b52a5a,not hispanic or latino,female,white,TCGA-EE-A29R_demographic,Alive,metastasis,071efd05-82da-4bb7-a60b-481c80c53f07,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A29R_diagnosis6,"Lung, NOS",TCGA-EE-A29R_treatment14,9eba7046-0dd6-4a5c-8647-f406f8a12e90,no,"Surgery, NOS",0.0,0.0,0.0,0.0,1.0,0.0,0.0,Metastatic,-0.1632619222503661,-1.0489799636881405,0.3341499702949567,0.019563195617336,-0.6102029432367251,-0.7225786451491647,0.3341634457486955,1.1705207309913417,-0.3390564996872801,-0.3663355150863108
FR,1059.0,1.0,d781260c-f969-456e-bf16-044dc5b181a4,992.0,78.0,-28680.0,29672.0,992.0,1059.0,1059.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Small intestine,TCGA-FR-A8YC,False,United States,dcd9b1fd-173f-5ca3-af29-d7797e4d0880,not hispanic or latino,male,white,TCGA-FR-A8YC_demographic,Dead,primary,bedb3e96-2016-494e-9226-e011a2eb08d9,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-FR-A8YC_diagnosis3,"Skin, NOS",TCGA-FR-A8YC_treatment3,2594eeba-9e85-400b-bd68-e1cbe727a6c7,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.638970669159112,-0.1526888027473593,0.3761963497847336,0.1553996222025038,0.7190415107288396,-0.1570104798766766,-0.0416892921938928,-1.3154919941185776,-0.6263482347171702,0.1513894034765291
DA,2193.0,0.0,d7ade261-b624-4e47-8a82-591bf1a8faa4,,83.0,-30623.0,31677.0,1054.0,,2193.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-DA-A95V,False,United States,e43e5553-01c0-5555-aef5-9452d864f034,not hispanic or latino,female,white,TCGA-DA-A95V_demographic,Alive,Progression,4dbf36fd-f5cb-4a0f-86cb-16cc52137f54,True,8720/3,"Malignant melanoma, NOS",No,"Lymph nodes of head, face and neck",TCGA-DA-A95V_diagnosis2,"Skin, NOS",TCGA-DA-A95V_treatment5,80d382b5-b39c-45e6-b451-25fd3a88ff7c,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.4266157147654233,0.1776771745623716,-0.7003016596974773,0.4745558984622585,0.7609890520876575,0.711732883875502,-0.508234970717428,1.0113894665819123,-0.0740074567492885,1.137845739667388
BF,717.0,0.0,d7e86c99-a716-48b8-b067-e73d68b14dee,-3.0,81.0,-29801.0,29801.0,0.0,,717.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-A3DN,False,Russia,49018b50-b191-558c-9e3f-8d08715b3635,hispanic or latino,female,white,TCGA-BF-A3DN_demographic,Alive,primary,a3064040-67e0-5e38-bd12-a70f60b56a29,True,8720/3,"Malignant melanoma, NOS",No,"Skin, NOS",TCGA-BF-A3DN_diagnosis,"Skin, NOS",TCGA-BF-A3DN_treatment4,116124d0-331a-4d37-a6ce-93ecdd2bc03a,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.356710445600471,0.2004693714783522,-0.6226096976743231,0.4649450199544723,-0.7531343380179393,-0.7281139462320939,0.5151948254818626,-0.11230438516923,1.007499776012197,0.328089545942955
EB,645.0,0.0,d7ee2693-39a8-4e3a-b6f6-e4729800e34e,31.0,72.0,-26439.0,26939.0,500.0,,645.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A24D,False,Ukraine,99641b9d-3e63-5a3c-8b69-1d51670332c0,not hispanic or latino,male,white,TCGA-EB-A24D_demographic,Alive,primary,a327c6a3-f286-51b2-b6af-90abb2de99f6,True,8720/3,"Malignant melanoma, NOS",No,Skin of upper limb and shoulder,TCGA-EB-A24D_diagnosis,"Skin, NOS",TCGA-EB-A24D_treatment4,4c281ccd-10d4-4dad-a562-3f6a05606d84,yes,Immunotherapy (Including Vaccines),0.0,0.0,0.0,1.0,0.0,0.0,0.0,Primary,0.1501719718233328,-0.3767732377784906,0.8889751428554432,0.5907569773285022,0.5735882017251263,-0.2631266673328375,0.6109495629330879,-1.8676357941155248,1.5555317602240566,1.7575614327338906
D3,368.0,1.0,d7f251c3-8312-47d8-a9cc-2917d2284cc3,175.0,24.0,-8952.0,9220.0,268.0,368.0,368.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A2JK,False,United States,56c63843-234e-503c-a2ab-71af8e41b8b8,not hispanic or latino,male,white,TCGA-D3-A2JK_demographic,Dead,not reported,0898b84f-ce2a-5a25-809d-a9a2d8b432c9,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-D3-A2JK_diagnosis,"Skin, NOS",TCGA-D3-A2JK_treatment2,3a3c4c30-0bae-4b48-80a2-d7ea051228a0,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-2.0615589692944947,-0.0583069357184164,-1.0885118902044386,0.3139968497504356,0.0461666559858281,-0.8659140396898962,-0.7317661056103997,-0.8589419527777012,-1.445950679443704,-1.3235454599102114
EE,263.0,1.0,d84d9c7b-b464-4ea1-8c39-9c929bb34c08,,57.0,-20970.0,21109.0,139.0,263.0,263.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-EE-A17Z,False,Australia,e3325914-67e4-5aa3-aef8-bb104e42a373,not hispanic or latino,male,white,TCGA-EE-A17Z_demographic,Dead,primary,0e6c9543-f496-4a30-9f29-31b438ab1e11,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A17Z_diagnosis3,"Skin, NOS",TCGA-EE-A17Z_treatment3,923ab240-9ebc-4212-8490-a42c5a80e2d3,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.4446170008416385,0.7603959266222207,0.8357231303094914,0.7024239569591807,-2.5214135038100234,-1.7821822342721017,0.5836788323976194,1.1015207247433505,-0.3882000392829901,0.4720818443597238
DA,6873.0,1.0,d8eac750-9daf-4465-b672-9e31fd369057,,45.0,-16701.0,23542.0,6841.0,6873.0,6873.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-DA-A3F5,False,United States,4cae6c15-0691-58cf-9668-479f8ddd0963,not hispanic or latino,male,white,TCGA-DA-A3F5_demographic,Dead,Progression,b2511d32-3288-4707-8d17-947c1e6dd220,True,8720/3,"Malignant melanoma, NOS",No,"Lymph nodes of head, face and neck",TCGA-DA-A3F5_diagnosis2,"Skin, NOS",TCGA-DA-A3F5_treatment5,881e1a95-6763-437b-bb64-4fb53603a16c,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0202379206912342,0.3653719420501927,0.0390950647362069,-2.2446785477606057,-0.8685451245958022,0.2460841017511705,0.6041192519896795,0.1776393910853509,-1.673268663545181,-0.8127745621113931
D3,2639.0,0.0,db239624-3dba-48bb-9889-f479dc2ba046,9.0,53.0,-19644.0,19644.0,0.0,,2639.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A2JC,False,United States,2f55f09e-c002-540c-a159-cde762217bc8,not hispanic or latino,female,white,TCGA-D3-A2JC_demographic,Alive,Progression,8f782946-59ba-5a18-a2a3-753ddbc2e449,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-D3-A2JC_diagnosis,"Skin, NOS",TCGA-D3-A2JC_treatment4,07594c49-fd5e-4342-862c-f1ee0c10a2a7,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4913934009059339,-0.2664701730525131,0.0490223636870811,0.566523783631004,-0.2586028859646752,0.5834601711480237,0.8008042546662516,1.183170732136808,-0.0755213572581596,-0.1017816532637192
W3,122.0,1.0,db950f20-c869-4e1a-ada2-dbdc82b5865e,31.0,85.0,-31351.0,31382.0,31.0,122.0,122.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-W3-AA1O,False,United States,f95d1c08-7299-5c6c-802a-7ee35f2817aa,not hispanic or latino,male,white,TCGA-W3-AA1O_demographic,Dead,not reported,95274445-d74c-5e56-9bcb-8b3cb7269d26,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-W3-AA1O_diagnosis,"Skin, NOS",TCGA-W3-AA1O_treatment4,2f81be7c-2b3d-4e53-83fa-9974da8e3f41,yes,Chemotherapy,0.0,0.0,1.0,0.0,0.0,0.0,0.0,Metastatic,0.5540363195019411,0.0149300165800884,-0.2647015336473977,0.2650762308627133,-1.0146103300950096,-0.4441047016814679,0.2210044210549517,1.6989457788405409,0.9318047505685706,0.7785199503698699
D3,804.0,0.0,dcc005ba-f8c9-4845-bf08-0dbabe291c9a,139.0,26.0,-9517.0,9576.0,59.0,,804.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-D3-A8GE,False,United States,91f66af9-58c5-5c4a-b6f2-f44e78bd4f9b,hispanic or latino,male,white,TCGA-D3-A8GE_demographic,Alive,Progression,de7429f3-fefc-5b18-8043-c57871060871,True,8772/3,"Spindle cell melanoma, NOS",No,Skin of upper limb and shoulder,TCGA-D3-A8GE_diagnosis,"Skin, NOS",TCGA-D3-A8GE_treatment3,3d4d6761-2159-4d6c-9c8a-739e9294f409,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.2651337820976197,-0.7044052390122747,0.2423650706834377,-2.8883536820994946,-0.8865135200431422,0.843263012244123,0.5143396751831102,-1.621248271804989,-0.9833958470404938,0.1009170340767935
D3,5110.0,1.0,dceb4909-cb3e-4aa5-8ff6-23d27b39aca3,3035.0,70.0,-25784.0,29003.0,3219.0,5110.0,5110.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A2JB,False,United States,32957fd5-dcd6-5251-80fb-0b9551ee19f2,not hispanic or latino,female,black or african american,TCGA-D3-A2JB_demographic,Dead,primary,09f0486b-5afe-4b4a-a0ce-98442d94c807,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-D3-A2JB_diagnosis3,"Skin, NOS",TCGA-D3-A2JB_treatment3,ac42fc5c-2c38-4294-bd86-2bb52243c3ff,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.2607025714367286,-0.3282826055571027,0.3481428138067917,-5.7768498191324016e-05,0.295995516156716,0.7276144422348616,0.233935586517174,0.6439644333113571,-0.4720468366974684,0.650293652734908
EE,1026.0,1.0,dde0b2be-ea43-4de7-8feb-ccdc073c6978,,82.0,-30003.0,30995.0,992.0,1026.0,1026.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A181,False,Australia,76c156df-18d7-5246-a6ac-3aa613f87cb0,not hispanic or latino,female,white,TCGA-EE-A181_demographic,Dead,recurrence,53e47e70-e9ce-45a4-bd54-49b549ee4140,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A181_diagnosis4,Not Reported,TCGA-EE-A181_treatment6,08b0176b-b6a4-4451-b136-3dbec89b16a6,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.094195245293333,-0.2202563639135892,0.7464938483998028,0.2787660546257008,1.3133726193413993,0.7405502175733775,0.3923268998373811,0.0609143805158311,0.0543247248489847,0.2429135391997854
EB,326.0,1.0,debd7156-8b97-4bdf-9dd9-7e469277d252,-2.0,82.0,-30225.0,30225.0,0.0,326.0,326.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A4P0,False,Ukraine,82152679-3bb6-5d03-ae50-f626c166291c,not hispanic or latino,male,white,TCGA-EB-A4P0_demographic,Dead,primary,73ff022a-9f1c-4e6a-894f-f866d8c5a584,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A4P0_diagnosis2,"Skin, NOS",TCGA-EB-A4P0_treatment3,90c7fcb6-6fba-4f2b-bd3c-36c7f04513d3,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.8501771299202627,-0.6132669423241376,0.4012506784599843,0.4896481911464406,1.0448422646697817,-0.5017653442346987,-0.6127178297057008,-1.1961794833147592,-0.8612357213630107,-0.1788526359544386
D3,4053.0,0.0,df6303cd-ffb5-422f-9865-b09029a6d54f,760.0,42.0,-15531.0,16620.0,1089.0,,4053.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A1Q7,False,United States,5e4d0494-061f-54b3-a93c-e297459b6034,not hispanic or latino,female,white,TCGA-D3-A1Q7_demographic,Alive,metastasis,055a78e0-8e8d-4f0f-b884-0b6870a71bfa,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A1Q7_diagnosis4,"Connective, subcutaneous and other soft tissues of pelvis",TCGA-D3-A1Q7_treatment7,56249835-d7e5-4ce8-b796-0e2a625f0626,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.3745319241199944,0.0958118107967901,0.3394625077129026,0.4430443032216273,1.4001408179837451,1.4099347829782474,1.187781890609557,1.178714481733292,0.3636262442001739,-0.246419465154904
DA,2703.0,0.0,dfe8baa8-1c2c-4c36-92c9-61548cebec19,,62.0,-22940.0,23695.0,755.0,,2703.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,Skin,TCGA-DA-A1I7,False,United States,fd39fb49-330f-5d14-9cc6-783b7918dbf0,not hispanic or latino,male,white,TCGA-DA-A1I7_demographic,Alive,not reported,4b3dbffb-150d-5f38-b3cb-0bd1ddf074d7,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-DA-A1I7_diagnosis,"Skin, NOS",TCGA-DA-A1I7_treatment,c8e05c00-bd2d-5c5e-8bc3-579d1cef5d88,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.4264702033540598,-0.2678033016480545,0.7486852688485106,-1.8203258763963124,0.9004720435792356,0.2668120997200582,-0.1968750903277712,-0.4485356656151712,-1.3411421826756051,0.0306584235273829
BF,476.0,0.0,dfe9d2bd-2317-4103-b493-41c5469e08a0,0.0,73.0,-26750.0,26750.0,0.0,,476.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-AAOU,False,Russia,d46e539f-66ac-5ed4-a281-f543babd93a8,not hispanic or latino,female,white,TCGA-BF-AAOU_demographic,Alive,primary,279cd641-fca8-4552-9985-3ca9c3915ade,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-BF-AAOU_diagnosis2,"Skin, NOS",TCGA-BF-AAOU_treatment3,747214b1-9426-4f8f-a66c-6bbb300b81b3,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.7719365630476027,-0.411388850811912,-0.7606633255777159,0.2713357270002136,0.2353634194816131,-0.0616834985984523,-0.4727895171632394,-0.5743169270047366,-0.6086472441518911,1.0416162260696489
FS,470.0,1.0,e0d36cc0-652c-4224-bb10-09d15c7bd8f1,,78.0,-28491.0,28624.0,133.0,470.0,470.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A1ZF,False,Germany,384c4585-c091-5610-ae03-a19fd7f7c34d,not hispanic or latino,female,white,TCGA-FS-A1ZF_demographic,Dead,Prior primary,275132fe-ab17-4fce-9d25-06ad3b93f2c2,False,Not Reported,Not Reported,Unknown,Not Reported,TCGA-FS-A1ZF_diagnosis4,Unknown,TCGA-FS-A1ZF_treatment3,0593de01-7f85-4411-8e4a-4cc9a0227673,unknown,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.5353697506897365,0.4602404722822594,0.4669051020454462,0.2087983499569085,-1.415050072121766,-0.7026273933563179,0.2900637020624841,-1.1764857315314785,-0.2595184960288239,-1.120657712917318
ER,4634.0,1.0,e11a109d-31cb-40f7-aa17-50797b287a4f,3549.0,40.0,-14935.0,18508.0,3573.0,4634.0,4634.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-ER-A19H,False,United States,df32dd5f-d3d0-5d34-b229-fd9157ee8fa4,not hispanic or latino,male,white,TCGA-ER-A19H_demographic,Dead,primary,38e4f819-50a1-4872-95d9-3d33ecd6a54c,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-ER-A19H_diagnosis3,"Skin, NOS",TCGA-ER-A19H_treatment4,fba4751d-a24b-4336-a37f-99e5a30ca927,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,1.3394985299369944,0.6580246076733163,0.6499288450384489,0.0489555020819946,-0.391437690767408,0.2605370701518564,0.4166420100271382,0.0111768760120718,-0.651269366170918,-1.1662031336149807
ER,279.0,1.0,e218fc54-1139-4944-82e2-742839e5553a,129.0,86.0,-31661.0,31780.0,119.0,279.0,279.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-ER-A199,False,United States,ebb5315e-36f4-5c66-9864-537817308d6b,not hispanic or latino,female,white,TCGA-ER-A199_demographic,Dead,primary,4767c98e-5122-5194-aa79-7199ab79cf57,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-ER-A199_diagnosis,"Skin, NOS",TCGA-ER-A199_treatment2,4754ff20-6973-475e-b1bc-d313467f7df1,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2154742863662526,-0.0022250149418034,-0.127798700441248,0.2365166338391932,0.9830236230840178,0.6936989802883685,0.3931620323018306,0.3282894047267973,1.291414348368448,0.1660018878061688
DA,4107.0,0.0,e2271488-1a7d-4733-a1ea-38bbaeb97b4c,,27.0,-10017.0,11928.0,1911.0,,4107.0,TCGA-SKCM,Consent Exemption,Nevi and Melanomas,Diagnosis,Skin,TCGA-DA-A1I5,False,United States,05d4ec07-2656-56cb-ae4f-8e46ab5e5f27,not hispanic or latino,female,white,TCGA-DA-A1I5_demographic,Alive,primary,2dffb8ac-5874-4d22-8ac3-61aec1881c88,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-DA-A1I5_diagnosis3,"Skin, NOS",TCGA-DA-A1I5_treatment3,804f65a9-54fa-4d8c-9fef-7a4cd93952f6,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.2930433710938408,-0.4397094681869217,-0.458331143881386,0.2073053069716585,0.6838118898978275,0.9165721422542684,-0.0789315911897189,0.32095815406295,-0.1155814938006328,0.6029991294998327
ER,1429.0,1.0,e35be832-6972-4677-b985-02e90d51141a,316.0,55.0,-20354.0,21776.0,1422.0,1429.0,1429.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-ER-A3EV,False,United States,85d317c0-9c17-5249-8a6a-b41c5ffcb02f,not hispanic or latino,male,white,TCGA-ER-A3EV_demographic,Dead,metastasis,1769cfec-fe5f-4c23-bc49-1dfba099ada3,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-ER-A3EV_diagnosis5,Liver,TCGA-ER-A3EV_treatment9,4a96f910-de94-419a-9e6b-16eca1be0a14,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1055565956405931,-0.3017703360429526,-0.0773770901327546,0.7280342733498231,0.414085174505985,-0.2811158062675891,0.6527083821432038,2.372845839862589,-0.0918249011998652,0.1754096688241933
GN,4255.0,0.0,e36c9411-773b-4a8e-9b43-895b3cb044c7,2957.0,47.0,-17239.0,20902.0,3663.0,,4255.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-GN-A262,False,United States,32f765cd-1a62-5637-9e56-d80fa540eb4f,not hispanic or latino,female,white,TCGA-GN-A262_demographic,Alive,recurrence,353d2151-e8c7-44d6-9b58-afa9493af616,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-GN-A262_diagnosis4,Not Reported,TCGA-GN-A262_treatment6,33431724-fb65-427e-a5fd-a5853e788279,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.1729882378284933,0.4731534974642991,-1.5558955225085365,0.3905305669749885,-2.4345268262838826,-1.6846043951438954,-0.5772428416526667,-0.7048419388238557,-1.8095197093437108,-1.0188222172090902
FR,1164.0,0.0,e3905d75-9d0a-4981-ab42-83ce2c20c4ea,767.0,65.0,-24032.0,24792.0,760.0,,1164.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FR-A7UA,False,United States,3dd3c6c7-6e6a-5d1a-83a3-0f64fa7e08d5,not hispanic or latino,female,white,TCGA-FR-A7UA_demographic,Alive,not reported,80874f32-0a1a-5a10-8bde-041ed4982d5d,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-FR-A7UA_diagnosis,"Skin, NOS",TCGA-FR-A7UA_treatment2,73df01d1-8696-4275-964c-ecae955b48c4,yes,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.1846444789340621,-0.7022900466999804,0.0523292046227895,-0.43524380942894,1.039991199942042,1.9579797089424045,0.3731612500035223,0.7210144402882824,-1.4542189052998555,0.0024269524660005
EE,1803.0,0.0,e58bed18-503c-4182-bcf3-5af6f20e1b8a,248.0,51.0,-18876.0,19124.0,248.0,,1803.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2GB,False,Australia,812eb5d0-1fa3-5cbf-8a92-9e6010681944,not hispanic or latino,male,white,TCGA-EE-A2GB_demographic,Alive,not reported,40a9e7ce-f5e5-5393-93c3-c2209f4d665b,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-EE-A2GB_diagnosis,"Skin, NOS",TCGA-EE-A2GB_treatment,009dc292-9ce7-5905-a9d2-db2b65904ab0,yes,"Radiation, External Beam",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.5396956024421874,0.5670359939396743,-0.2448514893216165,0.5079309646217902,-0.627227749338056,-0.4756025510273133,0.6055216673661848,1.087289473454702,1.8727521437755044,-0.2194167727786207
FW,1124.0,0.0,e5bc45ce-8a14-40b5-b9b5-ce45609fef3a,695.0,68.0,-24868.0,25535.0,667.0,,1124.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FW-A3R5,False,United States,d82b8c59-5f83-5c85-8ec4-012e48d8f7e0,not hispanic or latino,male,white,TCGA-FW-A3R5_demographic,Alive,Progression,546bac1f-78cf-4218-9296-0c163c28c99e,True,8720/3,"Malignant melanoma, NOS",No,"Lymph nodes of head, face and neck",TCGA-FW-A3R5_diagnosis2,"Skin, NOS",TCGA-FW-A3R5_treatment6,0a6192c0-0555-403b-9c0a-18b97cebd248,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.257516279481831,0.1794518200653272,0.2376534317057983,0.6893523652980698,-0.5767571307345304,-0.0011469802628498,0.1019940882901351,0.8834519549970946,1.0241526816097957,0.0546745475532353
D3,1002.0,0.0,e63a9717-7851-4706-951a-dc0b87c45edf,36.0,51.0,-18971.0,18991.0,20.0,,1002.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A51K,False,United States,fd64ef60-9bfe-53d0-af22-288b762ec7d8,hispanic or latino,male,white,TCGA-D3-A51K_demographic,Alive,not reported,18203393-b4da-51fd-924c-2ba3b882a0e3,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-D3-A51K_diagnosis,"Skin, NOS",TCGA-D3-A51K_treatment2,47d9a94d-2d05-4b7f-be15-13377e95ef73,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.2718514901321427,0.0613261120231783,-0.009208261149445,0.3330884431433215,0.8814602700958405,-0.2100801848528402,-1.0604020042230105,-1.7990670379065823,-2.607112369748944,0.6301798446064011
EE,3139.0,1.0,e653f888-37cf-41d5-a1cf-45397c90b31d,,23.0,-8405.0,11502.0,3097.0,3139.0,3139.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2MG,False,Australia,76f9eaf5-e74f-58b3-bb39-318db693f3cf,not hispanic or latino,male,white,TCGA-EE-A2MG_demographic,Dead,metastasis,18a1f543-002b-4ec6-8bbb-c679919e010f,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A2MG_diagnosis6,"Mediastinum, NOS",TCGA-EE-A2MG_treatment15,9a06d04c-6742-49ae-94cf-72168045db27,yes,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4493515789847508,0.0265991165308132,0.1399241554963488,0.162932629129233,0.1328972266542472,0.6828479529247303,0.6636512091108296,-0.4667919172682839,0.5477398368561358,0.2807759783358419
EE,828.0,1.0,e699a2a7-dbff-4122-8114-87d70a56f59f,,69.0,-25281.0,25788.0,507.0,828.0,828.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-EE-A17Y,False,Australia,d52c4a10-8dea-5732-a566-509859824789,not reported,male,asian,TCGA-EE-A17Y_demographic,Dead,not reported,01251404-3805-5e07-8473-655efb72a48a,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-EE-A17Y_diagnosis,"Skin, NOS",TCGA-EE-A17Y_treatment3,63aac387-7e14-4b54-8ad1-e00d4ff65613,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.0417577627832488,-0.2168074108062674,-0.1627782152553036,-0.3801261196595425,-0.3772654123564218,-0.4523611446915298,-0.1512251777637091,0.4984894201385108,-1.1448009320633667,-0.6027601937026997
D3,3408.0,0.0,e85c07ed-51ef-4c91-8431-0dc738d9ccc6,28.0,53.0,-19687.0,19716.0,29.0,,3408.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A1Q4,False,United States,5aef2b59-aab0-5eef-bbfd-ed379c1cda83,not hispanic or latino,female,white,TCGA-D3-A1Q4_demographic,Alive,Progression,7d1d594d-690d-4e56-80a5-1344294a5cbe,True,8720/3,"Malignant melanoma, NOS",No,"Lymph node, NOS",TCGA-D3-A1Q4_diagnosis2,"Skin, NOS",TCGA-D3-A1Q4_treatment5,4902cf69-0da4-48e2-8cc3-1b7dec3b0d39,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.107503896573821,-0.3874461362286704,0.6210358788300517,-1.0011649619807952,-0.8164735726293184,-0.599820733369287,1.3857292142284812,-0.6323919322634626,-0.9893349951906868,0.9287688999896292
WE,614.0,0.0,e865b9be-ca10-4805-9634-2f35ad18b63e,41.0,85.0,-31308.0,31308.0,0.0,,614.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-WE-A8K4,False,United Kingdom,46011fbb-b8aa-5763-aa2e-1ae5adf7f5e6,not hispanic or latino,male,white,TCGA-WE-A8K4_demographic,Alive,primary,30b6b3f7-0e11-54b3-b7a7-35f2d79c7108,True,8721/3,Nodular melanoma,No,Skin of upper limb and shoulder,TCGA-WE-A8K4_diagnosis,"Skin, NOS",TCGA-WE-A8K4_treatment8,8536da9f-8452-4668-9096-5fe767ce318a,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.3180722401358976,0.3338364137116149,-0.3421388536901114,0.6236494042859735,0.9202864505323638,1.0889906585124352,-0.7660920881958736,1.754433283864968,0.86670702868705,-1.6071172873253163
ER,4507.0,1.0,e952fd3d-8e99-4199-bbcd-03c9a3430ee2,3813.0,48.0,-17830.0,21956.0,4126.0,4507.0,4507.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-ER-A19W,False,United States,33b669b2-5e42-5819-af63-ae21ddf747fe,not hispanic or latino,female,white,TCGA-ER-A19W_demographic,Dead,metastasis,65c66f9c-f016-4931-a548-07f9fa0b02dc,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-ER-A19W_diagnosis4,"Brain, NOS",TCGA-ER-A19W_treatment6,32dcad53-35e3-4e24-b43b-0fdb9c9cf35f,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0227348034286808,0.4067671852693132,-0.1736573957955156,0.4763624913862081,0.7999502466697713,1.5424042253407182,0.3474888816327975,3.032658399609008,0.3041183088129533,-0.6146234432196962
D3,1812.0,0.0,e9a42a85-9513-41b2-a71d-6d62f70b00e4,14.0,37.0,-13552.0,13779.0,227.0,,1812.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A2JP,False,United States,56540a23-b233-52a8-a0b5-3b7ba71e31e9,not hispanic or latino,male,white,TCGA-D3-A2JP_demographic,Alive,metastasis,1ed5149a-a09c-4605-b3b2-aae883b25ecf,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A2JP_diagnosis2,Liver,TCGA-D3-A2JP_treatment6,79afa2bd-1c8d-4e8d-abb1-e769583d14b0,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.5947083546903629,-0.3510728427817017,-0.1197923590578218,0.0201083219962071,0.1717751902433347,0.1348595799478848,-0.5303227939990229,0.0865018828327962,-1.0129751339061566,-0.3453796450311839
D3,723.0,1.0,e9e615a1-9323-49d3-904c-fcf4887fea61,69.0,75.0,-27428.0,27979.0,551.0,723.0,723.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A2J9,False,United States,4e1cc994-4918-53ad-a94d-06d7c382539c,not hispanic or latino,male,white,TCGA-D3-A2J9_demographic,Dead,metastasis,02772d77-7069-438a-a37a-e6a58309539d,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A2J9_diagnosis8,"Peritoneum, NOS",TCGA-D3-A2J9_treatment19,21e53e19-0da8-44db-9317-582f2a8768b1,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1139842800707341,-0.7713438913671486,0.3071521481160044,-0.1700583989979558,1.7911199004903058,1.4075952632511053,0.3445004761687535,0.4194269129793546,0.4088103516957546,-0.0180356939084729
BF,769.0,0.0,e9f0f030-d9aa-47c8-9f4d-a9ce58888c41,-4.0,84.0,-30805.0,30805.0,0.0,,769.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-A3DL,False,Russia,36c19780-7635-5f77-812e-7fe120cbaa83,not hispanic or latino,female,white,TCGA-BF-A3DL_demographic,Alive,primary,d002affd-c9f2-5172-bec3-eb51a292ff6b,True,8720/3,"Malignant melanoma, NOS",No,"Skin, NOS",TCGA-BF-A3DL_diagnosis,"Skin, NOS",TCGA-BF-A3DL_treatment5,360cb249-3289-4428-b904-27571a7fcdca,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.4571568444800648,0.3242532973952505,-2.088027784300244,0.3780223224825121,-0.3824319753162615,-0.1144071017046945,-0.7718690299053337,-0.9162982079713456,0.4280252427699068,0.864563396695617
ER,1544.0,1.0,ea240769-e51c-45f5-a131-ba123e598622,341.0,45.0,-16540.0,16916.0,376.0,1544.0,1544.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-ER-A198,False,United States,e4293e2e-5510-5eb2-8283-91449e0d15ca,not hispanic or latino,male,white,TCGA-ER-A198_demographic,Dead,primary,255e1177-7fa3-4554-a752-ca9656527bf9,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-ER-A198_diagnosis3,"Skin, NOS",TCGA-ER-A198_treatment5,bbb0f48f-7dd4-4185-ad36-17804c983010,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.6716976486010188,1.0425341390398364,0.4068925425661076,0.2340033534370296,0.1799020881695615,0.5933582748603577,0.1806042716465958,1.4479582561134727,1.2698703795883373,-2.01409032723599
ER,426.0,1.0,ea3c0988-17c7-4eb0-a1a6-cef1e0865384,84.0,76.0,-28110.0,28369.0,259.0,426.0,426.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Anus and anal canal,TCGA-ER-A42H,False,United States,aabe7f25-3e94-559a-8078-c3e3ff8376d0,not hispanic or latino,male,white,TCGA-ER-A42H_demographic,Dead,not reported,3fa67678-1ed9-4122-aba8-97ac8d62e30a,False,Not Reported,Not Reported,Yes,Not Reported,TCGA-ER-A42H_diagnosis4,Not Reported,TCGA-ER-A42H_treatment5,83953e25-5fb4-48df-bfd0-79b6124d93f5,yes,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4629495762475715,-0.1581392732505772,0.3427942892881723,0.4483988844801736,-1.1455650125052137,-1.429098039598082,-0.260631548338736,-1.224354485866023,-0.1853373710940685,1.242479440364073
FR,583.0,0.0,ea6337b3-3b5e-489e-ae2f-2908447f6300,7.0,54.0,-19936.0,20000.0,64.0,,583.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-FR-A728,False,United States,fcb32fd5-df66-5e88-900e-6625a0c4f629,not hispanic or latino,female,white,TCGA-FR-A728_demographic,Alive,not reported,1fbd9979-cb28-5770-8777-7983ff806729,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-FR-A728_diagnosis,"Skin, NOS",TCGA-FR-A728_treatment3,418c8145-6368-4b34-85fc-77ae37df439d,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.2076361596510035,0.4117856935081615,-0.0122008452107777,0.1502321243988011,1.2095961301137157,1.1623645036172634,-0.3414792699487642,-0.3964981609031431,0.5514663611856678,-1.1263445799835186
GN,1807.0,1.0,ec4c4296-6ab4-420c-80a4-e7a34b9bf4a2,20.0,59.0,-21851.0,23538.0,1687.0,1807.0,1807.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-GN-A9SD,False,United States,f18880ee-e36f-5342-be0e-fd57eb65309a,not hispanic or latino,female,white,TCGA-GN-A9SD_demographic,Dead,metastasis,15611e96-cc31-44ee-8df0-6587bca71c10,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-GN-A9SD_diagnosis6,"Lung, NOS",TCGA-GN-A9SD_treatment16,5e517c31-2d84-4215-84e2-df4bde776dc7,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0388229470818931,-0.7505279148688703,0.1128559980013113,0.3577450800039504,0.5791428046815054,0.4231792287599767,0.1544463766986039,-0.4907981694420644,-0.1210548264096352,-0.0024729991552874
GF,591.0,0.0,ec4cc744-04df-4ba9-9159-e4940c702281,22.0,74.0,-27114.0,27114.0,0.0,,591.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-GF-A4EO,False,United States,c8f783de-1eb5-5ffc-879e-ddf0eefc0e2a,not hispanic or latino,female,white,TCGA-GF-A4EO_demographic,Alive,Progression,51003a25-7a05-5ea7-94b5-fc14ec15e14f,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-GF-A4EO_diagnosis,"Skin, NOS",TCGA-GF-A4EO_treatment3,1adc2e10-1e11-4134-8724-ff06cdc065ba,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4705436457695254,-0.260697904936862,0.2395790839969543,0.1503369137972243,0.9374364103958036,1.3517565446589863,-0.1291979669783853,0.7108081893640987,-1.101480086732552,-0.4366388283948755
W3,6940.0,0.0,ed471051-41dc-404c-87ec-db4a281ecfb5,1461.0,63.0,-23131.0,30071.0,6940.0,,6940.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-W3-A824,False,United States,015f320f-7b44-5233-9604-132611cb61d9,not hispanic or latino,male,white,TCGA-W3-A824_demographic,Alive,Progression,29f11755-8917-49eb-82fc-39463b32b86d,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-W3-A824_diagnosis2,"Skin, NOS",TCGA-W3-A824_treatment5,5a2cc8a5-cbea-48bc-8437-efcc4bb74cf7,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.749658220654508,0.4927987398186702,-0.3278315772905333,0.5188203514400914,0.8899833478225728,0.8757939891052263,-0.2674943224488279,-0.5405356739458264,-0.0946197944470142,-0.2777336676614368
EB,360.0,0.0,ee08eda6-033e-403b-a26a-747b118ae897,-6.0,66.0,-24263.0,24401.0,138.0,,360.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A85J,False,Ukraine,d83cd4bd-e640-5190-904d-3e9f824b13cb,not hispanic or latino,female,white,TCGA-EB-A85J_demographic,Alive,primary,35af533b-5a2c-4e34-abf6-d6feea9f1bf7,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A85J_diagnosis2,"Skin, NOS",TCGA-EB-A85J_treatment4,2e8fe41c-36ea-4b38-b33d-dba3754c0155,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.2020256075478612,0.2126367906184437,0.1480243256644951,0.293921845750669,1.1203903574168024,0.6976547411950512,-0.2514285210709156,0.4425706650750347,0.0260264307215977,0.0156021242561329
EB,0.0,0.0,ee143e06-0334-45dd-a2b0-1169527d6b4e,0.0,89.0,-32872.0,32872.0,0.0,,0.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A41A,True,Ukraine,c35fb99a-e094-5a73-9c37-bd7632e16f8b,not hispanic or latino,male,white,TCGA-EB-A41A_demographic,Alive,primary,5a9cbee1-c878-4757-95e2-f49b07cde76d,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A41A_diagnosis2,"Skin, NOS",TCGA-EB-A41A_treatment3,77e5954d-8cd3-435e-ab3c-224d1d4903b3,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.0293071564486965,0.2882887034866925,-0.2354224018822908,0.3651854258956999,-0.424485395054814,-0.8666853170683743,-0.9766306661762542,-0.4629106669168357,-0.3304389121752378,0.3214746247260049
EB,441.0,0.0,eea5ea8b-6579-44c2-a205-47befe82ee9f,3.0,49.0,-18157.0,18157.0,0.0,,441.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A42Z,False,Vietnam,c6c34020-8073-5073-8ddb-058d074d9795,not hispanic or latino,male,asian,TCGA-EB-A42Z_demographic,Alive,primary,28622f83-3d26-4594-a7c2-381bb74d2896,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A42Z_diagnosis2,"Skin, NOS",TCGA-EB-A42Z_treatment,0e25951e-e2ee-5bf0-85c8-7c45a36a37b1,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.5302462904044031,-0.4939496401709242,-0.7484552979478906,0.1439693092678413,0.0336946604750195,-0.4981807762758699,-0.6193498932836191,-0.5714419267444052,-0.5641618599680981,0.5159050017686839
BF,490.0,0.0,ef40fa3d-807b-47c1-9f77-58e9778ce391,-1.0,76.0,-28092.0,28092.0,0.0,,490.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-A5ES,False,Russia,348947a1-be09-597f-96ea-b518817c5b2f,not hispanic or latino,female,white,TCGA-BF-A5ES_demographic,Alive,primary,5cd1caff-dbe1-5d51-b792-39f6c38cab1e,True,8720/3,"Malignant melanoma, NOS",No,Skin of trunk,TCGA-BF-A5ES_diagnosis,"Skin, NOS",TCGA-BF-A5ES_treatment2,495ed004-374f-4f90-adeb-bd81443082ac,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.1021981626917881,0.1378254598846909,-0.1682477710909872,0.5597127615954255,1.0033648227668506,-0.2630373183765747,-0.3025295887323581,0.4159769126669528,0.619824791855528,1.394453413088484
EE,425.0,1.0,ef608754-3f87-458e-9bcf-4434c54c8c9e,93.0,87.0,-31790.0,31876.0,86.0,425.0,425.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A29D,False,Australia,1d16d83f-7d6c-5326-9d94-a023311318b1,not hispanic or latino,male,white,TCGA-EE-A29D_demographic,Dead,Progression,449fcd8b-f48b-4767-9977-4c69b490d18c,True,8720/3,"Malignant melanoma, NOS",No,"Lymph nodes of head, face and neck",TCGA-EE-A29D_diagnosis2,"Skin, NOS",TCGA-EE-A29D_treatment5,217958b4-b3fc-4fbb-917e-c7c91484aa69,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.6495832085510036,-0.1286053042536953,0.519905948503062,0.3937291022932189,-1.127385293784697,-0.5737907861695636,0.3597050878300575,0.7691706946488599,1.009130130406368,0.0456539623273999
EB,721.0,1.0,ef7bc188-6aec-467e-801a-ab2109a28104,1.0,73.0,-26712.0,27433.0,721.0,721.0,721.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A42Y,False,Vietnam,57dcaa21-3a4a-54e3-ba1f-da425524ce97,not hispanic or latino,female,asian,TCGA-EB-A42Y_demographic,Dead,primary,748ed0de-f0c5-4e92-9421-a37cfa15f5ab,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A42Y_diagnosis2,"Skin, NOS",TCGA-EB-A42Y_treatment6,b4f4c070-86da-4995-9fc3-e703f658b999,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.4631913969523721,-0.4495466171258209,0.6818862446254129,-0.4562683030941552,-0.2771820379730897,-0.772694919535854,0.1297274459244269,-1.1907169828201265,-0.0509495874603067,1.071614210344927
OD,9061.0,1.0,ef9f1829-0eed-47b3-9d44-06d0a8bb2bfb,8685.0,49.0,-17910.0,26955.0,9045.0,9061.0,9061.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Bronchus and lung,TCGA-OD-A75X,False,United States,6a376220-6f99-5076-9af3-5a375844c526,not hispanic or latino,male,white,TCGA-OD-A75X_demographic,Dead,primary,1e9730c8-121f-4dcd-9ad6-8784571b65be,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-OD-A75X_diagnosis3,"Skin, NOS",TCGA-OD-A75X_treatment3,548d3545-379d-4108-a9a0-2a9514e05a3d,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.9603985919845804,-0.2553300324238787,-0.1618431686425027,0.4922605442640358,0.2734825170017463,-0.2794370141856148,1.1002349674213214,0.8873332053485453,0.3915751766716681,-0.2311825062364954
BF,14.0,0.0,eff78af6-0f68-49b9-866b-0d511606f2b1,1.0,74.0,-27124.0,27124.0,0.0,,14.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-BF-A1PV,False,Russia,e250d944-db38-50fc-847f-45fddca70ed3,Unknown,female,white,TCGA-BF-A1PV_demographic,Alive,primary,c4aea89b-95ed-58e1-8249-c9f75bfb7e33,True,8720/3,"Malignant melanoma, NOS",No,"Skin, NOS",TCGA-BF-A1PV_diagnosis,"Skin, NOS",TCGA-BF-A1PV_treatment,2f506c3b-d157-552f-89ea-c2c604491cc6,unknown,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.6448540941408766,0.3572820608976044,0.1214175315886161,0.1885384924286107,-2.066674205787387,-1.2895108550706624,-0.7160683136490842,-0.0671668810820029,0.4465414105322713,-0.6725735047137724
FR,2828.0,0.0,f027da44-6adc-4207-93ac-e8bf45a1bf3d,2278.0,44.0,-16278.0,18546.0,2268.0,,2828.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FR-A3YN,False,United States,0d7a9eda-ff71-5fb6-8372-7594a91555d0,not hispanic or latino,male,white,TCGA-FR-A3YN_demographic,Alive,primary,5b1e506b-571d-4710-bc48-ce86695253de,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-FR-A3YN_diagnosis3,"Skin, NOS",TCGA-FR-A3YN_treatment3,5063fa10-a20a-42d4-9e7e-c23fd0b93eaf,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.7036917902677752,-0.6991625890200308,-0.3184302195201945,0.3888038080108826,0.8413529757705543,0.5812501307559882,0.1485899001209742,0.6770269363051884,0.674558117945536,0.4506411736331444
D9,551.0,0.0,f0744fa2-db4a-40de-9fd2-f61863fd98d4,0.0,63.0,-23171.0,23171.0,0.0,,551.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-D9-A1X3,False,Poland,d38c79e7-a978-5d63-81f4-1bf9d1cff587,not hispanic or latino,male,white,TCGA-D9-A1X3_demographic,Alive,Progression,9880da50-53ed-41c9-b6c8-a5972ae1a553,True,8720/3,"Malignant melanoma, NOS",Unknown,"Skin, NOS",TCGA-D9-A1X3_diagnosis2,"Skin, NOS",TCGA-D9-A1X3_treatment4,3636fc5d-bf62-49ab-8b3f-f485d51fe684,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.9337766204294692,1.2065368285756244,0.9496165418133442,0.8293180009772916,-1.1990487724396752,-1.4920307811969966,0.1255780099587999,-0.3989419111244255,0.7935739887199772,-0.2145750224568793
EE,1265.0,1.0,f09f3062-f904-4aff-9cd6-38eed201e652,224.0,25.0,-9161.0,9916.0,755.0,1265.0,1265.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-EE-A3AG,False,Australia,04933fc2-18a2-5dad-aa5b-dd4f3c346f36,not hispanic or latino,male,white,TCGA-EE-A3AG_demographic,Dead,Subsequent Primary,105809de-33e4-4248-b9ec-0b8a9c5a7193,False,9863/3,"Chronic myeloid leukemia, NOS",Yes,Not Reported,TCGA-EE-A3AG_diagnosis9,Not Reported,TCGA-EE-A3AG_treatment6,1537d12e-8ab3-4c66-9ac2-af86f5c959a6,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4625759674239996,0.0753616661791283,-1.0121980128706636,-1.529240237637556,-2.1213202701710543,-0.979298627828848,-0.0937033473194888,-1.4496107562631098,-0.7557285012831241,-0.3457830991797166
WE,1089.0,0.0,f11b1e99-c14f-442e-acab-6353a5c77266,26.0,45.0,-16736.0,17062.0,326.0,,1089.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-WE-A8ZX,False,United Kingdom,2f966d95-e9ea-5a26-9c2f-e8d4aafeaa68,not hispanic or latino,male,white,TCGA-WE-A8ZX_demographic,Alive,Progression,53ba7e33-5451-48ed-86bd-dbc593cee492,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-WE-A8ZX_diagnosis2,"Skin, NOS",TCGA-WE-A8ZX_treatment4,26b854d6-d3fd-41d0-b81a-d4eb4e56c561,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4123135792661049,-0.8602592876222372,0.0085554177287939,0.3861396906944507,-0.0229154830810461,0.5336561330627868,-0.5839259245133661,0.4488956656477652,-1.694696178439994,-0.1016167848682144
YG,439.0,0.0,f1713c39-26b8-4667-a08b-f8cf6d2b8e13,294.0,63.0,-23219.0,23515.0,296.0,,439.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-YG-AA3P,False,Puerto Rico,8f4fe752-e2bf-5442-8d61-87177e874b1a,hispanic or latino,female,Unknown,TCGA-YG-AA3P_demographic,Alive,not reported,09156d71-55b6-5eb0-8b08-021a6083bfd7,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-YG-AA3P_diagnosis,"Skin, NOS",TCGA-YG-AA3P_treatment,0cdf4d9a-a93c-55be-8a39-782cc95c4437,yes,Immunotherapy (Including Vaccines),0.0,0.0,0.0,1.0,0.0,0.0,0.0,Metastatic,-0.6223087197087819,-0.3134541306039436,1.2164025230001982,0.5452654878435046,-1.3489475522741137,-1.3635248505563695,-0.1824813288105115,-3.038048400097076,-1.3165704128777522,1.1111229169716288
EE,1665.0,0.0,f18cfe4a-fffd-4e09-9eef-343ba9ffd0d1,1191.0,46.0,-16879.0,18377.0,1498.0,,1665.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A2GK,False,Australia,a02673f8-52b1-58c2-b932-6cc65a27766d,not hispanic or latino,female,white,TCGA-EE-A2GK_demographic,Alive,not reported,040d707a-9b23-5dda-b35d-44bce7d7ef9b,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-EE-A2GK_diagnosis,"Skin, NOS",TCGA-EE-A2GK_treatment2,9ec34296-7efa-425e-b93b-3439fb80eec5,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.1536179734650359,-0.8361847905291836,1.0925206265752,-1.593462207436651,0.442175791988519,0.9510905411498124,0.6027242757745768,-1.2183169853193223,-1.6205150535052386,-0.0946222114001001
FR,368.0,1.0,f1a69042-8347-45c1-b925-8526a8443b86,,49.0,-18122.0,18438.0,316.0,368.0,368.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-FR-A2OS,False,United States,2f8927c5-a5ba-5af2-8b04-2331094016ff,not reported,female,white,TCGA-FR-A2OS_demographic,Dead,metastasis,56ac769b-f5de-48e8-bc38-89d6cc85e7c1,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-FR-A2OS_diagnosis4,Skin of scalp and neck,TCGA-FR-A2OS_treatment10,0be386db-ea0d-4b5f-b06c-82647cfcedd4,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.4536556157441541,0.0044109180482782,0.6619590744800269,0.3710156582900142,-1.4180106192433437,-1.338131236591566,0.1218928909367554,-1.3399294963314072,0.0207860058831925,0.6463365432947109
WE,1794.0,0.0,f311877d-021a-423b-a6f5-e574c9a3ca7c,1092.0,57.0,-20942.0,22547.0,1605.0,,1794.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-WE-A8ZN,False,United Kingdom,0199b88d-0020-5146-a687-870703fcb943,not hispanic or latino,male,not reported,TCGA-WE-A8ZN_demographic,Alive,metastasis,453e07ce-8fc4-456a-a77b-21817f2e53f3,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-WE-A8ZN_diagnosis6,"Skin, NOS",TCGA-WE-A8ZN_treatment11,05c7c5cf-012e-4377-a1bf-988b57cc3959,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.2623437715788857,0.3432880968589462,-0.1507016885985748,0.1375819818225019,1.0121181762150435,0.7197321632103421,-0.4470888552216981,-0.7108794393705536,-1.67175476303631,0.5401890616182938
FS,237.0,1.0,f3bb6362-6801-4c95-a828-09c0002a8b87,,19.0,-7293.0,7429.0,136.0,237.0,237.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A1Z7,False,Germany,e64466fb-d37b-58d8-9ad9-5f29097aef54,not hispanic or latino,male,white,TCGA-FS-A1Z7_demographic,Dead,metastasis,02bb640f-70c3-44eb-bcd8-53da859e49d3,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-FS-A1Z7_diagnosis4,"Lung, NOS",TCGA-FS-A1Z7_treatment,49840acb-22f3-5356-ba82-974650396f07,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.0665865643212789,-0.418237119768002,0.0819983401161221,0.378931388958541,-0.5327761692961122,-0.837653142526158,1.2252535404135456,0.3344706552865141,0.3816765964213479,0.9870526159482832
ER,1505.0,0.0,f405c603-bcbc-434f-b620-c32eb27b215b,56.0,81.0,-29603.0,29639.0,36.0,,1505.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-ER-A19S,False,United States,a9fbb7f8-eb2c-55dd-bd2c-66d27bbbb9c0,not hispanic or latino,female,white,TCGA-ER-A19S_demographic,Alive,not reported,b6dc6b55-9beb-57fd-bf5b-5085748b6dcf,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-ER-A19S_diagnosis,"Skin, NOS",TCGA-ER-A19S_treatment2,57453649-e918-4dc4-b1b1-b3735a37de14,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.0489476087702279,-0.683806080996711,0.467481780075212,0.1060854915563215,1.6398297186424624,1.5285187546935388,-0.1862964129143864,0.2454893972292092,0.1788139282324263,0.2842349749377252
D9,216.0,1.0,f505058f-74f2-4476-887f-06590a605980,124.0,80.0,-29323.0,29518.0,195.0,216.0,216.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D9-A1JX,False,Poland,f6ff398b-7241-5d3d-8adc-c138b9b3d156,not hispanic or latino,female,white,TCGA-D9-A1JX_demographic,Dead,metastasis,38777320-3bbf-4a5d-acca-e76ebbb4decf,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D9-A1JX_diagnosis4,Pelvic lymph nodes,TCGA-D9-A1JX_treatment5,7028b70f-0809-45d1-a0d5-087208c48476,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4573955995557058,-0.2757020463920983,-0.3016068438722229,0.5508518009780682,0.8053091617443133,0.5861645543473994,-0.4126439441004265,-0.1025293842840977,0.6481230859829149,0.6039112488375811
FS,295.0,1.0,f52ae9f4-8a61-4ff2-9c24-23f4048d3da6,,60.0,-22252.0,22392.0,140.0,295.0,295.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A1ZG,False,Germany,8833dd01-dd96-5168-bd72-0d6b039305f3,not hispanic or latino,female,white,TCGA-FS-A1ZG_demographic,Dead,primary,09cf8378-622e-57f4-b371-e284addafcc2,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-FS-A1ZG_diagnosis,"Skin, NOS",TCGA-FS-A1ZG_treatment,09ee8d10-afe0-529d-8fe8-9aba9a55c694,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.5282589684718423,0.4629649579597736,0.5395247656293262,0.7125687230642631,-0.8746171196712184,-1.1140266623137254,-0.6821677792962539,-0.0512106296371537,0.965576377304958,-0.9300931571070418
FR,6716.0,0.0,f55914f3-f19a-4d93-b368-554ec1a9cf40,6173.0,38.0,-14043.0,20342.0,6299.0,,6716.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FR-A729,False,United States,10be3422-7dcb-5ee5-a64a-6478c4830ddf,not hispanic or latino,female,white,TCGA-FR-A729_demographic,Alive,primary,51198ced-37e5-4771-b85e-92e1459e94e0,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-FR-A729_diagnosis3,"Skin, NOS",TCGA-FR-A729_treatment3,27b402bf-8fd2-4806-89f7-1da089016833,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2999568139451553,-0.0569306491569084,-0.0083504078231757,0.50673185932543,0.8632154564514679,0.9265877402491842,-0.3353882436168494,-0.332098155071684,-1.5100003163575422,-0.2482139754751252
D3,1378.0,0.0,f581a9b5-8956-4ac3-9375-370c446cad29,572.0,38.0,-14236.0,14725.0,489.0,,1378.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-D3-A3MV,False,United States,3f43779f-444b-580d-b3cd-73fc699e6207,not hispanic or latino,female,white,TCGA-D3-A3MV_demographic,Alive,Progression,58080daa-173f-4bb3-9a9f-8155623f360a,True,8720/3,"Malignant melanoma, NOS",No,"Connective, subcutaneous and other soft tissues of lower limb and hip",TCGA-D3-A3MV_diagnosis2,"Skin, NOS",TCGA-D3-A3MV_treatment5,34226407-514e-48c4-9a08-2f602f672ab6,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4652694248972405,0.6369400317861693,0.3093633148563287,-0.0772616693935742,-1.2276658164313523,-0.7636116988783805,0.4138768732959949,-0.463054416929852,1.5813845227601877,-0.900907875954406
EB,891.0,0.0,f5f42370-9974-4375-b338-5f68bb0c3958,107.0,71.0,-26058.0,26178.0,120.0,,891.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EB-A5UL,False,Ukraine,fe82a2e3-d412-575e-ba60-4ab4adc73202,not hispanic or latino,male,white,TCGA-EB-A5UL_demographic,Alive,primary,4861c049-29fb-405f-a18b-5f360c7d0dd0,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A5UL_diagnosis3,"Skin, NOS",TCGA-EB-A5UL_treatment5,780ec381-03f0-4716-969b-19f1ca43a685,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2706346674378033,0.0599014632918254,-1.0216825968019907,0.3074082242765757,0.4007106778447172,0.6825681760561869,-0.2161201451571028,1.0710457219838203,-0.2977153704065311,0.6738403089695195
EE,4070.0,0.0,f632effd-be12-41ab-8e4f-2a5f38af8bae,2312.0,66.0,-24445.0,26683.0,2238.0,,4070.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EE-A20B,False,Australia,25984bec-4267-509b-8943-2448a7627358,not hispanic or latino,female,white,TCGA-EE-A20B_demographic,Alive,primary,331e91d7-8ff4-4a0b-851f-8334aab52fd3,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A20B_diagnosis3,"Skin, NOS",TCGA-EE-A20B_treatment3,c9fd1242-6699-4f89-ba2f-ef515a362272,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.7325463961177731,0.3246007900171712,-0.1768295552238851,0.0035268426768083,-0.2619339658957074,0.4972932723715604,-0.0301582271278751,-0.145510638176075,0.0153126732741921,-0.5709023730216531
FS,822.0,1.0,f6ff5e77-60d8-4987-9a92-654fd4db81f1,,54.0,-19733.0,20396.0,663.0,822.0,822.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-FS-A1ZZ,False,Germany,be5cd032-4f47-54fd-a730-fef0c7582ec2,hispanic or latino,female,white,TCGA-FS-A1ZZ_demographic,Dead,metastasis,09c9520d-be65-468f-8eb3-17ab33061322,True,8720/3,"Malignant melanoma, NOS",Yes,"Lymph node, NOS",TCGA-FS-A1ZZ_diagnosis2,"Skin, NOS",TCGA-FS-A1ZZ_treatment4,080e3e28-b6bc-484a-afae-f34c006d69cd,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2880003787713303,0.0368647055565473,0.4636077800875024,0.644637826766934,0.3979152850424698,-1.1959659508780307,0.0997076465612229,1.597027019611737,1.399017738383696,-0.7641334958944778
ER,2993.0,1.0,f7368803-c545-4407-9a14-2220560a8f80,2718.0,42.0,-15437.0,17664.0,2227.0,2993.0,2993.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-ER-A19B,False,United States,c7191fd7-5ee1-50d5-aab8-67724ddaa903,not hispanic or latino,male,white,TCGA-ER-A19B_demographic,Dead,not reported,027e16be-a6a1-5669-88c6-02bceccbe083,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-ER-A19B_diagnosis,"Skin, NOS",TCGA-ER-A19B_treatment2,86f9afc4-6bc4-4d02-8cfb-8af90971e65e,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.5058646678283167,-0.2386851004562115,0.2047689978566896,-0.2323983386725567,-1.3259799259047549,0.2427136760907023,0.2920677471628654,1.089445723649952,-1.1237227788244484,0.2513269201477559
ER,1490.0,1.0,f788f950-7953-47a6-b833-f9e5daa28fd3,670.0,43.0,-15903.0,17056.0,1153.0,1490.0,1490.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-ER-A2NG,False,United States,bff1fa6a-befb-582e-942c-0387c62eff3d,not hispanic or latino,female,white,TCGA-ER-A2NG_demographic,Dead,metastasis,0e2a087a-9ca2-4bfa-910a-8ccfc475b1ee,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-ER-A2NG_diagnosis5,"Thorax, NOS",TCGA-ER-A2NG_treatment12,911e78b0-efbe-4d72-94db-62044362378f,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.0298351444557258,0.1103220639766992,0.0575072605211213,0.420554779065078,0.6409272486240164,1.2875547413315949,0.2107423616614188,1.4887832598102029,0.4627285005886772,-0.125719652149809
WE,3082.0,0.0,f8e01148-6fc7-4451-b24a-f3510cd24f9d,2232.0,70.0,-25869.0,28951.0,3082.0,,3082.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-WE-A8ZM,False,United Kingdom,131773ce-709f-5320-a500-de83450e0b0a,not hispanic or latino,male,white,TCGA-WE-A8ZM_demographic,Alive,recurrence,21e3c965-5083-496b-92fd-d309060cc94c,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-WE-A8ZM_diagnosis6,"Connective, subcutaneous and other soft tissues of thorax",TCGA-WE-A8ZM_treatment12,af7f8643-8220-4b66-b12a-2fff05358955,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.5592383842681282,-0.8054454994669941,-0.0236011296464711,-0.1200493023263544,-0.5695739373892682,-0.8350877713793983,1.0677344012103842,-1.9205357989056504,0.7877512944550819,-0.8357590173666591
GF,301.0,0.0,f94ae8f2-d555-4c2a-97b0-dbe7d642c566,19.0,58.0,-21359.0,21607.0,248.0,,301.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-GF-A3OT,False,United States,b28d28df-580a-5d73-90f5-7f691610ab68,not hispanic or latino,female,white,TCGA-GF-A3OT_demographic,Alive,Progression,71753403-9075-5c61-9f3a-9d3c4d4cfbc5,True,8720/3,"Malignant melanoma, NOS",No,Lymph nodes of axilla or arm,TCGA-GF-A3OT_diagnosis,"Skin, NOS",TCGA-GF-A3OT_treatment8,17f9c8d7-73ab-439b-b7f8-6677836907ca,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.4537526627897866,0.2809654786305988,-0.0617302695302554,-3.822469080333687,-0.0636947374240042,0.9776251025713526,0.4115925304361755,0.5186144219608407,-1.3434712603815635,0.4863604505765442
ER,469.0,1.0,f9e36bc2-484f-48e8-82ba-99026957277a,44.0,79.0,-28916.0,29191.0,275.0,469.0,469.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-ER-A19K,False,United States,32ce2f0c-73b5-5f82-a372-cda9382b8b76,not hispanic or latino,female,white,TCGA-ER-A19K_demographic,Dead,not reported,11772c5f-8fcb-55be-be16-9b094c3bb1f9,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-ER-A19K_diagnosis,"Skin, NOS",TCGA-ER-A19K_treatment,bd15be95-7794-5be2-b538-3090586dd682,yes,Chemotherapy,0.0,0.0,1.0,0.0,0.0,0.0,0.0,Primary,0.4573870157033026,0.6610459963289259,0.2358438515217157,0.7028786295612288,1.1284763071555608,0.2528203277674267,0.26974196215905,1.4823145092244534,1.3172671109045788,0.6038498118841479
GN,821.0,1.0,fa099993-ef30-4eff-a8fb-aa41b5ea671a,,77.0,-28336.0,29091.0,755.0,821.0,821.0,TCGA-SKCM,Consent by Death,Nevi and Melanomas,Diagnosis,Skin,TCGA-GN-A26C,False,United States,514c29a6-870a-5b0e-8a6c-22783e69a5a4,not hispanic or latino,male,white,TCGA-GN-A26C_demographic,Dead,primary,1215ac43-d6fb-4c43-a878-1f38528dbaea,True,8772/3,"Spindle cell melanoma, NOS",No,Skin of trunk,TCGA-GN-A26C_diagnosis2,"Skin, NOS",TCGA-GN-A26C_treatment4,03180c4b-8451-4c9c-a229-acec8b3ba353,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.72793206173905,-0.1234553641490228,-0.625812138824949,-2.4749962189714294,1.2672848315188026,1.3360751509705346,-0.2026184202964865,1.1677894807440266,-0.3144847298894271,0.0498821829665558
EB,1109.0,0.0,fb620e8b-4be7-4e53-af04-8e9c27b4dcf0,364.0,55.0,-20172.0,20537.0,365.0,,1109.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EB-A6L9,False,Vietnam,03ebac24-6e9a-5148-81ac-f011f27752c9,not hispanic or latino,male,asian,TCGA-EB-A6L9_demographic,Alive,primary,9dfe65d5-1173-47ae-b7dc-b8be5709ca98,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A6L9_diagnosis3,"Skin, NOS",TCGA-EB-A6L9_treatment,09eed551-c480-5c0d-8dc8-802350659e8c,unknown,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.6714070736654347,-0.5828407866505616,-0.5494111074594074,0.1693404887839477,0.8412384919591034,0.5695655098156333,-0.4285977546273522,-1.0344607186710286,-0.7080988621962873,0.3108249217630578
D3,2765.0,0.0,fbee9fe7-8bed-41a6-bcfe-de9f1bc80d01,27.0,55.0,-20223.0,22776.0,2553.0,,2765.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-D3-A1QA,False,United States,0dfe9b8d-7ac7-54f6-a2de-901583289f88,not hispanic or latino,male,white,TCGA-D3-A1QA_demographic,Alive,primary,0d406e4c-51e5-46aa-bfb0-8b5ac5b01cff,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-D3-A1QA_diagnosis3,"Skin, NOS",TCGA-D3-A1QA_treatment3,a82ed1c6-3e5c-4583-bb15-19c31aa7004e,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.944724777260135,-0.0203086725167122,-1.3721925109795772,0.6242274621260512,-0.1245325973631999,0.0733809928291464,-0.0560630271066534,1.4907957599924335,1.0671241652847154,0.0573408766968125
EE,2402.0,1.0,fc5b5d2f-0d03-45c2-b7a0-ba6ec108fe51,308.0,20.0,-7510.0,9722.0,2212.0,2402.0,2402.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EE-A29C,False,Australia,93d520e6-6577-5276-94e2-ed39c8b10e01,not hispanic or latino,male,white,TCGA-EE-A29C_demographic,Dead,primary,33c37133-2f97-4557-ad21-3998476b158b,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EE-A29C_diagnosis3,"Skin, NOS",TCGA-EE-A29C_treatment7,5fc96033-6d92-42f7-9a85-eb4b29fdec39,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,-0.2473457713128095,-0.7225832468327322,-0.0403765758001314,0.1505073661288514,-0.8986710576098212,-0.2838507043957734,0.24561024303021,0.0136206262333542,1.493461839360282,1.0563313249935828
EE,1716.0,0.0,fd1a49f2-fb3b-481d-888e-f4224d59f6d1,1429.0,73.0,-26899.0,28567.0,1668.0,,1716.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Lymph nodes,TCGA-EE-A29P,False,Australia,b204fd82-a13c-5ffc-aa96-7372248bab48,not hispanic or latino,female,white,TCGA-EE-A29P_demographic,Alive,metastasis,61bcf21b-3f56-4f0c-8ca6-d8e7d2a254ad,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-EE-A29P_diagnosis4,"Lung, NOS",TCGA-EE-A29P_treatment6,5c0acff7-4147-4827-b74f-06bd700904b5,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-0.078530652465565,-0.0467924429799788,0.5989009358586816,0.412927349607586,2.0478644396361005,0.9558115685627024,0.2440664084292361,0.3067269027743017,0.0493172077811747,0.3373055074926459
EB,401.0,1.0,fda160c9-efdc-4263-98f1-e38b00571b4d,-1.0,73.0,-26965.0,27332.0,367.0,401.0,401.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-EB-A5SE,False,Russia,70448ac0-81b3-574d-854c-d5f2df375a8d,not hispanic or latino,male,white,TCGA-EB-A5SE_demographic,Dead,primary,7f24cca1-26ed-48c7-9d15-6671632ddf82,False,Not Reported,"Malignant melanoma, NOS",Unknown,Not Reported,TCGA-EB-A5SE_diagnosis2,"Skin, NOS",TCGA-EB-A5SE_treatment3,e1fa91d1-d12d-4c19-85ca-81e5e0bbfd55,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Primary,0.5387613511836016,0.475231672219651,-0.739596490107269,0.6525636735479884,-0.335428066647187,-0.7531122574304487,0.354241488836107,0.8581519527061647,-0.0536280268221581,0.0769509920764202
D9,190.0,1.0,fdbbdbf8-cf2e-4550-9727-b023aed9b8d9,0.0,50.0,-18462.0,18542.0,80.0,190.0,190.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Skin,TCGA-D9-A4Z2,False,Poland,87daf097-b18a-515f-9352-36dec62604d8,not hispanic or latino,male,white,TCGA-D9-A4Z2_demographic,Dead,primary,5d74b015-5155-511b-bde4-74a19d6b142f,False,8720/3,"Malignant melanoma, NOS",No,Not Reported,TCGA-D9-A4Z2_diagnosis,"Skin, NOS",TCGA-D9-A4Z2_treatment,d2c15dc0-df0e-524d-a30c-5079c3af9a07,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Primary,0.1976010704805349,-0.2498059812726011,-0.5645233189634989,0.4201333070407532,-1.5058319784787366,-1.1108733099478254,0.1354096472056288,-1.0764357224718917,-0.1874335410294297,-0.8484853787708837
D3,3943.0,1.0,fe1ec057-f8d0-4155-925a-5b5ea0c11cc4,1756.0,54.0,-19973.0,23748.0,3775.0,3943.0,3943.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Small intestine,TCGA-D3-A8GR,False,United States,786dae70-6d25-522f-bab1-1b6e3721bcca,not hispanic or latino,female,white,TCGA-D3-A8GR_demographic,Dead,metastasis,3427abf2-dcd4-4e7f-8aa0-64dddc3b039b,False,8720/3,"Malignant melanoma, NOS",Yes,Not Reported,TCGA-D3-A8GR_diagnosis6,Liver,TCGA-D3-A8GR_treatment12,319760b8-fbba-4794-ace7-c27f050b44ba,no,"Pharmaceutical Therapy, NOS",1.0,0.0,0.0,0.0,0.0,0.0,0.0,Metastatic,-1.280806660385187,-0.7228391207126895,0.1139279344858928,0.2964373905499128,0.6150209564450453,-0.7132087345998944,-0.7765119375496509,-0.4056981617362102,-0.9419382638744452,-2.159501080193757
ER,4930.0,1.0,fecff768-2cf4-487f-8ea4-c24a947330b7,4743.0,47.0,-17511.0,21863.0,4352.0,4930.0,4930.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,"Connective, subcutaneous and other soft tissues",TCGA-ER-A19P,False,United States,a74f5d99-1205-5f08-81bf-20afeba36acd,not hispanic or latino,female,white,TCGA-ER-A19P_demographic,Dead,Progression,537dd749-91f7-4ec6-923d-5e18bbf4da61,True,8720/3,"Malignant melanoma, NOS",No,"Connective, subcutaneous and other soft tissues of pelvis",TCGA-ER-A19P_diagnosis2,"Skin, NOS",TCGA-ER-A19P_treatment4,3b3af016-b569-4b3c-af73-72f4bb1dce74,no,"Radiation Therapy, NOS",0.0,1.0,0.0,0.0,0.0,0.0,0.0,Metastatic,0.2111661455612596,-0.3073056016525273,0.8446840746987455,0.0624080511317333,1.6411608572177805,1.4570631614953766,0.1286205892186431,-0.6023481795429841,-0.3220542324337888,-0.0483453508200544
D9,4609.0,0.0,fed23055-1600-4128-8d73-e1aa902a9d1d,4020.0,40.0,-14805.0,19169.0,4364.0,,4609.0,TCGA-SKCM,Informed Consent,Nevi and Melanomas,Diagnosis,Breast,TCGA-D9-A148,False,Poland,a3212c16-4dd7-5431-8763-51b647e2132f,not hispanic or latino,male,white,TCGA-D9-A148_demographic,Alive,Progression,31a40a5f-bb1f-432a-a35a-6eabe48dff9a,True,8720/3,"Malignant melanoma, NOS",Yes,"Breast, NOS",TCGA-D9-A148_diagnosis2,"Skin, NOS",TCGA-D9-A148_treatment4,ed477acc-d2f3-4078-b5d5-a714624decc6,yes,Immunotherapy (Including Vaccines),0.0,0.0,0.0,1.0,0.0,0.0,0.0,Metastatic,0.4961287608665811,0.6262643416379727,0.0653381756404064,0.5023782197904324,0.0384949150411382,0.4500890296061177,-0.0550044614910161,-0.2881106510885899,1.5700884958862935,-0.5843102754605488
